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Abstract
A breathing therapy is a technique (invasive or non-invasive) that improves respiration. Nasal
high flow (NHF) is a relatively new breathing therapy which involves the delivery of humidi-
fied and warmed air via a nasal cannula at a constant flow rate (up to 60 L/min). Conditions
alleviated with NHF include sleep apnea, hypercapnic respiratory failure and hypoxemic
respiratory failure. The proposed mechanisms of action of NHF include improvement in
oxygenation; attenuation of inspiratory resistance; generation of positive airway pressure;
and reduction in work of breathing (WOB) (energy expended by the respiratory muscles
during breathing). This work was motivated by the scarce data on the effect of NHF on
work of breathing and gas exchange. Models of the upper airways of an adult and neonate
were 3D printed. A physiologically realistic breathing flow was driven through the models
(with a piston pump) along with the recording of tracheal pressure (with and without NHF).
Airway resistance (with and without NHF) was defined by the coefficients of a quadratic
fit to the tracheal pressure versus breathing flow. This work is the first to estimate airway
resistance under NHF conditions in this way. In the adult model, with and without NHF,
tracheal pressure during mouth closed breathing was 3 times that of mouth open breathing.
Airway resistance increased in an NHF-dependent manner in both breathing directions (in-
spiration and expiration) and both mouth states of breathing (mouth open and mouth closed).
At peak breathing flows of 30 L/min (for the adult model) and 5 L/min (for the neonate
model), the neonatal airway resistance was found to be 4 times that of the adult model. The
increased pressures generated by mouth closed breathing suggests that the efficacy of NHF
at preventing lung collapse (atelectasis) may be improved via closed mouth breathing. A
viii
mathematical model for WOB (based on the Otis equation, which uses the experimentally
measured airway resistance) was developed by taking into account reported NHF-induced
physiological changes in minute volume and I:E ratio. WOB per minute (rWOB/min) during
NHF was greater than without NHF, if minute volume did not change with NHF. A fall in
minute volume by 40 % reduced rWOB/min by 90 % (at NHF of 60 L/min) compared to
a no NHF condition. NHF can drive part or all of the inspiratory breathing flow across the
upper airway and produce a fall in inspiratory rWOB/min. The rWOB/min for mouth closed
breathing was 3 times that of mouth open breathing assuming equal fall in minute volume.
The adult rWOB/min was found to be 16 times that of the neonate. The effect of NHF on
alveolar CO2 tension was estimated by metering CO2 at a specific rate into the piston pump
chamber and recording tracheal CO2 tension during breathing, with and without NHF. Apnea
was simulated by intermittently stopping the breathing flow for a definite time. End-tidal
CO2 concentration (EtCO2) reduced with NHF and reached a plateau at NHF of 40 L/min.
Compared to breathing without NHF, 40 L/min of NHF reduced the maximum end-tidal CO2
by 18 %, which suggests a lowering of alveolar CO2 tension and rWOB/min (via attenuation
of hyperventilation). It is speculated that NHF may ameliorate the frequency of apnea per
hour. A two compartment (lung and dead space) mathematical model of the respiratory sys-
tem was developed to predict EtCO2 tension during apnea under NHF conditions. The model
assumed a sinusoidal breathing flow, constant metabolic CO2 production, instantaneous gas
mixing and flushing of the nasopharynx by 3 % of NHF. Apnea was modelled by making
the breathing flow zero over a definite time. The model capnogram and EtCO2 for apnea,
spontaneous breathing and NHF matched those of the bench-top experiment. The EtCO2 at
NHF of 30 L/min differed from that of experiment by 0.9 % (V/V).
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Chapter 1
Introduction
For inspiration to occur, the diaphragm and intercostal muscles contract to create a greater
intrathoracic volume thereby reducing the pressure in the lungs relative to the airway opening
(mouth or nostril). This pressure gradient drives inspiration and carries oxygen into the
lung’s blood-gas interface where pulmonary blood absorbs the oxygen and gives up carbon
dioxide. The mechanical work done by the diaphragm and intercostal muscles together
is called mechanical work of breathing (Otis et al. (1950)). There is also some amount
of metabolic energy expended in warming the inspired air to normothermia (37 °C) and
humidifying it to 100 % relative humidity (Rouadi et al. (1999)) – this constitutes thermal
work of breathing. Though work of breathing constitutes a small percentage of the metabolic
energy, the respiratory control center changes breathing pattern to minimize this energy
(Fincham and Tehrani (1983)). In this study, mechanical work of breathing will be used
synonymously with work of breathing.
Respiratory failure results when respiratory injuries or diseases cause the respiratory
system to become ineffective at delivering oxygen to the cells (hypoxemic respiratory failure)
or expelling carbon dioxide from the lungs (hypercapnic respiratory failure). Consequently,
respiratory assistance such as low flow oxygen therapy (administered gas flow rate is less
than inspiratory demand) (Cairo (1999)), humidified nasal high flow therapy (flow matches
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inspiratory demand), continuous positive airway pressure (boosting airway pressure to keep
airway open) or mechanical ventilation (device provides part or all the energy required
for breathing) may be recommended to the patient. Major indications necessitating the
use of a mechanical ventilator include acute respiratory failure, exacerbation of chronic
obstructive pulmonary disease (COPD), coma and neuromuscular disorder (Esteban et al.
(2000)) whilst those for continuous positive airway pressure (CPAP) therapy include post-
operative pulmonary complications, atelectasis (collapsed alveoli), obstructive sleep apnea
(collapse of airway during sleep) and pneumonia (Ferreyra et al. (2008)).
Nasal high flow (NHF) therapy is a relatively new therapeutic modality involving the
administration of humidified and warmed air at constant flows up to 60 L/min for adults
(Ward (2013)) and 8 L/min for neonates (Manley et al. (2013); Motojima et al. (2016);
Ojha et al. (2013)). NHF is delivered via a nasal cannula with nasal prongs that inserts
into the nostril without sealing it. NHF is applied continuously and not synchronized with
inhalation or exhalation. Since the commencement of its use in the early 2000s amongst the
neonatal population, it has seen a broad application and success even in the adult population.
Some medical conditions for which NHF is applied include hypoxemic respiratory failure,
obstructive sleep apnoea and acute heart failure (Kernick and Magarey (2010); Nishimura
(2015)).
In spite of the reported potential and clinical successes of NHF, its mechanisms of actions
are not wholly understood (Dysart et al. (2009)). See section 1.4 for a fuller description of
the mechanisms of action of NHF. The reports on clinical trials, bench-top and computational
modelling involving NHF over half a decade now have lent a good support to the generation
of postive airway pressure (Kubicka et al. (2008); Kumar et al. (2015); Locke et al. (1993);
McGinley et al. (2007)) and improvement in oxygenation (Frizzola et al. (2011); Maggiore
et al. (2014); Roca et al. (2010)).
The motivation for this thesis has been the absence of quantitative data on the extent
to which NHF affects work of breathing coupled with the absence of a predictive tool for
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estimating the degree to which CO2 is cleared from the airway upon the administration
of NHF. Accordingly, this thesis aims at examining the physical influence of NHF on the
mechanical aspects of breathing followed by a quantitative assessment of these effects
on metabolic energy cost. These ends have been achieved via in vitro and mathematical
modelling.
1.1 Anatomy and Physiology of the Respiratory System
The ventilatory system of humans has two sections i.e. the upper and lower respiratory tracts.
The nasal cavity, nasopharynx, oropharynx, hypopharynx (laryngopharynx) and the trachea
constitute the upper airway (Fig. 1.1). The trachea divides into two major branches known
as bronchi, which further divides into smaller units called bronchioles (Fig. 1.2). There
are about twenty-three generations of division from the trachea up to the sac-like structures
known as alveoli (Fig. 1.2) (West (2012)).
The lower respiratory tract is subdivided into three zones namely the conductive zone,
transition zone and respiratory zone. The bronchi plus the next fifteen generations of
the bronchioles form the conducting zone. The seventeenth generation to the nineteenth
generation mark the transition zone, which consist of respiratory bronchioles that possess
anatomic features to engage in substantial gaseous exchange. Finally, the last four generations
constitute the respiratory zone - the first three being alveolar ducts and the very last generation
being alveolar sacs (Fig. 1.2). There are about 300 to 500 million alveoli in the human lungs
having a combined surface area in the range of 50 - 100 square meters (approximately equal
to one-half the size of a tennis court) (Tsuda et al. (2008); West (2012)). The alveolar wall
is replete with a network of pulmonary capillaries (7 - 10 µm in diameter). The blood-gas
barrier is approximately 0.3 µm thick (West (2012)). Gaseous exchange across the blood-gas
interface is significantly enhanced by the large surface area of the alveoli and the very thin
epithelia lining it. A lipoprotein complex, surfactant, secreted by type II cells lining the
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Fig. 1.1 Upper airway (adapted from http://www.pittsburghdentalsleepmedicine.com)
Fig. 1.2 Lower airway generations (adapted from http://users.atw.hu)
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alveoli maintains stability of the millions of alveoli by preventing them from completely
collapsing. The hydrophilic heads of the lipoprotein complex are radially oriented and
bonded to the inner lining of the alveoli, with the hydrophobic tails repelling each other
(Johansson et al. (1994); West (2012)). The elastic recoil of the alveoli is opposed by this
repulsive force and this serves to reduce respiratory effort as a relatively small amount of
work is required to inflate the alveolar sac in this condition. To further enhance efficiency of
gaseous exchange, each red blood cell has a residence time of 0.75 seconds and traverses
about three alveoli before exiting the capillary network (Johansson et al. (1994)).
Together, the alveoli, conducting airways and associated blood vessels comprise the lungs.
The lungs are encased in a thin two-layer membrane (pulmonary pleurae) envelope which
forms the pleural space (Fig. 1.3). The right lung is compartmentalized into three lobes
whilst the left is made up of two lobes as shown in Fig. 1.3. Total lung capacity, defined as
the volume of air that the lungs can be filled with, varies with body size but has an average
value of 7 litres for healthy adults (Tobin et al. (1983)).
Fig. 1.3 The lungs (adapted from https://basicmedicalkey.com)
There are five other lung volumes namely tidal volume, inspiratory reserve volume,
expiratory reserve volume, functional residual capacity and residual volume. Tidal volume
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is the volume of air inspired during spontaneous breathing (see Fig. 1.4). The volume of
air that can be further inspired after spontaneous inspiration is called inspiratory reserve
volume. The volume of air remaining in the lungs after spontaneous expiration defines the
functional residual capacity. Following spontaneous expiration, the extra volume of air that
can be expired is known as expiratory reserve volume. The volume of air that remains in
the lung irrespective of how hard one expires is known as the residual volume (Fig. 1.4).
During ventilation, the lungs get periodically inflated and deflated (constituting one cycle)
and the number of cycles per minute is known as respiratory rate. The product of respiratory
rate and tidal volume defines another parameter known as minute ventilation, which is the
total volume of air inspired in a minute. See Fig. 1.4 for the relationships between the lung
volumes.
Fig. 1.4 Lung volumes (adapted from http://www.clevelandclinicmeded.com)
1.1.1 Driving forces in breathing
In respiratory physiology, atmospheric pressure is the conventional datum (i.e. zero) and
alveolar pressure equals the atmospheric at the end of expiration. The pressure within the
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pleural cavity is known as intrapleural pressure and varies with position. For instance, it
may have a value of -5 cmH2O at the apical portions of the lungs and approximately -3
cmH2O at the basal portions. This disparity originates from the pressure exerted by the
weight of the lungs on the basal portions (Galvin et al. (2007); West (2012)). The trans-chest
wall pressure is the differential pressure between the pleural cavity and the outer surface of
the chest (atmosphere) whilst the transmural pressure is the difference in pressure between
alveolar space and the pleural cavity. The intrapleural pressure is driven by intercostal and
diaphragmatic muscular effort, which in turn drives inspiration. At the onset of expiration,
elastic recoil forces generated by the lungs increase alveolar pressure relative to atmospheric
pressure and expels air out of the lungs. Fig. 1.5 shows the variation of intrapleural pressure,
alveolar pressure and lung volume during one cycle of breathing (obtained via mathematical
modelling, Chapter 8 ).
Fig. 1.5 Cycle variation for alveolar pressure, intrapleural pressure and tidal volume
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1.2 Respiratory Diseases
Living organisms survive by metabolizing food substances to release energy. Central to the
metabolic process is oxygen, which is taken from the organism’s surrounding. The process by
which air enters and exits the lungs is known as breathing or ventilation. Respiration refers to
gaseous exchange via a membrane interface. External respiration refers to gaseous exchange
between the air and the blood stream across the alveolar walls whilst internal respiration
refers to gaseous exchange between the blood stream and body cells across the interstitial
spaces. The respiratory system can be impaired by congenital and acquired diseases, which
in some cases markedly reduce its gaseous exchange capability. Disorders of the respiratory
system can be classified according to etiology, severity, duration (chronic or acute), affected
regions, mode of acquisition, etc. Respiratory disorders can loosely be classified into four
categories (Tocris (2017)) namely:
• Obstructive diseases (those that impair expiration) - examples include emphysema,
chronic bronchitis, asthma
• Restrictive diseases (those that impair inspiration) - examples include pulmonary
fibrosis, pleural effusion, sarcoidosis
• Pulmonary vascular diseases: examples include pulmonary edema, pulmonary em-
bolism
• Infectious and occupational diseases: examples include pneumonia, tuberculosis,
asbestosis, byssinosis
The mortality rate and economic impact of COPD and asthma are one motivation for this
work. The present work contributes to the global effort of mitigating the mortality rate of
COPD and asthma. The pathogenesis, prevalence and mortality rate of COPD and asthma
are reviewed in the following subsections.
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1.2.1 Pathophysiology of chronic obstructive respiratory disease
Chronic obstructive pulmonary disease (COPD) is the general term used for chronic bronchitis
and emphysema. Inflammatory cells in the human body respond to triggering factors such
as toxins in tobacco, indoor pollutants, occupational dusts and industrial fumes. Prominent
among these cells are neutrophils, macrophages and lymphocytes. When activated by the
mentioned risk factors, these cells synthesize a battery of inflammatory mediators such as
cytokines, chemokines and chemo-attractants which ensure prolonged inflammation (Brashier
and Kodgule (2012)). During chronic bronchitis the airways become swollen, accompanied
by hyper-secretion of mucus. Emphysema is simply a loss of lung elasticity due to the break
down of the elastic fibers that make up the alveoli. It is engendered when inflammatory
mediators and cells like neutrophils stimulate the production of proteolytic enzymes such as
elastase, proteinase-3 and perforin whose effect include denaturing of elastic fibers and in
some cases expediting apoptosis (self-destruction) of alveolar epithelial cells (Brashier and
Kodgule (2012)). The denaturing of the elastic fibers causes increased compliance of alveolar
sacs and a subsequent retention of inspired air in the lungs (hyperinflation). Depending on
the extent of destruction, the alveolar sacs may completely collapse (atelectasis), and this can
reduce the amount of exchanged gas. In the end, accumulation of CO2 leading to respiratory
acidosis may ensue (Juan et al. (1984)).
COPD was the fifth leading cause of death as of 2002 and it has been estimated that
it will be the third leading cause of mortality worldwide by 2030 (WHO 2017). In New
Zealand, COPD is the fourth leading cause of death, attracting $ 192 million in government
expenditure by the close of 2002. The cost of respiratory diseases per year in New Zealand
as at 2016 has been estimated to be $ 6.16 billion (Telfar and Zhang 2016). In the United
States, the cost of COPD in 2010 was $ 50 billion (Guarascio et al. (2013)).
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1.2.2 Pathophysiology of asthma
Asthma is a disease associated with variable and recurring airflow obstruction, hyper-
responsiveness and inflammation of the bronchioles (National and Prevention (2007)).
Asthma can be triggered by allergens linked to substances such as furs and fecal drop-
pings of pets, pesticides, pollen grains of some plants or ligands in some drugs (Agius et al.
(1991)). Other conditions such as exercise, pregnancy and menstruation may also trigger
asthma. When asthma is triggered, many inflammatory cells including mast cells, eosinophils
and T-lymphocytes are released (Barnes (1989); National and Prevention (2007)). Mast
cells are mainly involved in acute asthma aggravations whilst macrophages, eosinophils
and T-lymphocytes are noted in chronic asthmatic conditions (Barnes (1996)). When these
cells are activated, they stimulate the synthesis of protein bodies known as inflammatory
mediators, typically cytokines, histamine, leukotrienes and prostaglandins. These mediators
initiate events which lead to the contraction of the smooth muscle lining of the airway, hyper-
secretion of mucus, increased microvascular leakage and attraction of other inflammatory
cells thereby producing the observable symptoms such as labored breathing, shortness of
breath and wheezing (Barnes (1996)).
New Zealand is second only to the United Kingdom in terms of asthma prevalence, with
one out of every six adults being asthmatic (Menclova and Webb (2016)). Also, asthma is the
most common cause of admission to children in New Zealand (Menclova and Webb (2016)).
Historically, New Zealand has experienced two episodes of asthma epidemics occurring in
the 1960s and 1980s (Pearce and Hensley (1998)). Although the actual number of deaths is
not accessible, the recent mortality rate is still significant with 70 deaths (mostly people of
age 65 years and more) occurring in 2006 (Telfar and Zhang 2016). In the United Kingdom,
asthma and related lung diseases are responsible for about 6.5 % of all hospital admission
with 18.3 million work days lost to asthma related problems from 1995 to 1996 (Chung
et al. (2002)). Though developing countries contribute the most to global asthma-related
deaths, data on economic burden is scarce. A study has however suggested that asthma drugs
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cost between 3.8 % and 25 % of a patient’s monthly income in 24 developing countries in
Asia and Africa (Aït-Khaled et al. (2007)). The World Health Organization report, 2008,
suggested that 235 million people worldwide suffer from asthma with about 80 % of all
asthma deaths occurring in low and middle income countries and these numbers are estimated
to rise in the coming years.
1.3 Breathing Parameters
Biological systems are mostly non-linear systems and are difficult to model accurately
without sufficient experimental insight. The measurable respiratory quantities fundamental
to this work include airway resistance, airway pressure, and CO2 concentration profile. The
breathing flow pattern may be an input. From these quantities other pertinent parameters
such as breathing period, respiratory rate, minute volume, inspiratory to expiratory time
fraction (I:E ratio), work of breathing and power of breathing can be estimated.
1.3.1 Breathing flow patterns
The temporal changes in inspired and expired volume over the breathing period constitutes
the breathing flow pattern, which may vary in terms of shape, amplitude and period depending
age, disease condition and level of activity (exercising or resting). The breathing flow pattern
of a 24 year old male adult (Spence (2011); Van Hove et al. (2016)) is shown in Fig. 1.6.
From this data, the respiratory rate, tidal volume and I:E ratio can be computed. The area
under the inspiratory breathing flow plot represents tidal volume. The volume of inspired air
in a minute (minute volume), can be calculated as the product of respiratory rate and tidal
volume.
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Fig. 1.6 Breathing flow pattern
1.3.2 Airway resistance
Resistance of the airway is a significant parameter that can indicate the difficulty in breathing.
It is therefore an important criterion for diagnosing restrictive or obstructive lung diseases
and can also be used to evaluate the efficacy of the treatment administered to restrictive or
obstructive airway disease patients (DuBois et al. (1956)). A whole body plethysmograph
synchronized with a spirometer can be used to acquire breathing flow and alveolar pressure
data. The plot of alveolar pressure versus breathing flow yields a non-linear curve (example
shown in Fig. 1.7, adapted from Otis et al. (1950)) that can be fitted to a second order poly-
nomial whose coefficients describe the resistance of the airway. The degree of non-linearity
of the pressure versus breathing flow curve is often affected by pathological conditions of the
extra- and intra- thoracic airway (Verbraak et al. (1991)), thus serving as a good parameter
for detection of airway obstruction.
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Fig. 1.7 Flow versus alveolar pressure plot for the determination of airway resistance (adapted from Otis et al.
(1950))
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1.3.3 Work of breathing
The amount of work done by the respiratory muscles in ventilating the lungs is known
as mechanical work of breathing. In patients suffering from COPD and asthma, loss of
elasticity and increased airway resistance increase work of breathing and produces fatigue
which in turn leads to reduced ability to engage in physical exercise (Fleury et al. (1985)).
Work of breathing can be used as a metric for evaluating lung performance especially under
situations where the patient is recuperating from a diseased state. Clinicians can therefore
plan on the possibility of weaning a patient off a respiratory assistive device such as the
mechanical ventilator based on work of breathing, amongst other factors (Cabello and
Mancebo (2006)). Work of breathing can be estimated using two approaches: firstly, by
considering the mechanical work done by the lungs from pressure and volumetric changes
during ventilation and secondly, estimation of the amount of oxygen consumed by the
respiratory muscles (Brodovsky et al. (1960); Milic-Emili et al. (1999)). Of the two methods,
the present study will employ the first approach on the grounds of expediency in collecting
clinical data.
1.3.4 Carbon dioxide concentration
The respiratory center, located within the medulla oblongata of the brain performs a home-
ostatic function to maintain blood acidity within a specific range via cell receptors which
are sensitive to variation in blood pH, and CO2 and O2 partial pressures (Gray (1951)). It
maintains the partial pressure of arterial blood CO2 in the range of 35 - 45 mmHg (Parot
et al. (1980)) by effecting a hormonal response to increase or decrease respiratory rate when
CO2 tension falls out of range. Attendant with some severe forms of COPD is a medical
condition known as hypercapnia - a condition where the partial pressure of arterial blood
CO2 is greater than 45 mmHg (Parot et al. (1980)). Higher partial pressure of arterial blood
CO2 may be caused by an increase in CO2 retention in the lungs often resulting in increased
blood acidity (respiratory acidosis) (Dorman et al. (1954)). Respiratory acidosis can cause
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poor metabolism leading to fatigue; increased intracranial pressure; lack of alertness; and the
patient being comatose.
The CO2 tension versus time curve, known as a normal capnogram, is shown in Fig. 1.8,
adapted from Nagler and Krauss (2009). The normal capnogram has four phases. The
starting phase, Phase I (A-B) marks the end of inspiration and commencement of expiration,
Fig. 1.8 The normal capnogram, adapted from Nagler and Krauss (2009)
during which the dead space air (which has low CO2 tension) is expelled. This is followed
by Phase II (B-C) which involves the fast rise in CO2 tension as the CO2-rich alveolar air is
expelled. Phase III (CD) indicates an almost complete saturation of the airway with alveolar
air and peaks at point D, known as end-tidal CO2 tension (EtCO2). Inspiration sets in after
the EtCO2, where the influx of fresh atmospheric air speedily replaces airway air (Phase IV,
D-E)
1.4 Nasal High Flow Therapy
Nasal high flow (NHF) therapy has been used clinically for over a decade (since the early
2000s). It was mainly used in the neonatal population in its early years. More recently,
researchers have reported on its efficacy in the management of respiratory failure in chil-
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dren and adults. NHF involves the administration of warmed and humidified air at body
temperature and saturated pressure i.e. 37 °C and 100 % relative humidity. The purpose of
humidification is to prevent changes in the airway squamous epithelium, maintain airway
ciliary activity, prevent dehydration and thickening of secretions, and reduce heat loss (Waugh
and Granger (2004)). Presently, the maximum therapeutic flow rate is 60 L/min Ward (2013).
Dysart et al. (2009) propounded possible mechanisms of action of NHF therapy and these
include:
• Improvement in oxygenation
• Attenuation of inspiratory resistance
• Improvement of airway conductance and pulmonary compliance
• Reduction in thermal work of breathing
• Generation of a positive distending pressure
In spite of the reported efficacy of NHF, its mechanisms of action are not altogether
understood and evaluation of its effect on breathing parameters have been mostly qualitative.
In the next section, a review of the different areas of NHF research is presented along with
the research gaps which necessitated the present research work.
1.5 NHF: Application and Research Areas
Clinical research on medical devices serves the health community with new application
areas, contraindications of the device, mechanism of action and lastly suggestions for product
improvement. Kernick and Magarey (2010) have advised that more insight into the efficacy
of NHF can be gained if clinical studies are extended through the entire hospitalization period.
A recent review article on NHF by Nishimura (2015) found no reports of contraindications
for NHF, and advised on the need to use NHF with circumspection. The author further
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suggested that sample size of clinical trials for NHF studies may be increased to raise the
statistical and clinical power of findings. The cost of clinical studies is however very costly
and for this reason less expensive methods of filling the gaps in literature such as bench-top
and computer simulation have been explored in NHF studies, for example the works of
Kumar et al. (2015); Mündel et al. (2013); Van Hove et al. (2016) and Spence (2011)
Amongst the proposed mechanisms of actions, the generation of positive airway pressure
has received the most attention. Locke et al. (1993) reported on the inadvertent administration
of continuous positive airway pressure (CPAP) during the application of high flow oxygen
to preterm neonates. As was found for neonates, studies conducted by Groves and Tobin
(2007) and Parke et al. (2009) concluded that NHF engendered the same pressure effect in
healthy adult population. Recently, Kumar et al. (2015), perhaps for the first time, predicted
NHF-induced increase in pharyngeal pressure with a numerical model of the upper airway.
There exists a body of work on the effect of NHF on tidal volume and functional residual
capacity (Corley et al. (2011); Mündel et al. (2013); Riera et al. (2013)). Corley et al.
(2011) and Riera et al. (2013) used the electrical impedance tomography, which produces
cross-sectional images (slices) of tissues noninvasively. They conducted their research
amongst a post-cardiac surgery adult population and concluded that NHF gives rise to an
increase in functional residual capacity. Riera et al. (2013) concluded that "the application of
noninvasive NHF in healthy subjects significantly increases end-expiratory lung impedance
(EELI)" - meaning an increment in functional residual capacity. Mündel et al. (2013) using a
respiratory impedance plethysmographic band for lung volume measurement concluded that
NHF increased tidal volume during wakefulness but reduced it during sleep. Bräunlich et al.
(2013) however found a decrease in tidal volume upon administering 30 L/min to 16 awake
healthy individuals. The effect of NHF on lung volume therefore varies with wakefulness
and disease state.
Another area of research has been the effect of NHF on work breathing. To this end,
the work of Saslow et al. (2006) may be regarded as pioneering. In their study, estimates of
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intrapleural pressure of neonates (mean age of 26 days and mass of 1118 g) were obtained
with esophageal balloon catheter. It was concluded that administration of NHF at flows
3, 4 and 5 L/min to neonates produced work of breathing comparable to the delivery of 6
cmH2O of CPAP. How the work of breathing during therapy (NHF or CPAP) compared
to the work of breathing during spontaneous breathing was not reported. The work of
Saslow et al. (2006) was also limited by age group and range of NHF. In a subsequent study,
Rubin et al. (2014) conducted their study in an older infant population (age = 1.3 and 15.5
months) and used a wider range of NHF (2 to 8 L/min) compared to Saslow et al. (2006).
The product of the esophageal pressure and respiratory rate (pressure-rate-product) or the
esophageal pressure and breathing period (pressure-time- product) are surrogates of work
of breathing. Collett et al. (1985) found a good correlation between O2 cost of breathing
and the pressure-time product. Rubin et al. (2014) used the pressure-rate product and found
a fall in work of breathing with rising NHF. Pham et al. (2014) administered 2L/Kg/min
of NHF and measured the esophageal pressure, tidal volume and diaphragmatic electrical
activity of 14 infants with bronchiolitis and 14 infants with congenital heart disease. The
researchers reported on a decrease in work of breathing with NHF based on reductions in the
pressure-rate product and pressure-time product and off-loading of diaphragmatic electrical
activity. From the data presented in all three reports (Pham et al. (2014); Rubin et al. (2014);
Saslow et al. (2006)) it is concluded that the work of breathing due to NHF is comparable
to CPAP and is less than WOB during spontaneous breathing. To date, the only published
works that quantitatively examined the effect of NHF on WOB are these three (Pham et al.
(2014); Rubin et al. (2014); Saslow et al. (2006)) with none existing for the adult population .
The effect of NHF on gas exchange constitutes another body of research. Flushing of
CO2 from the airway has been suggested as a mechanism of action of NHF but quantitative
data has been lacking until recently. Recently, Ritchie et al. (2011) conducted a clinical trial
in which a group of 10 healthy adults (mean age of 30.1 years) were administered NHF
(titrated to inspired oxygen fraction (FiO2) = 0.6) at flows ranging from 10 to 50 L/min
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in steps of 10 L/min. EtCO2 was found to increase by 10 % when NHF was applied over
the same range during exercise. Open mouth breathing with NHF was however found to
produce a lower (by about 10 %) EtCO2 compared to closed mouth breathing. As suggested
by the authors, similar studies conducted amongst individuals suffering from respiratory
pathologies such as COPD would be interesting. Möller et al. (2015) filled an anatomically
correct upper airway model with a tracer gas (81mKr-gas) and separately administered NHF
of 15, 30 and 45 L/min, followed by a CO2 clearance measurement with infra-red based
capnography and 81mKr-gas radioactive gamma camera. The authors found a complete
tracer gas removal within 1.0 seconds with clearance half times decreasing with increasing
NHF. In their summary, the rapid clearance was attributed to a potential for NHF to reduce
dead space CO2 rebreathing though no such reductions have been observed clinically due to
the difficulty in quantifying CO2 clearance in the airway in vivo (Möller et al. (2015)).
1.6 Motivations and Thesis Summary
From the review of published data on NHF, it is notable that little attention has been paid to
evaluation of work of breathing and CO2 flushing in the adult population, and even in the
neonate and infant groups, the power of findings (impact of studies) has been limited by the
number of participants. Also, the number of parameters (airway pressure, breathing flow,
gas tensions) that can be measured simultaneously is often restricted by patient pathology
and technology. Additionally, inter- and intra- population variation do not permit data drawn
from different sources to be united into an accurate understanding of NHF therapy.
It is intuitive to think that administration of NHF will make inspiration easier and
expiration difficult as inspiration flow is along NHF jet and expiratory flow is counter to
the NHF jet. It has been observed that both inspiratory and expiratory pressure rise with
NHF (Groves and Tobin (2007); Parke et al. (2009)). The relationship between pressure
gradient and flow in a straight pipe is linear but non-linear for a complex geometry such as
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the airway (Ferris et al. (1960)) i.e. resistance to flow in the airway is dependent on flow
such that increasing flow increases airway resistance (Otis et al. (1950)). This suggests an
increased airway resistance to flow during inspiration if NHF adds to the breathing flow and
thus a rise in inspiratory effort. Further, some of the cannula flow exit through the leak area
between the prongs and the nares after recirculation in the nasal cavity. When inspiratory flow
demand exceeds the cannula flow, the extra flow entrained from the atmosphere would have
to overcome the resistance posed by the small entry area (difference between cannula prong
area and nares) and the momentum of the exiting cannula flow following recirculation. Does
it mean inspiration may be more difficult with NHF than without? It is worth mentioning that
the jet momentum can drive some flow through the airway during inspiration. When these
considerations are taken together, it is difficult to predict the influence of NHF on inspiratory
effort of breathing. Even with a correct prediction that NHF will raise expiratory resistance,
it is of interest to know how much rise is expected, for instance when there is a 10 % rise in
NHF. Finally, how the change in breathing flow parameters such I:E ratio due to NHF, may
affect overall breathing effort (inspiration plus expiration) is not readily straightforward.
In investigating the mechanism of action of NHF, the present work aims at providing
quantitative data via bench-top modelling and mathematical simulation on the effect of NHF
on work of breathing and CO2 flushing. Some interesting questions to be answered include:
• Does NHF increase or reduce inspiratory resistance?
• Does NHF increase or reduce expiratory resistance?
• What is the overall work of breathing with NHF, including inspiratory and expiratory
work of breathing ?
• What assumptions can be made to produce a simple mathematical model for gas
exchange and work of breathing?
• Can a simple mathematical model of gas exchange predict CO2 flushing?
1.6 Motivations and Thesis Summary 21
• Can a simple mathematical model be used to study effect of NHF on central sleep
apnea patients?
The Chapters of this thesis are ordered thus: Chapter 2 is a description of the tools devel-
oped for conducting bench-top model studies. In Chapter 3, results from the experimental
measurement of tracheal pressure (of a 3D printed upper airway model of a neonate and
adult) in closed mouth and open mouth states are presented for a range of NHF flows. Tests
aimed at finding the effect of nasal cannula size on tracheal pressure are also presented. The
chapter closes with estimation of the resistance of the upper airway model to airflow during
NHF. Chapter 4 encompasses the development of a model to estimate work of breathing
based on the calculated upper airway resistance parameters and clinically observed effects
of NHF on breathing parameters. Bench-top measurement of airway pressure and CO2
concentration were made to validate a computational fluid dynamics (CFD) model aimed at
investigating the effect of NHF on airway pressure, velocity distribution and CO2 clearance.
This is presented in Chapter 5. Chapter 6 is a study of the effect of NHF on CO2 clearance
in individuals suffering from central sleep apnea. In Chapter 7, the influence of breathing
flow waveform shape on EtCO2 concentration is investigated using four COPD breathing
flow waveforms collected from the literature. Chapter 8 embodies the development of a
mathematical model to predict how NHF affects EtCO2 clearance. The conclusion, essential
outcomes and future work are presented in chapter 9.
Generally, this work focuses on two main areas of research namely the impact of NHF
on breathing effort and airway CO2 content and how the breathing flow pattern of COPD
patient may bear on airway CO2 concentration. A road map summarising the research goals
pertaining to these focus areas and the approaches used is presented in Fig. 1.9.
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The parameters to be measured include airway pressure, airway resistance, and CO2 concen-
tration. Previous to the commencement of this work, an in-house pulsatile pump capable
of reproducing breathing flow patterns was built to study how NHF influences air velocity
distributions in the upper airway using particle imaging velocimetry techniques (Spence
(2011)). A capnograph was available (MiniMedi, manufactured by Oridion Medical Ltd,
USA) which uses infrared technology to quantify CO2 concentration by sampling at a rate 20
Hz via a 2 m capillary tube. Its response time and resolution are 2.7 seconds and 0.1 mmHg
respectively. The MiniMedi capnograph (Fig. 2.1) was used for the present work. It was
calibrated against the atmosphere and a 10 % CO2-air calibration gas mix.
The multi pressure sensor system (used by Dey (2014)) was made of MPXV7002DP
pressure sensors (Fig. 2.2). It has a measurement range of -2000 Pa to 2000 Pa and an
accuracy of ± 2.5 %. At the beginning of this work, a stability problem potentially due to
drifts in the output voltage characteristics of the sensors and the need to measure neonatal
airway pressure prompted the design of a more reliable and accurate pressure acquisition
system.
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Fig. 2.1 MiniMedi capnograph
Fig. 2.2 The MPXV7002DP pressure sensor (adapted from http:// www.aliexpress.com)
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A TSI 4000 flow meter was used to measure breathing flow rate. After examination, a
calibration of the TSI 4000 flow meter showed an error of 6.4 % therefore flow rates stated
or plotted in the thesis should be multiplied by 1.064 to find the best estimate of the true
flow rate. Also a new pulsatile pump identical to the one used by Dey (2014) was built with
some improvements. A description of the new pulsatile pump is presented in the next section
followed by a description of the new pressure acquisition system.
2.2 The Pulsatile Pump
The piston motion is achieved by converting the rotary motion of a stepper motor (AS-
TROSYN ML34HY1-9) into translatory motion via a pulley, belt and ball screw assembly.
As the stepper motor rotates in clockwise or anticlockwise steps, the belt transfers the rotary
motion to the ball screw which in-turn drives the piston fastened to it forward or backwards
depending on the direction of the stepper motor. The design step angle of the stepper motor
is 1.8 ° (equivalent to 200 steps/revolution). In a previous study aimed at investigating the
effect of compliance on models of arterial hemodynamics (see work by Geoghegan (2012)),
an Astrosyn P808A Micro-stepping motor driver was used to increase the number of steps
per revolution to 1050. This means an improvement in the resolution and hence quality
of data generated using the pump. The new pulsatile pump (Fig. 2.3) was fitted with the
same device. The plunger of the piston is supported on a rail (Fig. 2.3) via a ball bearing
arrangement to reduce friction. At a distance of 40 mm from either ends of the ball screw,
a terminal switch is installed to stop the stepper motor in case it fails to stop at the preset
displacement of the piston. The piston cylinder has an inside diameter of 140 mm, an outside
diameter of 150 mm and a length of 420 mm. It is held in place by two arched steel plates as
shown on Fig. 2.3.
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Compared to the old pump, the re-designed supporting arch allows for ease of removal
of the piston cylinder. The maximum volume and flow of air deliverable by the system are
4.6 L and 50 L/min respectively. A 10 mm diameter tapped hole is made at a distance of
35 mm from the front end of the cylinder for the purpose of bleeding CO2 into the cylinder
(Fig. 2.3). The CO2 inlet fitting (see Fig. 2.3), attached to the piston cylinder, has also been
redesigned to make it easy to replace.
Fig. 2.3 New pulsatile pump with labels on parts
The pump is controlled by an in-house software (originally developed for the older
pump), which is programmed in LabVIEW (version 2012). The software requires the Fourier
coefficients of a flow waveform (q) and its period to run. The Fourier coefficients are obtained
using Eq. 2.1











Where N and T respectively represent the number of Fourier coefficients and period of the
flow waveform. a and b are accordingly the cosine and sine coefficients required by the
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pump’s LabVIEW program. The first 8 Fourier coefficients contain 99 % of the energy of
the physiological flow waveform and therefore can accurately reproduce the flow waveform
(Geoghegan et al. (2012)). The displacement of the piston is computed in the software using







Where A is the cross-sectional area of the piston head.
2.3 The Pressure Acquisition System
The need to build a new pressure acquisition system was prompted by the detection of
instability in the existing pressure sensors and the need for a higher accuracy in measuring low
amplitude airway pressure. In this section, the system requirements, design considerations
and methods used to build the new multi pressure sensor system are discussed.
2.3.1 Selection of pressure transducer
In the selection of the pressure transducer, the following specifications were considered:
pressure range (< 500 Pa), response time (< 10 ms), voltage supply (< 5 V) and communi-
cation protocol (I2C or SPI). The AMS5915 pressure transducer (manufactured by Analog
Microelectronics GmbH, Germany) - see Fig. 2.4 - met these specifications. This pressure
sensor has an onboard chip to process and transmit pressure data as a digital signal using
I2C protocol. This is an advantage because noise and losses due to long transmission lines
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Fig. 2.4 The AMS5915 pressure sensor (adapted from http://www.messweb.de)
are avoided. The specifications of AMS5915 are listed in Table 2.1. Once the pressure
transducer was selected, the next step was to design the multi pressure measurement and
acquisition system.
Table 2.1 Specifications of the AMS5915 pressure sensor
Parameter Typical value Unit
Range -500 to 500 Pa
Accuracy ± 1.5 % FSO
Supply voltage 3.3 V
Current 5 mA
Reaction time 0.5 ms
Thermometer (on board) -25 to 85 ◦ C
Dimension 15.24 x 15.24 x4.3 mm
Transmission protocol I2 C -
2.3.2 Design of the data acquisition system
10 units of the AMS5915 were sourced to build the pressure data acquisition system. A
sampling frequency of 25 Hz was specified for the data acquisition system and to achieve
this an Arduino nano V.3 board (Fig. 2.5, right) which is powered by an Atmega328P
microcontroller was sourced. The nano V.3 board has a clock speed of 16 MHz; a program
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Fig. 2.5 The Arduino nano3 and the dual-in-line socket
memory of 32 KB; and the capability to read data from 128 pressure transducer devices via
its I2C lines. Additionally, its small size (43mm X 18mmX 10mm) makes it portable. A
dual-in-line pin (DIP) socket (Fig. 2.5, left) was sourced to make replacement of the nano
V.3 in the system easy.
The next phase involved the development of the schematic of a printed circuit board (PCB)
for the system. DesignSpark PCB 7.1 (PCB development software) was chosen because it
was relatively easy to learn and use, and it is open source. In Table 2.2, specifications for the
PCB design are listed.
Table 2.2 Specifications of the PCB
Parameter Value Unit
Board dimension 110 x 90 mm
Copper track width 0.64 mm
Minimum track spacing 0.25 mm
Pad type round mm
Pad diameter 1.82 mm
Dual-in-line package width 0.85 mm
Upon completing the schematic of the PCB (Fig. 2.6a) it was printed and developed on
a two-sided copper laminated board. Afterwards, 0.5 mm diameter holes were drilled at
positions marked for insert pins of electronic components (the pressure sensors, resistors, the
DIP socket). Following from this the AMS5915, DIP and pull-up resistors (required for the
I2 C circuitry) were soldered on the printed circuit board (See Fig. 2.6b)
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(a) PCB schematic (b) PCB with components soldered
Fig. 2.6 Schematic and built PCB
2.3.3 Programming the arduino nano 3 V.3
The embedded software was written in C program using the Atmel Studio 7 integrated
development environment. A flow chart which defines the structure of the embedded software
is shown in Fig. 2.7. The numbering on Fig. 2.7 shows the sequence of activities that define
the operation of the system.
Basically, the microcontroller issues an instruction that activates a pressure transducer
(activity 1 (Fig. 2.7)) and directs it to make a measurement (activity 2). The microcontroller
receives and acknowledges a signal which indicates completion of measurement by the
transducer and then requests the pressure data (in hexadecimal form) to be transmitted for
storage in memory (activities 3 and 4). Activities 1, 2, 3 and 4 (as encased in the dashed
rectangle), are repeated for all 10 pressure transducers allowing a time interval of 1µs (1
MHz) between repeats. The sampling frequency (25 Hz) is a negligible fraction of the repeat
frequency (of activities 1 - 4) and thus produces no significant inter sensor timing disparities
i.e. data from all sensors can be considered as arriving simultaneously for conversion and
transmission. Once the pressure data from all sensors are received, it is then converted into
decimal form (activity 5), bundled into a 50 word length signal and sent via the universal serial
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Fig. 2.7 Flow chart for pressure acquisition
asynchronous receiver-transmitter (USART) line (activity 6) to a computer for recording and
graphical user interface display.
According to its data sheet, the AMS5915 pressure sensors are factory programmed to
self-calibrate using sensor specific correction coefficients stored on its electrically erasable
programmable read only memory (EEPROM). All sensors were however checked against a
factory calibrated digital pressure device (Testo 510 differential pressure sensor) which has
an accuracy of ± 3 Pa, ±5 Pa and ± 10 Pa that respectively correspond to pressure ranges of
0 to 30 Pa, 31 to 100 Pa, and 101 Pa to 10000 Pa. The AMS5915 reported 3 % less pressure
than the Testo 510. This was corrected by scaling the digital output of the AMS5915 by 3 %.
2.3.4 Designing of the housing
To protect the PCB and on-board microchips of the pressure sensors from possible damage,
a housing unit was designed and built. The design (Fig. 2.8a) was done in SolidWorks
(Version 2012). A base cover was designed to enclose the housing unit. The prototype of
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the housing unit (Fig. 2.8b) was 3D-printed using ABS material by the fused deposition
modelling method. Four screws, each located at a corner of the horizontal surface (Fig. 2.8b),
were required to fasten the housing unit to the bottom cover. The completely assembled
prototype of the pressure acquisition system is shown in Fig. 2.8b.
2.3 The Pressure Acquisition System 33
(a) CAD model of housing
(b) Fully assembled pressure acquisition system
Fig. 2.8 Housing for pressure acquisition system
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2.3.5 Design of the graphical user interface
It was desired that the measured pressure be displayed on a computer screen during experi-
ment. A graphical user interface (GUI) that permits the display and recording of data from
any of the transducers was developed in MATLAB (Version 2014). A snap-shot of the GUI
is shown on Fig. 2.9. See Table 2.3 for information about the buttons and panes on the GUI.
Fig. 2.9 Graphical user interface for the pressure acquisition system
The pressure data measured in successive experiments can be stored together in one file.
Also, there is a functionality which allows simple statistical calculations (e.g. finding mean,
maximum and minimum data points) to be performed immediately on recorded data.
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Table 2.3 Functions of buttons and panes on GUI
Parameter Value




Reset Clear data and reset axis
Mean Compute data average
Max Find maximum value
Min Find minimum value
Time Show recording time
COM Select communication port
2.4 Airway Model Making
The airway models used in the present work were constructed by previous students from com-
puted tomographic (CT) images acquired retrospectively. The model acquisition, preparation
and printing process are briefly described here.
Modern medical imaging provide a rich source of information about anatomical struc-
tures that are otherwise difficult to replicate. Computed tomography and magnetic resonance
images are good examples. CT images slices (2D cross-sectional images) of the upper body
of a 44 year old male with no apparent physical abnormalities was acquired. Following
from this, a segmentation algorithm was used to demarcate pixels that belonged to a specific
range of intensities (thresholding). Segmentation was used to mark the areas of the airway
in each CT image slice. There are commercial and free software packages (e.g. 3D Slicer
(www.slicer.org)) that are able to group all the marked airway regions on the image slices into
a volume object. The software can then reconstruct a 3D object from the segmented image
slices. Manual editing of unwanted features (e.g. paranasal sinuses, Hasner’s membrane, au-
ditory tubes) and residual surfaces (due to little distinction in pixel intensity between airway
tissue and surrounding tissue) may be required. Editing of the geometry can be performed
with Meshlab (www.meshlab.sourceforge.net) and Meshmixer (www.meshmixer.com). Be-
cause the facial geometry around the nares may influence the inhalation flow profile, the area
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around the nostril and upper lips were retained during segmentation. A shelling algorithm
was used to produce a model shell of 3mm thickness (wall thickness of airway geometry).
After editing the model, it was printed in acrylic photopolymer material (Visijet EX200) with
a Project HD 3000 Plus printer.
2.5 Conclusion
A pulsatile pump capable of reproducing a breathing flow pattern was built to study pressure
and flow characteristics of the airway along with CO2 concentration fluctuations during
spontaneous breathing and breathing under conditions of nasal high flow (NHF). Following
from this, a ten-port multi pressure transducer system was designed to enable the accurate,
fast and simultaneous measurement of pressure at ten different regions of the airway. In
addition, an interactive graphical user interface program was developed in MATLAB (Version
2014) for immediate pressure data plotting and recording plus a functionality that makes
it possible to perform quick statistical analysis. Summarily, the hardware requirement to
successfully complete the present work have been presented in this chapter.
Chapter 3
Effect of NHF on Airway Pressure and
Resistance
3.1 Introduction
The resistance to flow of the airway must be known in order to estimate the work of breathing
(Otis et al. (1950)). NHF increases airway pressure in both neonates (Locke et al. (1993);
Wilkinson et al. (2008)) and adults (Parke et al. (2009)) and therefore affects the pressure -
flow characteristics of the airway. During expiration, the breathing flow is against the cannula
flow and it is thought that this may increase expiratory resistance however quantitative data
on this effect is lacking (Dysart et al. (2009)). Recently, Lee et al. (2013b) mentioned that
"whether high flow nasal cannula reduces work of breathing by mechanically stenting the
airway or by providing gas flow that matches or exceeds the patient’s peak inspiratory flow
as proposed by Dysart et al. (2009) remains to be determined". Furthermore, there is little
information on how the choice of nasal cannula size and mouth state (open or closed) may
affect work of breathing. This chapter provides measurement of tracheal pressure with
different cannula sizes and flow rates, from which the upper airway resistance of an adult
and neonate is estimated.
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3.1.1 Chapter nomenclature
K1 - laminar resistance coefficient
K2 - turbulent resistance coefficient
MO - mouth open
MC - mouth close
NHF - nasal high flow
NHF3 - 3 L/min of NHF
NHF6 - 6 L/min of NHF
NHF9 - 9 L/min of NHF
NHF20 - 20 L/min of NHF
NHF40 - 40 L/min of NHF
NHF60 - 60 L/min of NHF
OPT842 - small cannula size (adult)
OPT844 - medium cannula size (adult)
OPT846 - large cannula size (adult)
OPT314 - small cannula size (neonates)
OPT316 - large cannula size (neonates)
UAM - upper airway model
ZPIF - zero pressure inspiratory flow
3.2 Materials and Methods
3.2.1 Experimental setup
Existing adult and neonate upper airway models were used. In fabricating the adult upper
airway model, computed tomography (CT) images of the upper airway of a 44 year old
male adult, with no apparent airway abnormality, and in a mouth open resting state, were
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segmented to extract the airway. The sinuses were deleted and the model terminated at the
trachea. The 3D model (Fig. 3.1a) was 3D printed in acrylic (Visijet EX200). The upper
airway model of a neonate (healthy male weighing 3.6 Kg), Fig. 3.1b, was also 3D printed in
acrylic. This was a closed mouth model i.e. the baby had his or her mouth closed at the time
of the scan. A complete description of model making methods can be found in the report
by Geoghegan et al. (2012). To study mouth closed breathing, which is recommended for
NHF, the oral opening of the adult was sealed. In reality, during a mouth closed posture, the
tongue may or may not occlude the oral cavity. Since the tongue is absent in the model, an
unoccluded mouth closed posture was simulated. The mouth was unsealed to study open
mouth breathing.
(a) Adult UAM (b) Neonate UAM2
Fig. 3.1 Upper airway models: neonate and adult
A 1 mm diameter hole was drilled through the posterior surface close to the trachea
opening of the UAM for pressure measurement. Though the tracheal opening is circular,
pressure sampled at the anterior surface may be different. This is a limitation. A positive
displacement programmable piston pump (PP) (used by Van Hove et al. (2016) and Spence
(2011)) was connected to the adult UAM (Fig. 3.1a). The PP is able to produce bidirectional
flows up to 50 L/min. A TSI 4000 flow meter was used to confirm the flow delivered by the
PP was as expected from the piston velocity. After examination, a calibration of the TSI
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4000 flow meter showed an error of 6.4 % therefore flow rates stated or plotted in the thesis
should be multiplied by 1.064 to find the best estimate of the true flow rate. An AIRVO2TM
nasal high flow device (manufactured by Fisher & Paykel Healthcare Limited, Auckland,
New Zealand) was used to administer NHF via a breathing circuit and nasal cannula (Fisher
& Paykel Healthcare Ltd). The apparatus setup is shown in Fig. 3.2. The nasal cannula was
placed such that the two prongs rested in the nostril with mid-section of the space between
the prongs aligned with the septum of the nostril. A misalignment to the right or left can lead
7 - 14 % change in pressure (also observed by Buchajczyk (2017)). During the experiments,
the cannula base, which rests on the upper lip during NHF was firmly secured with Blu-tack
without obstruction to breathing flow. Before each test, rectangular flow waves were used
to ensure that variation in pressure due to cannula placement was less that 1 %. A pressure
transducer (AMS 5915, Analog Microelectronics GmbH, Germany) was connected to the
pressure tap at the tracheal opening (P1 in Fig. 3.2). P2 is the atmospheric pressure.
Fig. 3.2 Apparatus setup
Three different cannula sizes namely: small (OPT842), medium (OPT844) and large
(OPT846) (manufactured by Fisher & Paykel Healthcare) were used to administer nasal high
flow to the adult UAM. NHF was delivered to the neonatal UAM using the OPT314 and
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OPT316 nasal cannula (Fisher & Paykel Healthcare). See Table 3.1 for the dimensions of all
the cannula used in this work.














two holes (mm2) 42.2 60.5 113.1 9.1 16.6
Wall thickness
(mm) 0.4 0.4 0.5 0.4 0.4
Height
(mm) 13 15 18 8 8
Distance apart
(mm) 14 15 18 10.6 12
3.2.2 Experimental procedure
The resistance of the adult UAM itself was first determined by driving steady flow rates
(F), measured by the piston motion, and ranging from -50 L/min to 50 L/min through the
UAM. Negative flow rates denote inspiration. Rohrer’s equation (Otis et al. (1950)), Eq. 3.1,
describes the relationship between air flow and the driving pressure (P)
P = K1F +K2F2 (3.1)
where K1 and K2 are resistance coefficients, respectively for the laminar and turbulent
components of the resistance. Airway resistance, R, is defined as R = P/F thus Eq. 3.2
R = K1 +K2F (3.2)
is obtained by dividing through Eq. 3.1 by F. Due to the second term in Eq. 3.2, resistance
depends on flow rate. K1 and K2 in Eq. 3.1 are determined by least-squares fitting to the
recorded flow (F) and differential pressure data (P = P2 −P1)
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The mouth of the UAM was sealed and unsealed to simulate mouth open and mouth
closed breathing. Tracheal pressure was recorded without NHF, and with NHF delivered via
the small (OPT842), medium (OPT844) and large (OPT846) cannula. For each cannula, the
flow rate through the cannula (NHF flow rate) was set at 20, 40 and 60 L/min in turn. The
PP was used to deliver rectangular flow waves in which the steady flow ranged from -50 to
50 L/min in steps of 10 L/min. The piston motion determined the tracheal flow. Identical
sets of experiments were conducted using the neonate UAM (Fig. 3.1b) however tracheal
flows ranging from 1 to 6 L/min were used along with NHF of 3 L/min, 6 L/min and 9 L/min
which were separately administered via the OPT314 and OPT316 cannula.
3.3 Results
3.3.1 Adult airway pressure and resistance (mouth closed)
Fig. 3.3 shows the expiratory pressure flow plots for NHF at 20 L/min (NHF20), 40 L/min
(NHF40) and 60 L/min (NHF60) for all cannula sizes and flow rates induced by the piston
motion (tracheal flow). Fig. 3.4 is the inspiratory pressure flow plot. The error bars represent
two standard deviations in pressure calculated over 25 cycles (5 cycles from each of 5 separate
experimental repeats). During expiration, except for NHF20, the pressure produced by the
medium cannula is almost the same as that of the large cannula however during inspiration
the pressure produced by the medium cannula is less than that of the large (except for
NHF20). At each tracheal flow (ranging form 0 to 50 L/min), the expiratory tracheal pressure
produced by the large cannula was divided by the pressure produced by the small cannula.
The range and mean of the ratios at NHF20, NHF40 and NHF60 are 1.09 - 1.18 (1.14) ,
0.91 - 1.13 (1.09), 0.91 - 1.11 (1.08) respectively. The range of ratios and mean computed
for the inspiratory phase, respectively corresponding to NHF20, NHF40 and NHF60 are
1.00 - 1.20 (1.06) , 0.67 - 1.9 (1.13), 0.48 - 1.90 (1.07). In reference to the mean ratios,
expiratory tracheal pressure rises by 14 %, 9% and 8 % respectively at NHF20, NHF40 and
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NHF60 when the large cannula is used instead of the small. The corresponding inspiratory
rise in tracheal pressure are 6 %, 13 % and 7 %. It is concluded that for both inspiration and
expiration the large cannula produces a tracheal pressure increase of 6 - 14 % relative to the
small cannula.
For both inspiration and expiration, the pressure rises quadratically with flow rate i.e.
the K2 term in Eq. 3.1 cannot be neglected. NHF rates have a greater effect on pressure
than cannula size. The resistance coefficients, K1 and K2 were deduced from each of the
curves shown in Fig. 3.3 and Fig. 3.4 and used to compute the resistance at a tracheal flow
of 30 L/min - Fig. 3.5 and Fig. 3.6 - from which it is observed that resistance increases in
an NHF dependent manner. The NHF jet produced by the large cannula has a relatively
less momentum but a greater pressure compared to that of the small cannula due to the
Bernoulli effect. The change of trachea pressure per a change in breathing flow (defined by
the linear resistance coefficient) generally rises with NHF and cannula size (Table 3.2) for
both inspiration and expiration. Thus for mouth closed breathing, a rise in airway pressure
due to NHF and cannula size produces a corresponding rise in resistance to flow. During
expiration, the large cannula produces the greatest resistance at all NHF values (Fig. 3.5).
Replacing the large cannula with the medium cannula reduces expiratory resistance by 5 %,
4 % and 2 %, respectively corresponding to NHF20, NHF40 and NHF60. Replacing the large
cannula with the small reduces expiratory resistance by 12 %, 20 % and 16 % respectively.
In Fig. 3.6 (for inspiration), the overlap of error bars at NHF20 and NHF40 means cannula
size makes little difference to resistance however at NHF60, replacing the large cannula with
the medium and small cannula respectively reduce resistance by 6 % and 12 %. It can be
concluded that for mouth closed breathing in adults, between the small and large cannula
sizes, there is a significant difference in expiratory resistance at all NHF (20 - 60 L/min) but
during inspiration the difference in resistance between these two sizes of cannula is only
significant at NHF60.
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Fig. 3.3 Expiratory pressure flow relationship for adult UAM without NHF and with NHF20, NHF40 and
NHF60 administered via the small, medium and large cannula. The error bars represent two standard deviations
in pressure measured over 25 cycles
The pressure flow data obtained via the medium cannula for inspiration and expiration
(Fig. 3.3 and Fig. 3.4) have been plotted together (Fig. 3.7) to investigate the contribution of
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Fig. 3.4 Inspiratory pressure flow relationship for adult UAM without NHF and with NHF20, NHF40 and
NHF60 administered via the small, medium and large cannula. The error bars represent two standard deviations
in pressure measured over 25 cycles
inspiratory and expiratory resistance to the effort of breathing during NHF. The conclusions
can be generalised for all cannula sizes. Note that in Fig. 3.7, at zero tracheal flow (piston
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Fig. 3.5 A plot of expiratory resistance of the UAM at tracheal flow of 30 L/min when NHF20, NHF40 and
NHF60 were administered via the small, medium and large cannula sizes. The standard errors in resistance due
to errors in flow and pressure are shown by the error bars
not moving), the inflow through the cannula is balanced by the outflow through the leak area
between the nares and cannula prongs. The pressure (P2) at zero net flow is non-zero for all
NHF and increases with increasing NHF. These pressures are produced by the stagnation of
the cannula jet in the upper airway. The zero-therapy state, ZT, (no cannula in place, no NHF
flow) is also shown. It is observed that the pressure (effort) required to produce a particular
tracheal flow through the upper airway increases with NHF for expiration but reduces for
inspiration. However the pressure change required to produce a given change in flow is
greater during inspiration.
As shown in Fig. 3.7, the change in inspiratory pressure (dPi) required to increase tracheal
flow by 10 L/min is greater than that required by expiration (dPe). This suggests a greater
inspiratory resistance than expiratory resistance.
At the flow rate named zero pressure inspiratory flow (ZPIF) in Fig. 3.7, the pressure
at the trachea required to drive inspiratory flow is zero. This flow rate is referred to as the
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Fig. 3.6 A plot of inspiratory resistance of the UAM at tracheal flow of 30 L/min when NHF20, NHF40 and
NHF60 were administered via the small, medium and large cannula sizes. The standard errors in resistance due
to errors in flow and pressure are shown by the error bar
zero pressure inspiration flow (ZPIF). As NHF increases the ZPIF also rises. At flow rates
between ZPIF and zero no muscular effort is required to drive inspiration against upper
airway resistance. Inspiration is driven by NHF. In Fig. 3.8, the breathing flow of a male
adult (age = 24 years) is shown. The horizontal lines represent the ZPIF.
When NHF20 is applied, for instance, from the start of inspiration up to a flow rate of
7.5 L/min (ZPIF at NHF20), no respiratory effort will be required to overcome upper airway
resistance. Only the effort needed to overcome lower airway resistance and lung elastance is
required. Muscular effort is only required to overcome upper airway resistance between time
= a and time = b until expiration begins. As NHF flow rate increases, ZPIF rises and less
effort is required over the inspiratory phase. Note that the ZPIF at NHF60 is greater than the
peak inspiratory flow suggesting effortless inspiratory breathing across the upper airway.
The following illustration shows how the uncertainties in K1 and K2 (Table 3.2) were
calculated. At NHF60, the average pressure and standard deviation corresponding to the
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Fig. 3.7 Pressure-flow relationship for adult UAM during inspiration and expiration at ZT and NHF20, NHF40
and NHF60, administered via the medium cannula. The error bars represent two standard deviations in pressure
measurement
steady tracheal flows ranging from 0 to 50 L/min (in steps of 10 L/min) are 1.66±0.01,
1.89±0.05, 2.53±0.05, 3.37±0.05, 4.46±0.06, 5.77±0.1 (all in units of cmH2O). Subtracting
the greatest standard deviation i.e. 0.1 cmH2O (in the last data point) from all the pressure
averages except 5.77 cmH2O and adding 0.1 cmH2O to 5.77 cmH2O gives the following
data point (only averages): 1.56, 1.79, 2.43, 3.27, 4.36, 5.87 (in cmH2O), herein referred to
as uncertainty data. In Fig. 3.9, the averages of the latter pressure data (uncertainty data)
and those of the former are plotted against flow. It is seen that the uncertain data deviates
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Fig. 3.8 The breathing flow pattern of a male adult (age =24). The ZPIF for NHF20, NHf40 and NHF60
found for the UAM are shown
Fig. 3.9 Plots showing maximum deviation in pressure data
from the original data and represent greatest deviation that can be seen in the original data.
The K1 and K2 values for both plots (Fig. 3.9) were calculated (by fitting to Eq. 3.1). The
differences between these resistance coefficients for both plots indicates the uncertainty in
their estimation.
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The calculated K1 and K2 values (and uncertainties in their estimation) for inspiration and
expiration for all cannula sizes during ZT, NHF20, NHF40 and NHF60 have been presented
in Table 3.2.
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Table 3.2 Resistance coefficients of the adult UAM (in close mouth state) during ZT and administration of
NHF20, NHF40 and NHF60 via the small, medium and large cannula sizes. R2 denotes the coefficient of
determination of the least squares fit of the pressure flow plots Rohrer’s equation
Inspiration Expiration
K1 K2 R2 K1 K2 R2
ZT 0.04±0.01 4.89±0.11 0.99 0.19±0.01 4.09±0.09 1.00
Small cannula
NHF20 0.24±0.30 5.00±0.14 1.00 0.25± 0.08 4.43±0.06 1.00
NHF40 1.23±0.26 4.54±0.13 0.99 0.57±0.09 4.10±0.07 1.00
NHF60 1.64±0.53 4.72±0.35 1.00 1.15±0.69 3.63±0.48 1.00
Medium cannula
NHF20 0.48±0.36 4.90±0.22 1.00 0.61±0.07 4.09±0.05 0.99
NHF40 1.40±0.01 4.40±0.12 0.99 1.26±0.24 3.93±0.07 0.99
NHF60 2.28±0.50 4.14±0.33 1.00 1.13±1.07 4.63±0.83 1.00
Large cannula
NHF20 0.39±0.26 5.15±0.36 0.99 0.64±0.15 4.32±0.00 1.00
NHF40 1.49±0.40 4.26±0.22 0.99 1.26±0.29 4.00±0.15 0.99
NHF60 2.26±0.25 4.18±0.11 0.99 1.97±0.04 3.61±0.09 1.00
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3.3.2 Adult airway pressure and resistance (mouth open)
Fig. 3.10 shows the pressure flow characteristics of the adult UAM during open mouth
breathing. The error bars represent two standard deviations in measured tracheal pressure
over 25 cycles (5 cycles from 5 separate repeats).
Fig. 3.10 Expiratory pressure flow relationship for adult UAM without NHF and with NHF20, NHF40 and
NHF60 administered via the small, medium, and large cannula. The error bars represent two standard deviations
in pressure measured over 25 cycles
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Error bar overlap is observable at NHF40 and NHF60 between the plots of the small and
medium cannula. Th expiratory tracheal pressure produced at each tracheal flow (ranging
from 0 to 50 L/min) by the large cannula was divided by that of the small cannula. The range
and mean of the ratios at NHF20, NHF40 and NHF60 are 0.99 - 1.29 (1.09), 1.06 - 1.42
(1.21), 1.08 - 1.40 (1.22) respectively. Identical ratios were computed for the inspiratory
phase. The range and mean of the ratios corresponding to NHF20, NHF40 and NHF60
are 0.73 - 1.29 (1.0) , 0.69 - 2.66 (1.25), 0.67 - 1.40 (1.23) respectively. Comparing the
mean ratio during expiration to that of inspiration at NHF40 and NHF60, it is seen that
they are within a narrow range. By taking the average of the corresponding means (e.g.
(1.21+1.25)/2 = 1.23, at NHF40), it is concluded that in open mouth breathing, for both
inspiration and expiration, there is a tracheal pressure rise of 23 % at NHF40 and NHF60,
and 9 % at NHF20 when the small cannula is used instead of the large cannula.
Fig. 3.11 shows inspiratory pressure flow plots during mouth open breathing with the
small and medium cannula producing almost the same tracheal pressures (also greater than
that of the large cannula) at all tracheal flows as observed for the expiratory phase. In
the closed mouth breathing state, the large cannula produced the greatest airway pressure
(Fig. 3.3). In general, mouth open breathing engenders lower airway pressures compared to
mouth closed breathing. The resistance coefficients (and their uncertainties) calculated from
the pressure flow plots on Fig. 3.10 and Fig. 3.11 are presented in Table 3.3
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Fig. 3.11 Inspiratory pressure flow relationship for adult UAM without NHF and with NHF20, NHF40 and
NHF60 administered via the small, medium, and large cannula. The error bars represent two standard deviations
in pressure measured over 5 cycles
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Table 3.3 Resistance coefficients of the adult UAM (in open mouth state) during ZT and administration of
NHF20, NHF40 and NHF60 via the small, medium and large cannula sizes. R2 denotes the coefficient of
determination of the least squares fit of the pressure flow plots Rohrer’s equation
Inspiration Expiration
K1 K2 R2 K1 K2 R2
ZT 0.03±0.05 1.88±0.21 1.00 0.08±0.02 1.48±0.32 1.00
Small cannula
NHF20 0.05±0.02 1.91±0.16 1.00 0.20±0.19 1.35±0.24 1.00
NHF40 0.38±0.23 1.51±0.40 1.00 0.93±0.10 0.72±0.04 1.00
NHF60 0.95±0.85 0.98±0.70 1.00 1.65±0.70 0.32±0.07 1.00
Medium cannula
NHF20 0.08±0.03 1.88±0.12 1.00 0.20±0.17 1.40±0.22 1.00
NHF40 0.33±0.05 1.58±0.49 0.99 0.88±0.04 0.85±0.03 1.00
NHF60 0.92±0.85 1.58±0.49 1.00 1.57±0.56 0.51±0.45 0.99
Large cannula
NHF20 0.06±0.00 1.89±0.12 0.99 0.21±0.08 1.39±0.13 1.00
NHF40 0.23±0.04 1.69±0.38 0.99 0.74±0.01 0.93±0.04 1.00
NHF60 0.72±0.66 1.17±0.52 1.00 1.22±0.08 0.77±0.02 1.00
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3.3.3 Adult airway pressure: mouth closed (MC) versus mouth opened
(MO); expiration versus inpiration
From Fig. 3.3, Fig. 3.4, Fig. 3.10 and Fig. 3.11, it is concluded that tracheal pressure varies
with tracheal flow, NHF flow, mouth state (closed or opened) and cannula size. How the
airway pressure during mouth closed (MC) breathing compares to mouth opened (MO)
breathing under conditions of NHF may have clinical implications. The tracheal pressure, at
a particular NHF and tracheal flow, were averaged for all cannula sizes as:
([Pressure]OPT 842 +[Pressure]OPT 844 +[Pressure]OPT 846)/3 (3.3)
[Pressure]OPT 842, [Pressure]OPT 844, [Pressure]OPT 846 are the tracheal pressures correspond-
ing to the small (OPT842), medium (OPT844) and large (OPT846) cannula respectively. The
average pressure (Eq. 3.3) at all NHF (NHF20, NHF40, and NHF60) and tracheal flows (for
both MC and MO states) are presented in Table 3.4. The ratios of the MC pressure to the
MO pressure (MC/MO), are also presented in Table 3.4.
It is observable that the MC/MO ratio for all tracheal flows at a particular NHF are close.
This prompted the calculation of the averages of these ratios and their standard deviations
(see Table 3.4 (italicised)). Note how the average MC/MO ratios corresponding to NHF20
(2.81), NHF40 (2.75) and NHF60 (2.66) are within a narrow range i.e. 2.66 to 2.81 during
expiration. The difference in ratios at different NHF is less than one standard deviation i.e.
not statistically significant. The range of ratios for inspiration is 2.97 to 3.29. Due to the
very low inspiratory tracheal pressure (during MO breathing) at tracheal flows of 10 L/min
and 20 L/min for NHF40 and NHF60 respectively, – see asterisks in Table 3.4, the very high
corresponding pressure ratios were treated as outliers (as they are far greater than the other
ratios) and were not included in the calculation of the average of the pressure ratios. The
excluded values (outliers) are due to division by lower values of MO tracheal pressures.It
can be concluded that irrespective of the tracheal flow and NHF, expiratory MC breathing
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produces an average tracheal pressure (standard deviation) which is 2.7 (0.28) times that of
MO breathing whilst that for inspiration is 3.1 (0.34) times greater .
Table 3.4 Average tracheal pressure of small, medium and large cannula for MC and MO breathing
Expiratory pressure (cmH2O)
NHF









0 0.15 0.05 3 0.72 0.22 3.24 1.61 0.49 3.26
10 0.36 0.15 2.35 1.01 0.39 2.57 1.93 0.73 2.62
20 0.80 0.29 2.79 1.51 0.62 2.43 2.54 1.02 2.47
30 1.47 0.50 2.95 2.24 0.86 2.61 3.29 1.37 2.40
40 2.39 0.81 2.96 3.19 1.15 2.78 4.30 1.71 2.51
50 3.55 1.2 2.96 4.36 1.53 2.86 5.53 2.08 2.66
Average of ratios 2.81 2.75 2.66
Std. Dev. of ratios 0.23 0.28 0.31
Inspiratory pressure (cmH2O)
NHF









0 0.15 0.05 3.00 0.72 0.22 3.24 1.61 0.49 3.26
10 -0.08 -0.02 4.00 0.37 0.007 *5.61 1.13 0.26 4.35
20 -0.57 -0.18 3.09 -0.24 0.09 2.80 0.44 0.02 *18.81
30 -1.31 -0.45 2.91 -1.06 -0.34 3.16 -0.52 -0.19 2.67
40 -2.36 -0.83 2.85 -2.15 0.70 3.06 -1.69 -0.54 3.11
50 -3.70 -1.32 2.80 -3.48 -1.18 2.95 -3.13 -1.01 3.08
average of ratios 2.97 3.04 3.29
Std. Dev. of ratios 0.22 0.17 0.63
The change in tracheal pressure with breathing direction (inspiration or expiration) under
NHF conditions was also investigated. This was done by finding the ratio of the expiratory
and inspiratory tracheal pressure at all tracheal flows at a particular NHF in Table 3.4. For
instance, during MC breathing at NHF20, the expiratory to inspiratory pressure ratios for
tracheal flows ranging 0 - 50 L/min in steps of 10 L/min are 0.15/0.15 = 1,0.36/0.08 =
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4.35,0.80/0.57 = 1.40,1.47/1.31 = 1.13,2.39/2.36 = 1.01,3.55/3.70 = 0.96. It is seen
that these ratios are comparable except for second term (0.36/0.08 = 4.35 , which is due to
the low inspiratory pressure near the ZPIF) which is considered as an outlier. The average of
these ratios equals 1.10. Such average ratios were calculated for NHF40 and NHF60 and
these corresponded to 1.71 and 1.75. Note that these average ratios are based on pressure
data (Tabel 3.4) averaged over cannula size (Eq. 3.3). By taking into account the variations
due to cannula size, the ratio of expiratory pressure to inspiratory pressure was 1.04 - 1.14
(for NHF20), 1.59 - 1.86 (for NHF40) and 1.72 - 2.33 (for NHF60). Identical average ratios
were were computed for MO state. The range for ratios corresponding to NHF20, NHF40
and NHF60 are 1.09 - 1.12, 1.45 - 2.32, 2.18 - 2.33.
It is concluded that in both MC and MO states, the ratio of expiratory to inspiratory
tracheal pressure rises with NHF. Generally, for MC state, the percentage rise of expiratory
tracheal pressure over inspiratory tracheal pressure at NHF20, NHF40 and NHF60 are 9 %,
72 % and 103 % respectively. For MO state, the expiratory pressure rises by 11 %, 88 %
and 125 % for NHF20, NHF40 and NHF60 respectively. Note that these percentages are the
averages of the range of ratios presented above.
3.4 Neonatal Airway Pressure and Resistance
The pressure flow plots obtained when NHF of 3 L/min (NHF3), 6 L/min (NHF6) and 9
L/min (NHF9) were delivered via the OPT314 (smaller) and OPT316 (larger) cannula sizes
are shown on Fig. 3.12. That for zero-therapy (ZT) - no NHF - is also shown. The error bars
represent two standard deviations computed over 25 cycles (5 cycles from 5 separate tests). It
is observable that cannula size makes no significant difference to inspiratory (negative flow)
pressure flow characteristics (as the error bars overlap) except at NHF9.
During expiration, cannula size produces a significant difference in tracheal pressure
for all NHF except NHF3. OPT316 produces a greater tracheal pressure during inspiration
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Fig. 3.12 Inspiratory and expiratory pressure flow relationship for the neonate UAM without NHF and with
NHF3, NHF6 and NHF9 administered via OPT314 and OPT316 cannula. The error bars represent two standard
deviations in pressure measured over 5 cycles
and expiration at NHF9. This is consistent with the recommended use of OPT314 (which
is specified for NHF range of 2 - 8 L/min) and OPT316 (NHF range of 3 - 15 L/min).
At NHF6 however, OPT314 produces a greater tracheal pressure compared OPT316. The
resistance coefficients (and their uncertainties) calculated for the pressure flow plots shown
on Fig. 3.12 are presented in Table 3.5. It can be seen that the linear resistance coefficients,
K1, consistently increase with NHF for both inspiration and expiration irrespective of cannula
size. The nonlinear component, K2, decreases with NHF during inspiration for OPT314
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and expiration for OPT316. K2 follows no particular trend during the expiratory phase for
OPT314 and inspiratory phase for OPT316.
Table 3.5 Resistance coefficients of the neonate UAM (in closed mouth state) during ZT and administration
of NHF3, NHF6 and NHF9 via the small, medium and large cannula sizes. R2 denotes the coefficient of
determination of the least squares fit of the pressure flow plots Rohrer’s equation
Inspiration Expiration
K1 K2 R2 K1 K2 R2
ZT 3.62±1.31 84.97±24.94 1.00 3.18±2.18 76.77±36.15 1.00
OPT314 cannula
NHF3 5.86±1.79 75.02±11.04 1.00 11.33±3.50 53.55±27.18 1.00
NHF6 13.47±3.78 21.30±13.47 1.00 18.87±3.17 74.63±24.86 1.00
NHF9 20.05±2.91 12.88±3.02 1.00 23.19±5.02 88.87±41.44 1.00
OPT316 cannula
NHF3 6.47±3.44 63.46±25.83 1.00 8.94±2.59 74.03±18.40 1.00
NHF6 14.67±3.46 18.05±12.78 1.00 12.72±4.90 51.16±37.36 1.00
NHF9 32.61±12.45 91.21±35.89 0.99 20.80±3.07 22.15±5.01 0.99
The resistance of the neonate UAM to a tracheal flow of 5 L/min at ZT, NHF3, NHF6
and NHF9 have been shown in Table 3.6. At a tracheal flow of 5 L/min, inspiratory and
expiratory resistance consistently increase with NHF in both cannula sizes. OPT314 (which
is smaller) however produced a greater expiratory resistance but a generally lower inspiratory
resistance than OPT316.
Table 3.6 Resistance of neonate UAM at 5 L/min during NHF

















NHF3 12.11 15.79 11.76 15.11
NHF6 15.25 25.09 16.17 16.99
NHF9 21.13 30.59 40.22 22.65
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3.5 Discussion
The present study supports previously reported observations (Locke et al. (1993); McGinley
et al. (2007); Parke et al. (2009)) that airway pressure increases with NHF and varies with
cannula size (Mündel et al. (2013)). This study is however the first to explore the effect of
cannula size on airway pressure in anatomically realistic airway model of an adult and a
neonate and further examine the influence of mouth state (open or closed) on airway pressure
for a wide range of NHF (20 to 60 L/min). The use of an invasive method to obtain tracheal
pressure may be a reason why these studies have not been done clinically. Mündel et al.
(2013) found that NHF of 15 L/min produced a greater nasal pressure with the large cannula
compared to the small cannula. Their model was simpler than the current one, with an
axis-symmetric passage including a constriction that simulated the nasal valve. Their results
and the present results agree qualitatively.
In the closed mouth state, the leak area between the cannula prong and the nostril
contributes to the rise in pressure with cannula size as the expired flow must pass through a
smaller area with greater pressure loss. As expected, the large cannula was found to produce
the greatest resistance whilst the small cannula produced the least in the adult upper airway
model. At NHF40 (mouth closed state) for instance, the expiratory resistance due to NHF
administration via the large cannula was 20% higher than when delivered through the small
cannula.
In open mouth state (adult UAM), the small and medium cannula produced a greater
tracheal pressure than the large cannula during inspiration and expiration. Spence (2011)
found that during expiration, the cannula flow passing through the nasopharynx towards the
trachea joins the lung flow and exits via the oral cavity as shown in Fig. 3.13. The cannula
flow through the nasopharynx (towards the trachea) was observed to decrease with increasing
expiratory lung flow whilst the leakage through the area between the cannula prongs and
nostril greatly increased (Spence (2011)). Since the smaller cannula, compared to the large
cannula, produces a jet of greater momentum and penetration into the nasopharynx, relatively
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Fig. 3.13 Expiratory flow path during mouth open breathing
higher amounts of cannula flow will reach and exit the oral cavity. This explains the greater
tracheal pressure (due to the small cannula) as the expiratory lung flow must interact with the
cannula flow.
The inspiratory and expiratory airway resistance increase in an NHF dependent manner.
In Table 3.2 and Table 3.3 it can be seen that the inspiratory resistance is consistently greater
than the expiratory resistance. This can be attributed to the geometry of the UAM and NHF.
The airway geometry in the inspiratory direction differs from the geometry in the expiratory
direction. Ferris et al. (1960) measured the pressure flow characteristics of 6 spontaneously
breathing male adults and found a greater inspiratory resistance. NHF was observed to
cause a greater change in pressure over the same flow range in the inspiratory direction
than in the expiratory direction (Fig. 3.7). During NHF administration, inspired flow from
the atmosphere will require a greater pressure drop because of the relatively small area
between the cannula prongs and the nostril. Also, there may be a further pressure drop due
to the interaction of the cannula leak with the inspired flow. For both mouth state breathing
(closed and open), K1 increases monotonically with NHF but K2 decreases with NHF. The
uncertainty in the prediction of K1 and K2 is greater at NHF of 60 L/min as fluctuations in
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tracheal pressure at NHF of 60 L/min was relatively greater. In consideration of the range of
uncertainties, it appears that at any given NHF flow rate, K1 and K2 appear to be insensitive
to cannula size.
In the neonate UAM (which is a closed mouth model) the OPT316 (the largest) produced
a significantly greater inspiratory resistance at NHF of 9 L/min whilst OPT314 (the smallest)
produced a greater expiratory resistance at all other NHF. On the basis of the amount of
extrinsic positive end-expiratory pressure (ePEEP) that can be delivered at a greater NHF,
the present results supports the recommendation by the manufacturers to use OPT316 for
NHF in the range of 3-15 L/min.
On expiration, the breathing flow travels against cannula flow leading to more shear
and higher turbulence (i.e. higher K2 on expiration than inspiration): generally seen in
Table 3.5 with some exceptions the quadratic Rohrer equation does not describe the pressure
flow relationship well). However the values of K1 during expiration and inspiration are
comparable. In the adult UAM (mouth closed state) the opposite seems to hold (expiration
has higher K1 but lower K2 than inspiration). Most of the difference is in the laminar term
(K1).
A resting neonate, about the same size as the neonate model will have a peak inspiratory
flow of about 5 L/min (te Pas et al. (2009)). At this flow, its upper airway resistance will
be 10.77 cmH2O/L/s (Table 5). A healthy 44 year old adult (the adult UAM) will have a
resting peak inspiratory flow 30 L/min (Morris and Lane (1981)) which corresponds to an
airway resistance of 2.5 cmH2O/L/s. Therefore at peak inspiratory flow rates, the neonatal
airway resistance is about 4 times that of the adult model. This is not surprising as according
to the Poiseuille’s law for flow through a straight pipe (Resistance = 8nl/πr4,wheren =
viscosity,r = radius, l = length), the resistance varies with 1/r4 for a laminar flow regime.
It must be mentioned that the tracheal diameter of the adult model (at the mentioned peak
flows) is 3 times that of the neonate and the Reynolds number (at the same point, and for the
peak flows) is 1063 neonate model (trachea) and 2014 for the adult model (trachea). The
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upper airway produces a quadratic relationship between flow and pressure (Eq. 3.1) because
the flow in some regions of the airway (nasal valve for instance) is partly turbulent. Because
of the relatively large tidal volume of adults compared to neonates, the work of breathing
of an adult is expected to be greater than that of a neonate in spite of the observed lower
resistance of th adult UAM. See chapter 4 for a comparison of neonatal and adult work of
breathing.
3.5.1 Limitations
There are some limitations associated with this work. Measurements of resistance coefficients
was limited to one individual adult and neonatal airway model. Upper airway geometry
varies from one individual to another however the general shape is the same, as the range
of Reynolds numbers. It is expected that the results presented in this chapter will vary
quantitatively but agree qualitatively with results from other airway geometries.
The UAM lacks the mucosal layer and compliance which the biological upper airway
possesses. Though changes in airway surface properties may affect flow via development of
viscous forces, the thin mucosal layer present in the healthy individual is reported to produce
little effect on flow (Clarke et al. (1970))
Also, a significant upper airway compliance may require an extra pressure drop but the
small compliance of the upper airway (≈ 3 ml/cmH2O) (Mead (1969)) will exact a minimal
pressure drop. It is plausible however that under conditions of high airway compliance
and thick mucosal lining, the estimated upper airway resistance may disagree with those
presented here.
3.6 Conclusion
The data presented here suggests that in mouth closed state, the large cannula effects a
greater expiratory pressure than the small cannula during expiration (in inspiration, small
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cannula pressure is greater). During mouth open breathing the small cannula produced a
greater airway pressure than the large cannula. The disparities in airway pressure due to
cannula size were significant at NHF60 (no error bar overlap). Mouth closed breathing
produces approximately 3 times as much airway pressure as mouth open breathing at all
NHF. Inspiratory airway resistance was found to be greater than expiratory resistance though
both rise with NHF. In spite of the rise in inspiratory resistance with NHF, the concept of
zero-pressure inspiration flow (ZPIF) (see Fig. 3.8) suggests a possible reduction in work
of breathing due to effortless breathing at lower values of tracheal flow ( < ZPIF). At their
respective peak inspired flow (neonate =5 L/min, adult =30 L/min), the neonatal airway
resistance was found to be a factor of 4 greater than the adult airway resistance. In regards to
the range of uncertainty values calculated in the estimation of K1 and K2, the influence of
cannula size appears to be insignificant.

Chapter 4
How NHF may Affect Work of Breathing
4.1 Introduction
Individuals suffering from chronic airway disorders, mild obstructive sleep apnoea, acute
hypoxemic respiratory failure and post-operative hypoxemia have been reported to benefit
from nasal high flow (NHF) therapy (Porhomayon et al. (2016); Rea et al. (2010); Roca
et al. (2010)). NHF involves the administration of warmed and humidified air, which may
be enriched with more oxygen, at flow rates up to 60 L/min for adults and 8 L/min for
neonates (Manley et al. (2013); Motojima et al. (2016); Ojha et al. (2013); Ward (2013)). The
conditioned air is supplied to the patient via a breathing circuit connected to a nasal cannula.
Dysart et al. (2009) postulated some mechanisms of action of NHF and these included
a reduction in mechanical work of breathing (WOB) - the muscular effort which drives
breathing. Dysart et al. (2009) suggested that inspiratory WOB was reduced as NHF provides
air flow, which supplies inspiratory flow without effort by the patient. However, NHF may
raise expiratory WOB as the patient must expel air against the cannula jet.
Esophageal pressure is often measured as a surrogate for pleural pressure (Rubin et al.
(2014); Saslow et al. (2006)). The standard method for the measurement of mechanical WOB
is to compute the area under the pressure–volume loop, also known as Campbell diagram
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(Pandit et al. (2001)). In Fig. 4.1, a pressure-volume loop, adapted from Saslow et al. (2006)
is shown for the inspiratory and expiratory phases of a single breath cycle. The area of the
dashed triangle (stored elastic energy) plus the area labelled rWOBi represent the WOB at
the end of inspiration. rWOBi is the energy dissipated in overcoming inspiratory airway
resistance. In a healthy state, expiration is passive, as part of the elastic energy is used to
overcome expiratory airway resistance (rWOBe) (Cabello and Mancebo (2006); Otis et al.
(1950); Saslow et al. (2006)). The overall energy (rWOB) dissipated in overcoming airway
resistance equals the sum of rWOBi and rWOBe.
Fig. 4.1 Plot of pressure versus volume with bounded area indicating WOB
This method of finding work of breathing (as illustrated in Fig. 4.1) is known as planimet-
ric analysis. In the presence of a resistive disease (increased inspiratory airway resistance e.g.
pulmonary fibrosis), rWOBi will be greater relative to a healthy subject. In the presence of an
obstructive disease (increased expiration airway resistance) e.g. COPD and asthma, rWOBe
will be greater relative to a healthy subject. Rubin et al. (2014) and Willis et al. (2005) used
the pressure-rate product as a surrogate for WOB under conditions of NHF in a population
of neonates and children and reported a decrease in WOB due to NHF. By providing positive
end expiratory pressure (PEEP) with a pressure support device, Graham et al. (2006) arrived
at the same conclusion for children. A recent clinical study using electrical impedance
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tomographic techniques has provided some evidence on the reduction of diaphragmatic
electrical activity under the influence of NHF - suggesting in some sense, the ’offloading’ of
the diaphragmatic muscular effort during inspiration and hence a reduction in mechanical
work of breathing Pham et al. (2014). To date, evaluation of WOB has been limited to the
inspiratory breathing phase (Pham et al. (2014); Rubin et al. (2014); Saslow et al. (2006)). It
is reasonable to expect that breathing out against an NHF jet through the open area of the
nares when the cannula is in place will require more effort than when NHF is absent. The
resistance of the upper airway, from the nares to the trachea constitutes about two-thirds of
the total airway resistance (Ferris et al. (1960)). In Chapter 3, the upper airway resistances of
an anatomically representative rigid model of an adult and a neonate were measured under
NHF conditions. In this chapter, the WOB model proposed by Otis et al. (1950) is refined by
incorporating clinically observed changes in respiratory parameters during the administration
of NHF. The refined model is then used to predict the changes in resistive WOB (rWOBi and
rWOBe) due to NHF.
4.1.1 Chapter nomenclature
Ai - inspiratory flow amplitude
Ae - expiratory flow amplitude
CV - coefficient of variation
I:E ratio - ratio of inspiratory time to expiratory time
Kel - lung elastance MCB - mouth closed breathing
MOB - mouth open breathing
MV - minute volume
PEF - peak expiratory flow
PIF - peak inspiratory flow
RR - respiratory rate
rWOB - resistive work of breathing
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rWOBe - expiratory resistive work of breathing
rWOBi - inspiratory resistive work of breathing
rWOBzt - work of breathing during zero-therapy
St.D - standard deviation
Ti - inspiratory time
Te - expiratory time
Vt - tidal volume
WOB - work of breathing
ZT - zero therapy (no therapy)
ZPIF - zero pressure inspiratory flow
δZT (%) - percentage change in rWOB due to NHF
4.2 Work of Breathing Model Setup
Due to a lack of clinical data (which is necessary for planimetric analysis), a mathematical
derivation of WOB based on known equations which govern lung and airway mechanics will
be explored to examine the influence of NHF on WOB. Here, a basic assumption is made
that the flow wave is sinusoidal - this simplifies the computations involved but preserves
the generality of the conclusions to any flow pattern as the model is not history-dependent.
Fig. 4.2 shows a sinusoidal waveform with amplitude, A, and period, T, representing the flow
waveform.
The mathematical representation of the sinusoid is presented in Eq. 4.1. In this work, the
period of positive flow rate is inspiration, and negative flow rate is expiration. Note that by
assuming a sinusoid, an inherent assumption is made that I:E ratio equals unity. A method
for incorporating a more physiologically correct value of I:E ratio will be presented later in
this work. The tidal volume (Vt) equals the area under the inspiratory or expiratory portion
of the flow waveform and can be found by direct mathematical integration of Eq. 4.1 from 0
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Fig. 4.2 Sinusoidal signal representing the breathing flow waveform
to t = 0.5T (see Eq. 4.2 which also describes the relationship between the flow amplitude












P = KelVt +KaF +KbF2 (4.3)
Eq. 4.3 describes the pressure required to overcome lung elastance (resistance of the
lungs to inflation) and the resistance of the airway to air flow (second and third terms of
Eq. 4.3). In Eq. 4.3, Kel represent elastance of the lungs and Ka and Kb are the resistance
coefficients of the entire airway, upper plus lower. Since the upper and lower airways are
coupled in series, the total airway resistance must be equal to their sum i.e. Ka = K1 +Km
and Kb = K2 +Kn where Km and Kn are the laminar and turbulent resistance coefficients of
the lower airways and K1 and K2 are those of the upper airway.
72 How NHF may Affect Work of Breathing
The lower airway resistance consists of a principally laminar pressure loss due to flow.
The pressure loss due to flow, being largely laminar due to low Reynolds number, is the same
whether NHF is applied or not (losses are linear with flow, so integrated work over a given
volume passed is the same whether breathing a short fast flow or long slow flow if the patient
breathes the same MV). Only the pressure required to produce flow through the upper airway
during inspiration and expiration is relevant to the present work.
The pressure (PUA) required to produce flow through the upper airway during inspiration,
(iPUA), is described by Eq. 4.4 and that for expiration, (ePUA), is described by Eq. 4.5. iK1
and iK2 (Eq. 4.4) are the resistance coefficients of the upper airway during inspiration and
eK1 and eK2 (Eq. 4.5) are the expiratory upper airway resistance coefficients.
iPUA = iK1 + iK2F2 (4.4)
ePUA = eK1 + eK2F2 (4.5)
Given the breath-by-breath variability in tidal volume, which Tobin et al. (1983) estimated
to be 33 ± 14.3 % for 47 healthy young adults (mean age = 28.6 years), the WOB averaged
over a minute (work rate, WOB/min) was thought to be a better representation of the influence
of NHF on respiratory effort. Mathematically, the area under the upper airway pressure-
volume curve is equivalent to the integral shown in Eq. 4.6 which when solved, yields Eq.
4.7. The product of Eq. 4.7 and the respiratory rate (RR) (number of breaths per minute)
yields Eq. 4.8 – which was first presented by Otis et al. (1950). By replacing K1 and K2 in
Eq. 4.8 with the inspiratory and expiratory upper airway resistance coefficients, Eq. 4.9 is
obtained. Eq. 4.9 represents work done over a minute (expressed in J/min) in overcoming
the inspiratory and expiratory upper airway resistance by the close of the breathing cycle -
denoted as rWOB.








WOB = 0.25K1RR(πVt)2 +0.67K2π2RR2(Vt)3 (4.7)
WOB/min = 0.25(K1)(πRRVt)2 +0.67(K2)π2(RRVt)3 (4.8)
rWOB = 0.25iK1(πRRVt)2 +0.67(iK2)π2(RRVt)3+
0.25eK1(πRRVt)2 +0.67e(K2)π2(RRVt)3
(4.9)
The product of RR and Vt is the minute volume (MV). It can be seen (from Eq. 4.9)
that the work required to overcome airway resistance depends in part on MV. Nasal high
flow therapy has been widely reported to reduce RR but its effect on tidal volume (Vt) and
MV is complicated by disease state (Bräunlich et al. (2013)) and wakefulness (Mündel et al.
(2013)). The effect of NHF on I:E ratio has been investigated by Fraser et al. (2016) whose
results were used to infer how variation in I:E ratio might affect rWOB.
In what follows, rWOB for three categories of subjects are explored based on changes in
RR and Vt . These include subjects in whom (1) RR and Vt do not change (2) RR and Vt
change but I:E ratio is constant (3) RR, Vt and I:E ratio change with NHF. The values of K1
and K2 obtained for the adult and neonate upper airway models for varying NHF, cannula
sizes and mouth states (opened or closed) - see Chapter 3 (Tables 3.2, 3.3 and 3.5) - will be
used in the present Chapter. As a model for rWOB (during NHF) is being developed, only
the inspiratory and expiratory resistance coefficients of the adult upper airway model for
mouth closed state (with NHF delivered via the medium cannula) will be used.
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4.2.1 Subject in whom RR and Vt do not change
The Otis equation (Eq. 4.9) was used to compute rWOB for the adult upper airway model (see
Chapter 3, Figure 1) without NHF (zero-therapy, ZT) and with NHF of 20 L/min (NHF20),
40 L/min (NHF40) and 60 L/min (NHF60) administered during mouth close breathing. Here,
rWOB was calculated using the RR and Vt of a resting young adult i.e. 15 bpm and 0.5 L
respectively (Gisolf et al. (2004); Tobin et al. (1989)). The percentage change in rWOB due
to NHF was calculated using the formula: δZT (%) = 100(rWOBnh f − rWOBzt)/rWOBzt
where rWOBnh f is the rWOB during NHF and rWOBzt is the rWOB at ZT. The percentage
change in rWOB for NHF delivered via the medium cannula is shown in Table 4.1. Notably,
rWOB increases with NHF.
Table 4.1 Summary of results of rWOB using the Otis equation
NHF (L/min) NHF20 NHF40 NHF60
δZT (%) 24.54 66.54 93.40
Whilst the prediction made by the Otis equation makes sense as both inspiratory and
expiratory airway resistance were found to increase with NHF (see Tables 3.2 and 3.3,
Chapter 3), the Otis equation fails to capture the identified effect of zero-effort required to
inspire at flows below the zero-pressure inspiratory flow (ZPIF) (discussed in Chapter 3 and
re-illustrated here in Fig. 4.3). For the sinusoidal flow waveform being used (Fig. 4.2) the
half-sinusoid (Fig. 4.3) represents the inspiratory flow waveform and the horizontal lines
represent the ZPIF at NHF20, NHF40 and NHF60. By considering NHF20 for instance, at
the start of inspiration up to a flow rate of q L/min, no respiratory effort will be required to
overcome upper airway resistance but only that needed to overcome lower airway resistance
and lung elastance, which will be same as in spontaneous breathing. Therefore between times,
t = 0 and t = a , respiratory effort is reduced. Respiratory effort is generated to overcome
upper airway resistance for flows between q L/min and r L/min followed by another period
effortless breathing between time t = b to t = total inspiratory time (Ti).
4.2 Work of Breathing Model Setup 75
Fig. 4.3 Plot of sinusoidal inspiratory flow illustrating the ZPIF for NHF20, NHF40 and NHF60
This emphasizes the need to refine Otis’ approach to more accurately predict rWOB
under the influence of NHF. In the refinement of the Otis approach (Eq. 4.9), the integral








The ZPIF for mouth close breathing at NHF20, NHF40 and NHF60 were found to be 7.4,
16.5 and 24.8 L/min respectively (Chapter 3). Time a, can be found from the ZPIF using Eq.
4.11. Time b is simply the difference between inspiratory time, Ti and a for a symmetrical
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Note that at time 0 < t < a and b < t < Ti, i.e. at F < ZPIF, the tracheal pressure required
to drive inspiration is positive with respect to atmosphere. The diaphragm and intercostal
contraction yields negative pressure with respect to atmosphere (measured with respect to
atmosphere because atmospheric pressure acts on the outside of the chest wall). A negative
tracheal pressure requires muscular effort. A positive tracheal pressure requires no muscular
effort, and in fact the air is doing work on the chest (but this requires no expenditure of
calories in the muscles, and they cannot recoup energy by work being done on them).
Fig. 4.4 shows percentage changes in rWOB obtained using Model 1, which has been
juxtaposed with findings from the Otis Eq. (Table 4.1). It is noticeable that Model 1 predicts
a lower rWOB. NHF60 produces rWOB which is less than rWOB at ZT and it is partly due
to the effortless inspiratory breathing at NHF60 (as the ZPIF at NHF60 is greater than the
peak inspiratory flow).
Fig. 4.4 Comparison of result of the rWOB predicted the Otis Equation and Model 1.
Up to this point, rWOB has been computed with a flow signal which is a perfect sinusoid
– which implies that the inspiratory time (Ti) is equal to the expiratory time (Te) – I:E ratio is
unity - and that the peak inspiratory flow (PIF) is equal to the peak expiratory flow (PEF).
This assumption is not realistic. Physiologically, the Ti is lesser than Te whilst PIF is greater
than PEF during resting state breathing (Tobin et al. (1983)). These effects can be included
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by concatenating two sinusoids of different periods and amplitudes such that the rising phase
of one (Fig. 4.5, plot A) represents inspiration and the falling phase of the other (Fig. 4.5,
plot B) represent expiration as shown in Fig. 4.5, plot C. When a particular I:E ratio (Ti/ Te)
is specified, Eq. 4.12 can be used to compute Ti and Te as long as the period of the entire




;Ti = T −Te (4.12)
Fig. 4.5 Plot showing the concatenation of two sinusoids of different periods and amplitudes to define a more
realistic breathing waveform
By using the relationship between amplitude, tidal volume (Vt) and period shown earlier
(see Eq. 4.2), the inspiratory phase amplitude (Ai), will be equivalent to Vtπ/2Ti and in a like
manner, that of the expiratory phase (Ae) will be Vtπ/2Te – noting that inspired volume is
same as expired volume. In summary, a breathing waveform has been defined (Fig. 4.5, plot
C) such that by specifying three parameters i.e. I:E ratio, period, and tidal volume, the Ti, Te,
Ai and Ae can be modulated in a more physiologically correct way. Herein, this modification
incorporated into Model 1 will be referred to as Model 2. Using Model 2, the effect of NHF
on rWOB, re-evaluated using I:E ratio of 0.74 - measured average of 47 young adults (mean
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age = 28.6 years) by Tobin et al. (1983). Table 4.2 contains the rWOB and percentage change
relative to ZT (δZT (%)) computed using Model 2.
Table 4.2 rWOB results using Model 2
NHF (L/min) NHF0 (ZT) NHF20 NHF40 NHF60
rWOB (J/min) 0.86 1.06 1.32 1.13
δZT (%) - 24.54 66.54 93.40
Fig. 4.6 represents a summary of the progression of results obtained so far, starting with
the Otis equation (PIF = PEF, I:E ratio = 1) followed by Model 1 (ZPIF effect included
but I:E ratio = 1) and finally a definition of an adjustable waveform, Model 2 (PIF ̸= PEF,
I:E ratio 0.74). Note that the inclusion of a more realistic I:E ratio produces an increase in
Fig. 4.6 Plots of WOBr for MCB comparing results of the Otis equation, Model 1 and Model 2
rWOB. This makes sense because I:E ratio less than unity means a shorter Ti and a longer
Te which in turn produces a greater peak inspiratory flow (PIF) and a lesser expiratory flow
amplitude because Vt must be preserved. Note that the effect of the rising inspiratory flow
amplitude overbalances the effect of falling peak expiratory flow (PEF) because the ZPIF
effect is not applicable to the expiratory flow. It is concluded that rWOB rises with NHF if
MV remains unchanged and the Otis equation can be used as a first approximation of rWOB
for lower NHF (up to and including 20 L/min) under this condition (constant MV)
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4.2.2 Subject in whom RR and Vt change with NHF
The observed respiratory response to NHF where there is a fall in RR (Corley et al. (2011);
Riera et al. (2013); Sztrymf et al. (2011)) a rise in Vt (Corley et al. (2011); Riera et al. (2013))
but a general fall in MV (Bräunlich et al. (2013)) was considered. Bräunlich et al. (2013)
reported that 20 L/min NHF reduced MV by approximately 1 L in 15 patients suffering from
COPD (mean age = 67.7 years). Corley et al. (2011) studied 20 COPD patients (mean age
= 65 years), who were prescribed 50 L/min NHF, and observed a 3.4 bpm reduction in RR.
Based on these observations, MV was reduced by 1 L for every 20 L/min of NHF and RR
was reduced by 3.4 bpm for every 50 L/min NHF. Though a waveform with adjustable I:E
ratio has been defined, so far the assumption has been made that I:E ratio is not affected by
NHF so its value of 0.74 (Tobin et al. (1983)) will be constant in this section. A mathematical
expression which relates NHF to RR, MV and Vt such that an increase in NHF will reduce
RR, increase Vt but decrease MV was found. This was done by defining the NHF-induced
MV and Vt as linear functions of NHF (according to the clinical findings mentioned above)
of the forms respectively shown in Eq. 4.13 and Eq. 4.14. M, as defined by Eq. 4.15 is the
modifying function that reduces RR and increases Vt when NHF is applied. The parameters
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The inclusion of these NHF-dependent adjustments in MV and Vt to Model 2 defines
another model herein referred to as Model 3. The breathing flow predicted by Model 3 for
ZT, NHF20, NHF40 and NHF60, assuming a constant I:E ratio (0.74) have been presented in
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Table 4.3 Parameters defining modifying function, M
Symbol Name Value
nhf nasal high flow variable
dMV change in MV 1 (L/min)
nhfdMV NHF @ change in MV 20 (L/min)
MVZT MV @ ZT 7.5 (L/min)
dRR change in RR 3.4 (bpm)
nhfdRR NHF @ change in RR 50 (L/min)
RRZT RR @ ZT 15 (bpm)
VtZT Vt @ ZT 0.5 (L)
Fig. 4.7, where RR falls (period rises) and Vt rises with NHF. The ZPIF corresponding to the
applied NHF are also indicated.
Fig. 4.7 Flow signals respectively representing ZT and NHF breathing at NHF20, NHF40, and NHF60 with
NHF-adjusted MV
The percentage changes in rWOB relative to ZT, as predicted by Model 3 for NHF20,
NHF40 and NHF60 are shown in Table 4.4. It is noticeable that Model 3 predicts a lower
rWOB during NHF relative to rWOB at ZT. It is concluded that NHF increases rWOB when
MV remains unchanged but it produces a significant fall in rWOB when MV falls. This is
partly due to the ZPIF flow effect. Also, a fall in minute volume means a reduced Vt or RR
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Table 4.4 rWOB results predicted by Model 3
NHF (L/min) NHF0 (ZT) NHF20 NHF40 NHF60
rWOB (J/min) 0.86 0.71 0.53 0.14
δZT (%) - -17.04 -38.64 -83.75
or both, either of which requires lower muscular activity (lower muscular contraction for
reduced Vt and lower rate of muscular contraction for reduced RR).
4.2.3 Subject in whom RR, Vt and I:E ratio change
Fraser et al. (2016) found that administering NHF of 30 L/min caused a reduction in I:E ratio
of about 13 % in 30 males. This is the only report of I:E ratio variation with NHF to date and
was thus used to scale the I:E ratio with NHF (13 % fall in I:E ratio for every 30 L/min NHF)
– defined by Eq. 4.16
IEratio =−0.0032nh f +0.74 (4.16)
The inclusion of NHF-induced I:E ratio in Model 3 defines Model 4. According to Eq.
4.16, NHF20, NHF40 and NHF60 will respectively reduce I:E ratio by 8.6 % , 17.3 % and
26 %. The rWOB and percentage change in rWOB relative to ZT as predicted by Model 4 is
shown in Table 4.5. Fig. 4.8 compares the percentage changes in rWOB predicted by Model
3 to that of Model 4 during NHF. It is noticeable that Model 4 predicts a greater rWOB
relative to Model 3 for all NHF except NHF60. This happens because the peak inspiratory
flow (PIF) rises and peak expiratory flow (PEF) falls with I:E ratio to preserve Vt . Note
that the rise in PIF due to a fall in I:E ratio is greater than the corresponding fall in PEF.
Consequently, the energy loss due to the rise in PIF outweighs that due to the fall in PEF.
The ZPIF however remains greater than the PIF at NHF60 in spite of the fall in I:E ratio so
the energy required for inspiration remains zero whilst energy is saved due to the fall in PEF.
In summary, the rWOB for a situation where NHF is administered via the medium
cannula has been investigated for close mouth breathing in the adult UAM by incorporating
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Table 4.5 rWOB predicted by Model 4 for NHF20, NHF40 and NHF60
NHF (L/min) NHF0 (ZT) NHF20 NHF40 NHF60
rWOB (J/min) 0.86 0.77 0.66 0.09
δZT (%) - -9.61 -22.93 -89.42
Fig. 4.8 Percentage reduction in rWOB: Model 3 vs. Model 4
clinically observed changes in breathing characteristics sequentially into the Otis’ equation.
This process produced four Models for computing rWOB with Model 4 being the most
comprehensive. A flow chart summarizing the characteristics of each of the four models is
shown in Fig. 4.9 with the key additions highlighted.
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Fig. 4.9 Flow chart summarizing the rWOB Models
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4.3 Results
4.3.1 I:E ratio effect
On Fig. 4.10, the dashed lines represent flow waveforms predicted by Model 4 (MV and
I:E ratio reduces with NHF) and the continuous lines are those derived using Model 3 (MV
reduces with NHF, I:E ratio is constant). The ZPIF for NHF20, NHF40 and NHF60 are also
indicated. Reducing I:E ratio raises the PIF and lowers PEF.
Fig. 4.10 Plots showing the effect of I:E ratio on PIF, PEF and period
At NHF60, the ZPIF remains greater than the PIF in spite of the changes in I:E ratio
therefore inspiration will remain effortless and expiration will be relatively easier because of
the fall in PEF. For NHF to reduce rWOB via changes in I:E ratio, it must affect the breathing
flow characteristics in a way that raises the ZPIF above the PIF. Fig. 4.11 shows the changes
in rWOB and PIF as I:E ratio increases at NHF60. I:E ratio is expressed as a percentage of
the I:E ratio at ZT (I:Ezt) i.e. 100 % on the horizontal axis. The ZPIF for NHF60 i.e. 24.8
L/min is also indicated. It is noticeable that rWOB rapidly rises as I:E ratio falls below 60 %
of I:Ezt but rWOB rises gently as I:E ratio rises above 60 % of I:Ezt. This is because below
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60 % of I:Ezt, ZPIF (24.8 L/min) becomes lesser than the PIF. It can be concluded that the
optimum value of I:E ratio in regards to a lower rWOB is around 60 % of I:Ezt.
Fig. 4.11 Plot of changes I:E ratio with WOBr and PIF for mouth close breathing at NHF60
4.3.2 rWOB: mouth open versus closed state
So far the results presented have been obtained using the resistance coefficients derived from
the adult upper airway model in mouth closed breathing (MCB) state with NHF administered
via the medium cannula. The trends and conclusions reached are generally applicable to
the small and large cannula. Measurement of RR amongst 18 healthy participants made
by Ritchie et al. (2011) indicated that the RR during mouth open breathing (MOB) does
not fall as much as it does during MCB, though a possible decrease in MV was intimated.
The authors however did not measure variations in tidal volume. Information on the effect
of MOB on MV under NHF conditions is lacking. In a report on the effect of mouth flow
leakage on tidal volume and airway resistance during the administration of variable positive
airway pressure therapy (VPAP), Tuggey et al. (2007) observed a decrease of about 12 % in
tidal volume upon a switch from MOB to MCB. A direct comparison between VPAP and
NHF is however untenable.
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In what follows, the assumption was made that changes in Vt , RR and I:E ratio during
MCB and MOB are the same. Model 4 was then used to estimate rWOB during MOB. The
resistance coefficients as presented in Chapter 3 were used. The error propagated in rWOB
estimates, drWOB, due to uncertainties in the estimation of the resistance coefficients (dK1
and dK2) (see Chapter 3) is defined by Eq. 4.17 which reduces to Eq. 4.18 when the equation
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To compute the uncertainty propagation error for inspiratory rWOB, T in Eq. 4.18 was
replaced with Ti and dK1 and dK2 were respectively replaced with the uncertainties found for
the estimates of inspiratory K1 and K2 in Chapter 3. The same was done for expiration. The
uncertainty propagation error for total rWOB equals the sum of the inspiratory and expiratory
propagation errors. Fig. 4.12 shows a superimposed plot of the rWOB values for MCB and
MOB. MOB requires less muscular effort than MCB though rWOB for MCB and MOB
are close at NHF60. The error bars represent the uncertainty propagation error (computed
with Eq. 4.18) produced by the uncertainty in the estimation of the resistance coefficients
(Chapter 3).
In Fig. 4.13, it can be seen that MOB at NHF20 and NHF40 cause a greater percentage
fall in rWOB relative to ZT than MCB but lesser at NHF60. The inspiratory rWOB (iWOB),
expiratory rWOB (eWOB) and breath cycle rWOB (tWOB) for both MCB and MOB have
been presented in Table 4.6. The average (AVG) rWOB at a particular NHF, defined as the
sum of the rWOB of the small, medium and large cannula divided by three is shown in Table
4.6, with the standard deviation (St.D) of these three values presented in brackets. Also, the
coefficient of variation (CV) – defined as standarddeviationaveragerWOB is also shown. This also indicates
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Fig. 4.12 Plots showing the effect of cannula size and breathing state (MCB or MOB) on rWOB. S20 indicate
NHF20 via the small cannula. M and L respectively represent medium and large cannula. Error bars represent
uncertainty propagation error in rWOB due to uncertainty in estimation of resistance coefficients.
Fig. 4.13 Plot showing the percentage fall in rWOB due to NHF relative ZT for MCB and MOB. S20 indicate
NHF20 via the small cannula. M and L respectively represent medium and large cannula
variability in rWOB due to cannula size. The uncertainty propagation errors in the estimation
of rWOB due to uncertainties in the estimation of the resistance coefficients have also been
presented along with the changes in rWOB relative to ZT (δZT (%)).
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4.3.3 Effect of cannula size on rWOB
In Fig. 4.12, it is seen that for both MCB and MOB, changes in rWOB between the medium
and large cannula are insignificant (due to overlap of error bars) but significant between
the large and small cannula especially at NHF20 and NHF40. The coefficient of variation
(standard deviation/average) (in Table 4.6) rises with NHF for MCB and MOB (falls at
NHF60). In Chapter 3 it was observed that the error in tracheal pressure at NHF60 was
greater pressure.
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Table 4.6 Inpiratory, expiratory and cycle rWOB computed for ZT, NHF20, NHF40 and NHF60 during MCB
and MOB. S20, M20, L20 respectively denote NHF20 via the small, medium and large cannula
Mouth Closed Breathing (MCB)
iWOB eWOB tWOB Error δZT (%)
ZT 0.615 0.241 0.855 0.042 -
S20 0.574 0.158 0.732 0.031 14.5
M20 0.582 0.192 0.773 0.022 -9.6














S40 0.448 0.109 0.557 0.051 -34.80
M40 0.498 0.161 0.659 0.067 -22.90














S60 0.000 0.084 0.084 0.059 -90.20
M60 0.000 0.091 0.091 0.066 -89.40














Mouth Open Breathing (MOB)
iWOB eWOB tWOB Error δZT (%)
ZT 0.241 0.087 0.328 0.022 -
S20 0.191 0.063 0.254 0.012 -22.60
M20 0.197 0.065 0.261 0.009 -20.30














S40 0.158 0.085 0.243 0.030 -25.80
M40 0.158 0.083 0.241 0.031 -26.60














S60 0.000 0.083 0.083 0.066 -74.70
M60 0.000 0.081 0.081 0.041 -75.40
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A summary of the ratio of rWOB for MCB to MOB (for inspiration, expiration and total
breathing cycle) is shown in Table 4.7. The ratios were computed using the average values of
rWOB presented in Table 4.6. At ZT, the rWOB of MCB is a factor of 2.6 greater than during
MOB. The ratio of the average rWOB (for MCB) to rWOB (for MOB) at NHF20, NHF40
and NHF60 equalled 3.0 , 2.7 and 0.94 respectively. In reality, these ratios may be lower
than predicted as MOB will produce a lower fall in MV compared to MCB and therefore the
corresponding rWOB may be greater.
Table 4.7 Work of breathing: MCB compared to MOB
Ratio of WOB (MCB) to WOB (MOB)
Insp. Exp. Total
ZT 2.6 2.8 2.6
NHF20 3.0 2.9 3.0
NHF40 3.1 1.8 2.7
NHF60 - 1.3 0.9
4.3.4 Neonatal work of breathing
Saslow et al. (2006) used planimetric analysis (Fig. 4.1) to study the effect of NHF and CPAP
during inspiration. 18 preterm neonates (average weight = 1.1 Kg) were studied. The mean
Vt , RR and MV measured by the authors (Saslow et al. (2006)) have been presented in Table
4.8. The Vt has been matched to a 3.6 Kg neonate (weight of the neonate whose upper airway
model was investigated in Chapter 3). It is observable that as NHF increases, RR reduces, Vt
increases and MV decreases. This is consistent with the observation made by Bräunlich et al.
(2013).
By fitting the data in Table 4.8 to a linear equation, Eq. 4.19 (relationship between NHF
and RR) and Eq. 4.20 (relationship between NHF and Vt) were obtained.
RR =−3.2nh f +81.167 (4.19)
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Vt = 0.0001nh f +0.0109 (4.20)
Table 4.8 Summary of Vt and RR data for neonates, adapted from Saslow et al. (2006)
NHF (L/min) Vt (ml/Kg)
Vt for a
3.6 Kg neonate RR (bpm)
3 3.15 ± 1.36 11.34 ± 4.90 71.3 ± 22..2
4 3.08 ± 1.35 11.09 ± 4.86 68.9 ± 21.9
5 3.21 ± 1.31 11.56 ± 4.72 64.9 ± 23.4
These two equations were used in Model 3 (Effect of ZPIF included, I:E ratio = 0.64, MV
varies with NHF) to predict the effect of MV changes on rWOB. Miedema et al. (2013) found
the I:E ratio of 22 infants (gestational age =30 days, weight = 1.3Kg) to be 0.64. Model 4
was not used because information on the effect of NHF on I:E ratio is scarce for neonates.
A sensitivity study was however performed using Model 4 in which I:E ratio was increased
and decreased by 10 %. This changed rWOB by 6 %. Fig. 4.14 shows the rWOB due to the
application of NHF3, NHF6 and NHF9 via the OPT314 and OPT316 cannula. The error
bars represent the uncertainty propagation error in rWOB due to uncertainty in resistance
coefficient estimates.
The overlap of error bars at NHF3 (Fig. 4.14) is an indication that cannula size does not
make a significant difference. Cannula size has a statistically significantly effect on rWOB at
NHF6 and NHF9 with OPT316 producing a lower rWOB.
The percentage changes in rWOB due to NHF3, NHF6 and NHF9 are shown in Fig. 4.15
and Table 4.9. In Chapter 3, it was found that OPT316 engendered a lower airway resistance.
The lower resistance posed by the OPT316 and the NHF-induced fall in MV coupled with
the ZPIF effect explains why the rWOB is lower with therapy than without (i.e. zero therapy,
ZT) during NHF6 and NHF9. For OPT314, the rWOB is less with therapy than without (ZT)
only at NHF9.
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Fig. 4.14 Plot showing the effect of cannula size on neonatal rWOB
Fig. 4.15 Plot showing the percentage fall in rWOB due to NHF
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Table 4.9 Summary of rWOB - neonate model
rWOB @ ZT 0.053
NHF (L/min) NHF3 NHF6 NHF9
OPT314
rWOB 0.0613 0.061 0.026
δZT (%) 16.24 -15.28 -50.84
Error 0.0042 0.0035 0.0011
OPT316
rWOB 0.0581 0.045 0.02
δZT (%) 10.23 -14.49 -58.42
Error 0.0028 0.0022 0.0009
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4.4 Discussion
4.4.1 How NHF reduces work of breathing
Dysart et al. (2009) postulated that matching NHF with inspiratory flow demand may
attenuate nasopharyngeal resistance and lead to a reduction of work of breathing. The nasal
cannula is designed to reach past the nasal valve (which has significant resistance) leading
to a reduction of inspiratory work of breathing. Information on expiratory effort against
cannula jet is scarce in the literature (Dysart et al. (2009)). In the words of Lee et al. (2013a)
“whether NHF reduces work of breathing by stenting the airway or by providing gas flows
that matches or exceeds the patient’s peak inspiratory flow as proposed by Dysart et al. (2009)
remains to be determined”.
Findings from the present study indicate that the fall in inspiratory work of breathing due
to NHF can be explained in terms of the NHF-induced rise of the ZPIF (see Fig. 4.3), below
which inspiration requires no respiratory effort. Since a greater ZPIF is related to NHF, the
present finding lends credence to the theory that reduced work of breathing may be due to
the matching of PIF and NHF. The expiratory flow must negate the cannula jet momentum,
leading to a rise in static pressure towards stagnation pressure. It follows that the greater the
NHF, the greater the jet stagnation pressure and the effort that will be required to overcome
and reverse the jet flow. If NHF raises the total volume of air to be expelled, a rise in flow
rate through the leak area and a consequent rise in expiratory pressure is expected.
If RR and Vt do not change, the overall work of breathing can be reduced only if the
reduction in inspiratory work of breathing outweighs the NHF-induced rise in expiratory
resistance. When RR and Vt remain unchanged, an increase in overall work of breathing is
observed due to the increased expiratory resistance. However, the fall in RR and consequently
MV (at a constant I:E ratio) produced a reduction in overall work of breathing in an NHF
dependent manner in the adult model (Table 4.4). In the neonate model, the fall in rWOB
occurred at NHF9 (Fig. 4.15). For both adults and neonates, the fall in work of breathing
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was partly due to the rise in ZPIF with NHF. With variable I:E ratio, work of breathing will
further reduce if the ZPIF remains above the peak inspiratory flow after a fall in I:E ratio.
From Fig. 4.11, it seen that this may occur at 60 % of the I:E ratio prior to NHF.
It has been reported that chronic obstructive pulmonary disease (COPD) and airway
restrictive diseases are characterised by a rise in RR (Loveridge (1984); Tobin et al. (1983)).
Since COPD augments expiratory resistance, which in turn demands a greater breathing
effort, the fall in RR (Bräunlich et al. (2013); Diab et al. (2015); Lara et al. (2016)) coupled
with the possible decrease in work of breathing upon the application of NHF may provide a
significant relief to the respiratory musculature of COPD patients.
4.4.2 Mouth open versus mouth closed breathing
The work of Groves and Tobin (2007) and Ritchie et al. (2011) remain the only published
works where a comparison is made of airway pressure under mouth close breathing (MCB)
and mouth open breathing (MOB) in the adult population. In both studies, mouth closed
pharyngeal pressures were greater. Since the ZPIF rises with NHF-induced rise in pharyngeal
pressure, the saved energy due to ZPIF is less during MOB. Note that MOB in itself requires
relatively less effort compared to MCB because tracheal flow is supplied by the oral and nasal
pathways in parallel, their effective resistance being less than either one. The contribution of
cannula size to rWOB generally rises with NHF for MCB and MOB.
Particle imaging velocimetry experiments conducted by Spence (2011) show that all
the expired volume exits via the oral passage during MOB when NHF of 30 L/min was
administered to an adult upper airway model at a peak lung flow of 26 L/min. The nasal
passage bore only the inward-directed therapy flow. When therapy was supplied and equal
fall in MV was assumed for MCB and MOB, the average rWOB in the MCB state was found
to be a approximately a factor of 3 greater compared to MOB state at NHF20 and NHF40 but
almost unity at NHF60. This ratio can be less than 3 (at NHF20 and NHF40) as it is likely
for the rWOB in MOB to be greater than predicted.
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4.4.3 Adult versus neonate work of breathing
Cabello and Mancebo (2006) found the average (and range) work of breathing (resistive plus
elastic, for entire airway) of 7 healthy adults (mean age = 29 years) to be 2.4 (1.7 - 3.1) J/min.
Otis et al. (1950) concluded that the resistive component of work of breathing is about 30 % .
In a study of 9 males (age = 38.3 years) by Ferris et al. (1960) the upper airway resistance
was found to be about two-thirds of the total airway resistance during nose breathing. In
regards to the findings of Cabello and Mancebo (2006), the rWOB will be two-thirds of 30 %
of 2.4 (1.7 -3.1) J/min which equals 0.48 (0.34 - 0.61) J/min. This is lower than the rWOB
(0.86 J/min) estimated in the present study for the adult upper airway model (mouth closed
breathing state) at ZT. The difference could be attributed to variability in airway compliance
and resistance.
Compared to the neonatal work of breathing at ZT (0.053 J/min) - estimated from the
mean Vt (11 ml) and RR (81 bpm) for a 3.6 Kg neonate using the data of Saslow et al. (2006),
the adult rWOB (0.86 J/min) is greater than the neonate by a factor of 16. The ratio of the
work of breathing of an adult (70 Kg) to that of a neonate (3 Kg) as estimated from the report
of Cook et al. (1957) is 11. Note that the corresponding body weight ratio (70 Kg /3 Kg) is
23.3.
The breathing parameters of neonates, even of the same weight and age vary significantly
(Cook et al. (1957)). In the data reported by Cook et al. (1957) one of the neonates (age 22
hours, weight not indicated) had a RR of 136 bpm and Vt of 10 ml. In the same data, another
neonate (weight = 3.6 Kg) had a Vt of 20 ml and RR of 28 bpm. If the same resistance
coefficients determined experimentally are used in conjunction with a Vt of 20 ml and a
RR of 81 bpm, the rWOB predicted by Model 3 is 0.285 J/min. This equals an adult to
neonate rWOB ratio of 3. rWOB can thus vary significantly. Owing to the limited clinical
data, greater variability in Vt and RR, and the use of only one neonate and adult model in
the present work, it is unclear from the present work, which anthropometric parameter (e.g.
weight, height, age etc.) scales best with rWOB
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4.4.4 Limitation
The evaluation of the resistive component of mechanical WOB has been restricted to only the
upper airway due to a lack of information on the effect of NHFT on lower airway resistance
and lung compliance. For the same reason, the extra viscous component of mechanical WOB
involved in deforming surrounding tissues during pulmonary excursions (estimated to be 12
% (Otis et al. (1950)) during ZT) has not been included here. The effect of NHF on lower
airway needs further study.
4.5 Conclusion
Wakefulness and disease state complicate the influence of NHF on Vt and MV in adults. The
rWOB at NHF20, NHF40 and NHF60 is 10 %, 25 % and 88 % less than the rWOB without
NHF (ZT) during mouth closed breathing. At ZT, NHF20 and NHF40, the rWOB for MCB
was found to be a factor of about 3 greater than that of MOB but close to unity at NHF60.
This result assumes equal fall in MV for both states (MCB and MOB). The reduction in
rWOB is due to the ZPIF rising with NHF coupled with a fall in MV. For MCB, the influence
of NHF on I:E ratio may reduce rWOB if the new I:E ratio is greater than 60 % of the I:E
ratio prior to NHF.
Generally, in the adult model, the large cannula produced the greatest rWOB and the
small cannula produced the least. Variability in rWOB due to cannula size was found to be
NHF-dependent with coefficient of variability (standard deviation/ average rWOB) rising up
to 21.1% at NHF60 for MCB. In the MOB state, the coefficient of variability was up to 50 %
at NHF40. In the neonate model, the larger cannula (OPT316) caused a greater fall rWOB
relative to rWOB at ZT than did smaller cannula (OPT314). The ratio of the rWOB of adults
to rWOB of neonates varies significantly due to variations in RR and Vt .
Because of the convincing body of evidence supporting a fall in RR, a rise in MV due
to NHF will suggest a pronounced rise in Vt traceable to an increase in inspiratory flow.
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Under such circumstances work of breathing may be higher with NHF than without. The
interpretation of the therapeutic benefit of NHF to a patient must be comprehensive and not
restricted to work of breathing alone as other parameters such as dyspnoea, mouth dryness,
(Roca et al. (2010)) functional residual capacity (Corley et al. (2011); Diab et al. (2015)),
end-tidal and blood arterial CO2 concentration (Frizzola et al. (2011)) also indicate the
wellbeing of patients in response to NHF.
Chapter 5
An Experimental and Numerical
Investigation of CO2 Distribution in the
Upper Airways During Nasal High Flow
Therapy
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The material covered in Chapter 5 has previously been published in S.C Van Hove et
al. (2016). Annals of Biomedical Engineering
This chapter was motivated by the desire to understand the effect of nasal high flow (NHF)
on airway CO2 concentration to scrutinize the postulate that NHF improves oxygenation by
flushing nasopharyngeal dead space. In pursuing this goal, the present author used a bench-
top experimental approach and Van Hove used a computational fluid dynamics approach.
Van Hove used a segmented computed tomography images of the upper airway of a 44 year
old man as a model for this study. A physical model of the same upper airway geometry was
built using 3D-printing technology (printed in ABS plastic) for the experimental work. In
this work, my contribution has been the measurement, interpretation and documentation of
pressure and CO2 experiments to validate the results of Van Hove’s numerical models.
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5.1 Introduction
Computational fluid dynamics (CFD) has been used to model airflow, temperature and
particle deposition within the human nasal cavity. The majority of these simulations model
unassisted breathing. Simplifications commonly made in such studies include the use of a
single nasal passage (Keyhani et al. (1995); Martonen et al. (2002)), the use of a geometric
re-construction instead of an anatomically accurate model (Elad et al. (1993)) and simulating
steady inspiratory or expiratory flows (Weinhold and Mlynski (2004); Wen et al. (2008);
Zubair et al. (2010)) instead of resolving the full time-dependent breathing pattern. Flow
within the models is generally defined by specifying the velocity normal to the nostril opening
(Keyhani et al. (1995); Wen et al. (2008)), or by specifying a pressure difference between the
atmosphere and the nasopharynx/trachea end of the model (Ozlugedik et al. (2008)). The
latter “pulls” air through the model in a similar way to natural breathing so is considered
more physiologically accurate (Wen et al. (2008)).
NHF produces positive airway pressure which has been shown to improve oxygenation,
ventilation-perfusion matching and respiratory rates (Groves and Tobin (2007); Parke et al.
(2011)). Also findings by Dewan and Bell (1994); Frizzola et al. (2011); Tiep and Barnett
(2002) and Spence (2011) support the proposition by Dysart et al. (2009) that NHF reduces
the anatomical dead space and improves alveolar ventilation by making it a greater portion
of the patient’s minute ventilation (Dysart et al. (2009)).
CFD simulations with applied NHF have been performed by Kumar et al. (2015) who
simulated steady inspiratory and expiratory flow with applied therapy between 20 and 60 L
min−1 (Kumar et al. (2015); Spence (2011)). The pharyngeal pressure depended on airway
geometry and increased nonlinearly with increasing therapy flow rate. Simulations of the
CO2 concentration in respiratory therapies have been performed inside infant face masks
and oxygen hoods (Meyer (1989); Mundt et al. (2012)) but not for NHF and not within the
nasal cavity. To better understand the dead space washout provided by NHF, it is necessary
to understand the flow dependent nature of CO2 distribution in upper airways. The present
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Chapter describes an experimentally validated numerical study of the CO2 distribution in the
upper airway, with and without assisted ventilation, using experimentally measured breathing
waveforms and tracheal CO2 concentrations. How airway pressure varies with NHF is also
investigated.
5.2 Materials and Methods
5.2.1 Model geometry
In precursor studies a medical computed tomography (CT) scan of a 44 year old male with
mouth closed was used to create the upper airway model (Spence et al. (2011)). The model,
which included both sides of the nasal cavity and extended to the beginning of the trachea,
had no apparent airway abnormalities. The CT data was segmented and imported into
ANSYS ICEM to create a computational mesh for the numerical simulations. An extended
rectangular domain was placed around the nose of the CFD model thereby allowing air to
enter the nares at a wide range of angles to accurately model the in vivo scenario.
The nasal cannula of the NHF device investigated in this study, (OptiflowTM Fisher
& Paykel Healthcare Limited (F&PH), Auckland, New Zealand), consists of two prongs
of elliptical cross-section and a manifold that rests on the upper lip. Stereolithographic
(STL) files of the cannula geometry were inserted into the computational airway model. The
cannula positioning was chosen to reflect the normal clinical use of NHF. The two cannula
prongs in the CFD model were partially inserted into the nostril to approximately 74 % of
their total length. The angle of the prongs opening surface was approximately 33° from the
vertical and the cannula rested within 2 mm of the upper lip and the nostril junction. These
measurements were unavailable for the experimental model.
It was assumed the airway was rigid and the mucosal layers effects could be ignored. The
shape of the external nose was included as it is known to influence inspiration flow patterns
(Doorly et al. (2008)).
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5.2.2 CFD simulation
Meshes of the airway geometry were generated using an octree volume filling algorithm to
create the tetrahedral volume mesh while a patch-independent method was used to produce
a triangular surface mesh at the domain boundaries. A smaller element size was specified
within the nasal cavity, in particular around the cannula prongs and within the nasal valve, to
increase the accuracy of the computed solution in this area of rapid flow. Five inflation layers
of prism elements, with a growth ratio of 1.1, were added to accurately capture the high
velocity gradients occurring at the no-slip boundaries of the airway and cannula. The element
quality of the surface and volume meshes were improved before and after the generation of
the inflation layer.
ANSYS CFX 16.0 was used as the CFD solver. The total flow through the model consisted
of two components, humidified air and CO2, homogenously mixed with a reference pressure
of zero atmospheres and a diffusivity of 1.41 x 10−5 m2 s−1. Humidified air was modelled
as an ideal gas with a dynamic viscosity of 1.88 x 10−5 kg m−1 s−1 and density of 1.068
kg m−3, while CO2 was modelled with a dynamic viscosity of 1.45 x 10−5 kg m−1 s−1 and
density of 1.977 kg m−3. The model was solved isothermally with a total flow temperature of
37 ◦C as it was assumed the thermal effects on the flow were negligible (Hahn et al. (1993);
Keyhani et al. (1995)). NHF was humidified to 99 % relative humidity and no supplementary
oxygen was added. Unassisted breathing was simulated at the nasopharynx opening using a
five term Fourier series (displayed in Fig. 5.1) which represented an experimentally measured
in vivo breathing waveform.
An atmospheric boundary condition of 0.04 % CO2 was applied to the exterior domain
surrounding the nose. The airway domain was initialised with a relative pressure of zero
atmospheres, zero velocity and the concentrations of humidified air and CO2 set to 99.96
and 0.04 % respectively. All solid boundaries on the airway surfaces were specified as rigid,
no-slip walls, and the k–ω Shear Stress Transport (SST) turbulence model (Menter (1994))
was applied to the domain with a turbulence intensity of 5% specified for all flow boundaries
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Fig. 5.1 : Breathing waveform (solid line) and Fourier approximation of the breathing waveform (dashed line)
used to drive the stepper motor and used to specify the flowrate at the nasopharynx in the CFD simulations.
Positive flows indicate expiration while negative flows indicate inspiration
and for initialisation. This turbulence model has previously been used in respiratory flow
simulations (Elcner et al. (2016); Zubair et al. (2010)). Five spatially uniform flow rates
between 10 and 60 L min−1 were specified normal to the cannula openings to simulate
assisted breathing. Simulations over multiple breaths did not significantly alter the CO2
volume fraction profiles, hence data for only the first breath are presented.
Three significantly different meshes (with 1.6 x 106, 4.2 x 106 and 10.6 x 106 nodes)
were generated by reducing the global mesh density scale factor while maintaining the same
meshing parameters. Steady state expiration (uniform tracheal inlet velocity of 2.5 ms−1)
during NHF therapy of 40 L min−1 was simulated to assess the convergence of the results
with mesh size. The integrated force over the airway surface was used as an indicator of
mesh quality. A Richardson extrapolation was used to obtain an estimate of the exact value of
integrated force over the airway surface as the number of nodes in the mesh tends to infinity.
This gave an approximate relative error of 1.1 % for the finest mesh which was used in all
subsequent simulations.
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Fig. 5.2 Location of the four taps used to validate the numerical pressure and CO2 results on the airway model
of a 44 year old adult male
Transient simulations of the expiratory phase, with NHF therapy applied at 40 L min−1,
were initially performed using a range of time-steps (0.001, 0.002 and 0.004 s) to test
numerical stability. For each point specified in Fig. 5.2, the CO2 volume fraction at mid
expiration did not differ significantly, however the Courant–Friedrichs–Lewy (CFL) number
for the simulations increased with increasing time-step. The time-step used for all following
simulations was 0.002 s and had a CFL number of approximately 30. The solution was
considered to be converged once the RMS residuals for mass and momentum reached a value
below 10−4 or a maximum of 20 coefficient loops were achieved for each time-step.
5.2.3 Experimental procedure
Experiments were conducted for validation of the CFD process as well as to provide tracheal
boundary values for flow and CO2 concentration. A life sized airway model was 3D-printed
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in ABS plastic. The full experimental setup is outlined in Fig. 5.3. The breathing cycle
used (Fig. 5.1) is based on an adult human breathing at rest. It was measured in vivo on a
healthy 24 year old male and scaled to have tidal volume 450 ml, respiratory rate 14 breaths
per minute, representative of an average adult (Tobin et al. (1983)). The breath waveform
was reconstructed using the five term Fourier series shown in Fig. 5.1 and was physically
replicated using a computer controlled piston pump. The physical model had a functional
residual capacity (FRC) of 2400 ml created by the piston and piston barrel, and a dead space
of 150 ml (typical of the human adult (Ritchie et al. (2011)) which comprised of the airway
model (53 ml) and connecting tubing.
Fig. 5.3 A schematic of experimental apparatus used for CO2 and pressure measurements. It comprises of a
piston pump, CO2 bleed system, capnograph and F&P Healthcare NHF nasal cannula
The capnograph, Oridion MiniMediCO2 Microstream (OEM CO2 Module) was used to
measure airway CO2 concentration. Airway pressure was measured using the AMS 5915
pressure transducers (manufactured by Analog Microelectronics GmbH, Germany). The
physical airway model had numerous 1 mm diameter tap holes (some shown in Fig. 5.2)
where pressure and CO2 concentration could be measured. For each therapy flow rate, the
CO2 concentration was measured at tap location 4 and a Gaussian distribution was fitted to the
data. These functions were used to specify a time varying CO2 volume fraction condition at
the nasopharynx opening in the CFD simulations. The experimental measurement technique
did not allow for spatial recording of the CO2 concentration hence the spatially uniform
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boundary condition used for nasopharyngeal CO2 is a limitation of the study. CO2 was bled
from a compressed CO2 tank into a pump cylinder via a pressure regulator and rotameter. A
bleed rate of 98 scc min−1 with a 20 kPa back pressure was used to simulate a peak CO2
partial pressure of about 40 mmHg (Hess (2011)) which corresponds to the end-tidal CO2 of
a healthy adult (Ritchie et al. (2011)).
The miniMediCO2 capnograph constantly samples CO2 over a 400 mm conduit and
therefore requires correction for transit time delays and signal dispersion. The reduction of
signal intensities (dispersion) of sampled CO2 may be attributable to diffusion and turbulent
mixing as the gas travels along the conduit (Reischl and Beaucage (1986)). The datasheet
of the MiniMediCO2 capnograph indicate a transit delay time and rise time of 2.7 s and
190 ms respectively. The measured signal can be thought of as a convolution of the original
undispersed signal and a dispersion function. Extraction of the undispersed data requires a




Numerical simulations were performed using air at 20 °C to compare the static pressure at
the locations specified in Fig. 5.2. The pressure time-series for a single breath are displayed
in Fig. 5.4 for both unassisted breathing and for assisted breathing where the NHF rate was
40 L min−1. The numerical results have been time-averaged to give the same sampling
frequency as the experimental results. The experimental results are displayed with the
standard deviation from the mean breath as error bars. The first 2.3 s represent the expiratory
phase followed by 2 s of inspiration.
During unassisted inspiration the static pressure within the airway becomes sub-atmospheric
with the points closest to the lungs reaching the most negative static pressure values. Ap-
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Fig. 5.4 Time-series of the static pressure at the four comparison points for unassisted breathing (red & blue)
and for assisted breathing with applied NHF rate of 40 L min−1 (black & green)
plying NHF therapy raises the mean static pressure within the airway as shown in Fig. 5.4.
For unassisted breathing the magnitude of the experimental results are consistently greater
than the numerically obtained values suggesting that the experimental resistance to flow is
greater than that simulated numerically. This could be due to pressure losses associated with
the surface roughness of the printed model as well as a difference in airway resistance due to
uncertainty in the placement of the nasal cannula in the experimental setups. A zero drift
error of ± 5 Pa also affects the experimental results due to the sensor calibration. The results
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broadly confirm that the numerical solution is a reasonable approximation of the flow in the
airway model.
5.3.2 CO2 validation
Fig. 5.5 compares the experimental and numerical time-series for the CO2 volume fraction at
each of the points displayed in Fig. 5.2, for unassisted breathing (blue) and for a NHF rate
of 60 L min−1 (red). The experimental data was obtained by averaging several breaths over
a 5 min period and the standard deviation is shown by the error bars. No synchronisation
signal between the experimentally measured flow and CO2 was recorded, thus the temporal
initialisation of the experimental data is unknown. In order to compare the results a temporal
shift was applied to the experimental data to maximise the correlation between the data sets.
Increasing the NHF rate diminishes the peak CO2 volume fraction at each location
because the larger flow rates input a larger amount of gas with a low CO2 concentration
into the nasal cavity. The expired gas within the airway is diluted by the NHF therapy and
hence the therapy reduces the maximum CO2 volume fraction level at the pharynx. The
CO2 concentration during NHF assisted breathing begins to decrease earlier than during
unassisted breathing. This occurs because prior to flow reversal the air speed coming from the
trachea slows sufficiently that NHF therapy causes a net flow of low CO2 gas into the cavity
before inspiration which does not occur during unassisted breathing. The numerical CO2
concentration time series are consistently wider than the experimental profiles. This is due
to the capnograph sensor rise time, (Langer et al. (1985)) which could not be corrected and
which is greater than that recommended for clinical use (Rimensberger (2015)). Experimental
errors could also have been introduced by CO2 losses encountered in the experimental set-
up, such as in the piston and connections, as well as temperature differences between the
numerical and experimental model. The numerical simulations were performed isothermally
at 37 ◦C whereas the air introduced at the trachea in the physical experiments was not
maintained at this temperature.
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Fig. 5.5 Time-series of the CO2 volume fraction at the four comparison points for unassisted breathing (blue)
and assisted breathing with NHF flow rate of 60 L min-1 (red).
The numerical results are most similar to the experimental results at the inferior locations
(such as point 4) as these locations are closest to the trachea where the CO2 boundary
conditions are specified. The agreement is satisfactory implying that the CO2 distribution
calculated numerically is a reasonable estimate to that present in the airway model.
5.4 Discussion 111
5.4 Discussion
The numerical results for pressure and CO2 in the upper airway are similar to the experimental
validation data and are consistent with published in vivo measurements. Parke et al. (2009)
reported the mean expiratory pharyngeal pressure of post-cardiac surgery patients on NHF
rates of 35 L min−1 to be 2.7 ± 1.0 cmH2O (264.8 ± 98.1 Pa) while Groves and Tobin
(2007) measured a range of 5.5 – 8.8 cmH2O (539.4 – 863.0 Pa) in healthy volunteer subjects
to NHF rates of 60 L min −1. The inspiratory and expiratory pharyngeal pressures during
unassisted breathing simulated by Kumar et al. (2015) were - 30.9 and 7.1 Pa respectively.
With NHF rate of 40 L min −1 the inspiratory and expiration pharyngeal pressures rose to
38.3 and 184.4 Pa respectively which is similar to the pressures at point 4 in the present
simulations.
The current study shows that increasing NHF rate augments the mean nasopharyngeal
pressure which is consistent with clinical studies that show that NHF therapy delivers small
but significant positive airway pressure (Parke et al. (2009)). This positive airway pressure is
believed to lower total pulmonary resistance and improve gas exchange by keeping alveoli
open throughout ventilation (Dysart et al. (2009)). In the study by Kumar et al. (2015)
reversal of flow direction and recirculation in the nasal valve region during NHF therapy are
attributed to an adverse pressure gradient caused by negative pressures around the floor of
the nasal valve. Spence et al. (2012) reported two recirculating features within the anterior
portion of the nasal cavity during expiration. Such flow recirculation may cause the flushing
of nasopharyngeal dead space.
The present study has demonstrated that NHF therapy produces a nasopharyngeal washout
effect by simulating the concentration of CO2 in the upper airway during natural and assisted
breathing. Applying NHF provides the anterior of the nares with a source of air containing
a lower CO2 concentration than the expired air that would be found in the nasal cavity at
the end of expiration during unassisted breathing. During expiration, the jet of low CO2 air
causes circulation of the expired air in the anterior nasal cavity hence some of the higher
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CO2 concentration air leaves the nasal cavity via the nostrils and the anatomical dead space
is reduced. Frizzola et al. (2011) observed a flow dependent decrease in blood CO2 partial
pressure and increase in blood O2 partial pressure in neonatal piglets on NHF therapy,
suggesting that NHF therapy washes out the nasal cavity in a similar manner to tracheal gas
insufflation (Frizzola et al. (2011)). The flushing action causes the following inspiration
to have a greater proportion of air with a low CO2 concentration. This in turn improves
respiratory efficiency as the alveolar gas fractions are modified such that the CO2 fraction is
lower and the oxygen concentration is greater than during unassisted breathing (Frizzola et al.
(2011)). However, Chatila et al. (2004) did not find that high flow oxygen therapy altered the
arterial CO2 partial pressure compared to low flow oxygen therapy (Chatila et al. (2004)).
It is unknown whether nasopharyngeal washout translates into a decrease in alveolar CO2
partial pressure significant enough to alter blood arterial CO2 partial pressure.
The present model could be extended to incorporate the lower airways and gas trans-
port between blood and alveoli in order to determine whether the decrease in inspired CO2
observed is adequate to modify alveolar and blood gas compositions. In the present study,
discrepancies exist between the numerical and experimental results for both pressure and
CO2. Experimental errors that may explain these discrepancies include the absence of syn-
chronised experimental flow and CO2 measurements. The lack of synchronisation between
the experimental breathing flow and CO2 measurements was a significant limitation.
The use of a rigid, mucous free and cilia free model are limitations to the correct modelling
of the respiratory physiology. Both numerical and experimental models assumed a rigid
airway however physiologically the soft palate, epiglottis and tongue are compliant structures
compared to the remainder of the nasal cavity. At very high flow rates, such as during
vigorous sniffing, the nasal valve is capable of collapsing but this is unlikely to occur during
restful breathing hence a rigid wall assumption is appropriate for simulations of breathing
at rest (Bailie et al. (2006); Keyhani et al. (1995)). The application of NHF is somewhat
similar to sniffing in that a much higher flow rate passes through the nasal valve region. In the
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present study, the Reynolds number (Re) at the cannula prong opening during NHF therapy
of 40 L min-1 is approximately 4600 and the Re for sniffing is approximately 3050 (Keyhani
et al. (1995)). Hence, the use of a rigid model may be a limitation of the present study. The
models presented ignore the effects of the nasal mucous layer and assume a no-slip condition
on the nasal cavity wall. This assumption is commonly applied in computational models of
airflow in the upper airway because both the thickness of the mucus layer and the velocity of
the mucociliary escalator are sufficiently small in comparison to the flow structures in the
upper airway (Keyhani et al. (1995)). Finally, this study has only considered a single subject
which may not represent the features of an entire population. The model was chosen because
experiments have been published using the same nasal geometry (Spence et al. (2012)) hence
comparison of flow fields was possible.
5.5 Conclusion
Numerical simulations of the flow and CO2 concentration within the upper airway of a
subject undergoing nasal high flow therapy have been performed. The numerical simulations
were validated using an experimental model and the results are consistent with previously
reported airway measurements. A nasopharyngeal washout phenomenon was observed and
the amount of CO2 cleared from the nasal cavity was found to increase in a flow dependent
manner over the range of flows simulated.

Chapter 6
In-vitro Modelling of the Effect of Nasal
High Flow Therapy on Tracheal CO2
Tension During Episodes of Apnea
6.1 Introduction
There are three types of apnea namely obstructive sleep apnea, central sleep apnea and a
complex sleep apnea (combination of CSA and OSA). CSA is a sleep disorder marked by
intermittent cessation of breathing which lasts for 10 or more seconds at frequencies of 5
or more episodes per hour (Javaheri (2010, 1999)). CSA episodes can occur at up to 35 per
hour (Javaheri (1999)).
CSA ensues when the pontomedulary pacemaker (breathing rhythm generator) is tem-
porarily unable to send breathing rhythms to drive respiratory muscles (Javaheri (2010)).
This instability in breathing may be accompanied by an increased sensitivity to CO2 (Javaheri
(1999)). The decrease in alveolar ventilation during sleep raises alveolar CO2 tension which
initiates hyperventilation and drives arterial CO2 below the breath-stimulation threshold
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(apnoeic threshold) hence cessation of breathing. After a finite time, CO2 rises above the
breath-stimulation threshold and breathing commences (Dempsey (2005); Javaheri (2010)).
CSA has been reported to occur in 30 - 40 % of patients recovering from heart failure
(Cao et al. (2013); Javaheri et al. (2009); White (2005)). A retrospective study conducted
by Javaheri et al. (2009) amongst 1286 patients receiving obstructive sleep apnea (OSA)
treatment by continuous positive airway pressure (CPAP) titration indicated that the incidence
of CSA ranged from 3 - 10 % monthly. CSA is reported to occur more frequently at high
altitudes and in individuals on high doses of opioid drugs (White (2005))
The presence of adequate respiratory effort and reduced upper airway patency distin-
guishes obstructive sleep apnea (OSA) from CSA (Costanzo et al. (2015)). The reduced
airway patency in OSA is thought to be caused by the ineffectiveness of the phayrngeal
dilator muscles or a more negative pharyngeal pressure induced by an intense diaphragmatic
contraction (White (2005)). CPAP is widely reported as the standard treatment modality for
OSA patients (Aurora et al. (2012); Bradley and Floras (2003); Issa and Sullivan (1986)).
Nasal high flow (NHF) therapy involves the administration of warmed (37 oC), humidified
(100 % R.H) and oxygen-titrated air (>21 % O2 ) at flow rates up to 8 L/min in neonates
(Manley et al. (2013); Motojima et al. (2016); Ojha et al. (2013)) and 60 L/min in adults
(Ward (2013)). Clinical studies indicate that NHF is effective in treating OSA (McGinley
et al. (2009)). This work was motivated by the postulation that NHF flushes nasopharyngeal
CO2 (Dysart et al. (2009); Möller et al. (2015); Schneider et al. (2013)). These observations
led to the hypothesis that NHF may attenuate the EtCO2 during and after CSA. In the present
work, tracheal EtCO2 is measured in a physical model before, during and after CSA (without




The adult upper airway model (UAM) used in Chapter 3 was used in the present work. See
Fig. 6.1a. The UAM was connected to the programmable piston pump (PP) as shown in
Fig. 6.1b. The apparatus setup (Fig. 6.1b) is same as used in Chapter 5. Tests conducted by
placing a wire-gauze (to enhance mixing) at the entrance of the PP yielded no significant
difference in end-tidal CO2 concentration (EtCO2) (<± 3 %) showing that CO2 is adequately
mixed in the chamber. NHF was administered using AIRVO™2 device and OPT844 medium
cannula (Fisher & Paykel Healthcare Ltd, Auckland).
(a) Airway model (b) setup
Fig. 6.1 (a) Upper airway model (b) UAM is connected to the PP and AIRVO™2 device. CO2 source is
connected to PP for simulation of metabolic CO2 production. CO2 is sampled at the trachea during experiment
6.2.2 Experimental procedure
The PP was programmed to reproduce the breathing flow pattern of a 24 year old healthy
male adult with a respiratory rate of 14 breaths per minute and I:E ratio of 0.72 (Fig. 6.2).
Simultaneously, CO2 was bled into the piston cylinder of the PP at a flow rate of 98 scc/min
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(with CO2 source pressure maintained at 20 KPa). At this bleed rate, the capnograph
reported a capnogram that had an end-tidal CO2 tension (EtCO2) of 5.2 ± 0.3 (v/v) % (which
represents the EtCO2 of a spontaneously breathing healthy adult). Logging of the CO2 data
was commenced. Without NHF, central sleep apnea (CSA) lasting for 10 seconds (CSA-10)
was simulated by stopping the PP for 10 seconds.
Fig. 6.2 The breathing flow pattern of a healthy 24 year male adult. Characteristics: inspiratory time (Ti) = 1.8
s, expiratory time (Te) = 2.5, I:E ratio (Ti/Te) = 0.72, peak inspiratory flow (PIF) = 26 L/min, peak expiratory
flow (PEF) = 16.5 L/min, respiratory rate (RR) = 14 breaths per minute (bpm)
NHF of 10 L/min was then administered prior to the simulation of CSA-10 and a record
was made of the capnogram. This was repeated for NHF up to 60 L/min in steps of 10 L/min.
These two tests (with and without NHF ) were repeated for CSA lasting up to 40 seconds in
steps of 10 seconds.
6.3 Results
The capnograms for a 30 second CSA (CSA-30) with NHF ranging from 10 L/min to 60
L/min are presented in Fig. 6.3. With the PP operating (0 < time < 50 s), a repeatable cycle
6.3 Results 119
of CO2 with a peak of 4 - 5 % ([EtCO2]steady ) at the end of each expiration is seen. There
are some variations in [EtCO2]steady due to mixing from cycle to cycle. During apnea (50
< time < 80 s) CO2 at the trachea may drop due to diffusion but generally rises by 0.1 %.
When PP motion (breathing) resumes, the elevated level of CO2 built up in the piston is
forced out and registers in the trachea leading to the maximum EtCO2 ([EtCO2]max) on the
second breathing cycle. After this time, [EtCO2]max decays to the original steady breathing
value of 4 - 5 % ([EtCO2]steady) in a manner described by Eq. 1.
EtCO2(t) = [EtCO2]steady +([EtCO2]max − [EtCO2]steady)exp(−λ t) (6.1)
The decay time constant (λ ) estimated with 95 % confidence interval is 0.016 (0.0105 - 0.021
s−1). A prediction of the decay of [EtCO2]max using Eq. 6.1 is presented in Fig. 6.3a (see
solid curve). It is observable that the EtCO2 prior to CSA-30 falls with NHF up to NHF 40
L/min and then remains almost unchanged with NHF. The [EtCO2]max after CSA-30 follows
the same trend. The same trend was observed for all other CSA times.
120
In-vitro Modelling of the Effect of Nasal High Flow Therapy on Tracheal CO2 Tension
During Episodes of Apnea
(a) NHF10 (b) NHF20
(c) NHF30 (d) NHF40
(e) NHF50 (f) NHF60
Fig. 6.3 Effect of NHF ranging from 10 L/min to 60 L/min on EtCO2 after apnea
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The [EtCO2]max at all NHF (10 - 60 L/min), immediately after CSA, for all CSA duration
times (10 - 40 seconds) have been plotted in Fig. 6.4. Data for spontaneous breathing (SB)
- no CSA - is also presented in Fig. 6.4. The error bars represent 2 standard deviations in
EtCO2 measured over 5 separate experiments. At all NHF, [EtCO2]max increases with CSA
duration. The [EtCO2]max at zero-therapy (ZT) (NHF = 0), NHF of 40 L/min and NHF of 60
L/min (NHF60) during CSA-10 are 6.18 %, 5.04 % and 4.94 % respectively. The [EtCO2]max
at ZT, NHF of 40 L/min and NHF60 during CSA of 40 seconds (CSA-40) are 8.25 %, 7.07
% and 7.00 % respectively. The [EtCO2]max at NHF of 40 L/min and NHF of 60 L/min are
close, indicating a plateau of [EtCO2]max after NHF of 40 L/min (Fig. 6.4). In considering
the CSA-10 plot for instance, the fall in [EtCO2]max at ZT to the [EtCO2]max at NHF of 60
L/min is about 18 %. The fall is the same for CSA-20, CSA-30 and CSA-40.
Fig. 6.4 Plot of EtCO2 against NHF for CSA ranging from 10 to 40 seconds. The error bars
represent two standard deviations in EtCO2 measurement over 5 repetitions
Since the EtCO2 of the tracheal sample approximates the average alveolar CO2 tension
(Levine et al. (1997)), it is concluded that NHF of 60 L/min may reduce alveolar CO2 tension
by 18 %. During spontaneous breathing (no CSA), EtCO2 rises from 5.2 % (v/v) (39.2
mmHg) at NHF = 0 to 8.2 % (v/v) i.e. 62.3 mmHg at CSA of 40 seconds. This represents
122
In-vitro Modelling of the Effect of Nasal High Flow Therapy on Tracheal CO2 Tension
During Episodes of Apnea
a rise rate of 0.6 mmHg/second. In the physiological system, the flux of CO2 into the
alveolar space from the pulmonary capillaries is driven by diffusion gradients which means
the amount of flux decreases as the alveolar CO2 rises. As a limitation of the experimental
setup, CO2 was bled into the piston pump at a constant rate, which is not physiological.
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6.4 Discussion
CSA occurs frequently in obstructive sleep apnea patients Javaheri et al. (2009)Cao et al.
(2013) and can occur in healthy individuals Badr (2005). NHF has been reported to treat
OSA but there is scarce information on how it could be beneficial to CSA patients (McGinley
et al. (2009)). Findings from the present study indicate a rise in EtCO2 from 5.2 % (v/v) (39.2
mmHg) up to 8.2 % (v/v) (62.3 mmHg) over an apnea time of 40 seconds. This equals a CO2
concentration rise rate of 0.6 mmHg/second. In a group of 14 healthy adults (mean age = 36
years), anesthetized to simulate apnea, Stock et al. (1989) found a 0.2 mmHg/second rise in
arterial CO2 tension (PaCO2) in the first minute and 0.06 mmHg/second thereafter. This is
similar to the rate found in the current work, for the same duration (less than one minute).
Stock et al. (1989) notes that the rise in PaCO2 during apnea follows a logarithmic trend with
the fastest rate of rise occurring in the first minute followed by a gradual asymptotic ascent
towards a saturation point. In the work of Patel et al. (2011), the rise in EtCO2 concentration,
post apnea, from 5 % (v/v) (38 mmHg) to 8 % (v/v) (60.8 mmHg) occurred over an apnea
time of 20 minutes (equivalent to an average rise rate of 0.03 mmHg/second), which is of the
same order as found by Stock et al. (1989) after the first minute.
NHF of 60 L/min, which is tolerated well by patients (Ward (2013)) can reduce EtCO2
and consequently alveolar CO2 tension (PACO2) by 18 %. This results supports the reported
nasopharyngeal washout effect in which NHF reduces dead space and improves alveolar
oxygen fraction (Dysart et al. (2009); Möller et al. (2015)).
In patients for whom apnea is triggered by hypercapnia, there is a narrow difference
between the apnoeic threshold (PACO2 below which apnea occurs) and the PACO2 associated
with spontaneous breathing (baseline-PACO2). A broader difference produces greater breath-
control stability and a reduced number of episodes per hour (Dempsey (2005)). Figure 4
shows that EtCO2 during spontaneous breathing, [EtCO2]steady, (baseline-EtCO2) reduces
with NHF. The characteristics of the breath control system (central nervous system) may
explain how the reduction in baseline-EtCO2 influences susceptibility to apnea. Dempsey
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(2005) used the breath control characteristics proposed by Cherniack and Longobardo (1974)
and Khoo et al. (1982) to explain CSA occurrence. Figure 5 (adapted from Dempsey (2005))
illustrates how alveolar ventilation control may be influenced by NHF. The horizontal axis
represents PACO2 (in mmHg) and the vertical axis denotes alveolar ventilation (in L/min).
The points x, y, and z are representative of different baseline-PACO2 levels and the arrow
Fig. 6.5 Plant loop gain concept. The tips of the arrows represent apnoeic threshold and x, y, and z denote
different baseline-PACO2
heads point to their corresponding apnoeic thresholds. All arrows have the same slope to
indicate a constant sensitivity of the breath control system to CO2. dX, dY and dZ are
the changes in alveolar ventilation required for x, y, and z to drop to their corresponding
apnoeic threshold (tip of the arrow head). Note that apnea occurs when baseline-PACO2
goes below the apnoeic threshold (Dempsey (2005); Javaheri (2010)). It is observable that
as baseline-PACO2 rises (z > x), the alveolar ventilation change required to cause apnea
becomes smaller (dZ < dX) and the more likely it is for apnea to occur. This is known as the
plant loop gain concept (Dempsey (2005)). This implies that a hypercapnic patient (higher
baseline-PACO2) will be more susceptible to apnea because small fluctuations in alveolar
ventilation will cause their PACO2 to fall below the apnoeic threshold (Hernandez and Patil
(2016)).
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Arguing from the plant loop gain concept, it may be inferred that a reduction in the
baseline-PACO2 and maximum EtCO2 (immediately after apnea) - which can be up to 18 %
at NHF of 60 L/min, may improve the stability of the breathing control system by widening
the gap between the apnoeic threshold and baseline-PACO2. Consequently, we speculate that
NHF may be capable of reducing the number of apnea episodes per hour.
6.4.1 Limitations of this work
The experimental setup differs from the physiological system in terms of the rigidity of the
piston cylinder (lung compliance is ≈ 200 mL/cmH2O for healthy young adults (Galetke
et al. (2007))), absence of gas diffusion across walls of the pump, lack of a bronchial tree and
presence of a point CO2 source. The constant release rate differs from the physiologically
realistic system. In a human experiencing apnea, the rate of CO2 diffusion from the blood to
alveoli will reduce as CO2 builds up in the lungs. The oscillatory air motion in the airway
due to the heart motion moving the lung lobes (cardiogenic oscillations) have been observed
to influence CO2 mixing and clearance (Collier et al. (2015)). These were not included in the
experimental setup.
6.5 Conclusions
In conclusion, the EtCO2 before and after apnea reduces in an NHF dependent manner (0.15
mmHg/L/min) until NHF of 40 L/min where it reaches a plateau. The true plateau value
may be lower if cardiogenic oscialltions in the air flow are present. The maximum EtCO2
(immediately after apnea of 40 seconds) at zero therapy, can fall by 18 % with the application
of 60 L/min of NHF. Following the plant loop gain model we speculate that the frequency of
apnea per hour may be reduced by NHF.

Chapter 7
The Effect of Variation in the Breathing
Flow Pattern in COPD Patients on
End-tidal CO2 Tension (EtCO2)
7.1 Introduction
Previous studies have explored how CO2 tension modulates ventilation via a feedback
mechanism. It is reasonable to hypothesise that each breathing pattern (though influenced by
disease state) is optimized in terms of shape, magnitude and frequency to effect a specific
change in CO2 tension. How tidal volume, dead space volume, respiratory frequency and
metabolic CO2 rate influence end-tidal CO2 (EtCO2) has been studied. In a study by Parot
et al. (1980) the respiratory frequency and metabolic CO2 production in hypercapnic and
non-hypercapnic COPD patients were found to be similar however the hypercapnic group
showed a lower tidal volume. In hypercapnic individuals, the EtCO2 correlates well with the
ratio of dead space volume to tidal volume (Blanch et al. (2006); Calverley (2003)). Clinical
studies on how breathing flow pattern alone changes EtCO2 are scarce due to the difficulty in
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simultaneously maintaining the same tidal volume, peak airflow and I:E ratio over several
breaths.
EtCO2 has been reported to correlate well with arterial CO2 tension (Nagler and Krauss
(2009)) which can indicate hypercapnia. The capnogram of COPD patients is modulated by
the degree of obstruction of the airways (Gluncic et al. (2015); Krauss and Hess (2007); You
et al. (1994)) which causes the expiratory gas flow to be staggered and makes the capnogram
’shark finned’ in shape (Mieloszyk et al. (2014)). Depending on the degree of obstruction,
the COPD capnogram can be unique compared to those of healthy individuals (Jaffe (2006)).
Nasal high flow is administered to COPD patients to improve ventilation (Bräunlich et al.
(2013)) and prevent obstructive sleep apnea. An in-vitro study of the effect of breathing flow
pattern, with and without NHF on EtCO2 is explored to find if pattern of the waveform alone
makes sufficient difference to EtCO2 to affect the health of a patient. Also the influence of
I:E ratio variation on EtCO2 is explored.
7.2 Methodology
7.2.1 Waveform collection
Four breathing flow patterns obtained from COPD patients (age range = 19 - 77 years, FEV1
% predicted range = 36 to 63 %) were collected from the literature. In three of these flow
patterns (Colasanti et al. (2004); Dellaca et al. (2004); Williams et al. (2013)), flow was
plotted against time. In the remainder (Dellacà et al. (2009)), the flow pattern was presented
as a plot of tidal volume versus time which was numerically integrated (into flow vs. time
plot) after acquisition. Together with a healthy adult breathing flow waveform, which was
previously used by Van Hove et al. (2016) five waveforms were used in all.
A plot of all the collected flow waveforms is shown in Fig. 7.1 (a). Note that positive flow
represents inspiration and negative flow, expiration. The COPD flow waveforms have a sharp
concavity in the expiratory phase. The four COPD waveforms are designated as WF1, WF2,
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WF3 and WF4 with the healthy waveform labelled as WF5 (dotted plot). It is noticeable that
they vary in frequency and amplitude.
7.2.2 Normalization of waveforms
All the waveforms were normalized to the same tidal volume and respiratory rate via a linear
rescaling of time axis followed by a linear rescaling of the flow rate axis using different
scaling factors for inspiratory and expiratory phases. Also, the inspired volume was matched
to the expired volume. Two groups of breathing flow waveforms were obtained by scaling
each breathing flow to two different I:E ratios i.e. 0.67 (IE1-group) and 0.43 (IE2-group),
which corresponded to inspiratory time fractions of 40 % and 30 %. The fall in I:E ratio
from 0.67 to 0.43 is 35 %. The breathing flow patterns in the IE1-group and IE2-group
are respectively shown in Fig. 7.1b and Fig. 7.1c. Two different I:E ratios were needed to
investigate the effect of I:E ratio on EtCO2. I:E ratio difference > 30 % was hypothesized
to be sufficient to elicit a change in EtCO2. The choice of I:E ratios were not without
justification as Tobin et al. (1983) reported an I:E ratio of 0.72 ± 0.031 for healthy adults
and 0.53 ± 0.046 for adult COPD patients.
7.2.3 Experimental setup
The experimental set-up is identical to that shown in Fig. 6.1b (Chapter 6). The same adult
upper airway model (Fig. 6.1a, Chapter 6) - in closed mouth state - was used. A mixing test
was conducted by placing a wire-gauze (to enhance mixing) at the entrance of the PP. This
yielded no significant difference in EtCO2 (< ± 3 %). The volume of the piston chamber
at the end of expiration (functional residual capacity) was maintained at 2500 ml for all
experiments.
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(a) All breathing flow patterns (before scaling)
(b) All breathing flow patterns normalized to IE1
(c) All breathing flow patterns normalized to IE2
Fig. 7.1 (a) All waveforms before scaling (b) IE1-group of flow waveforms (c) IE2-group of flow waveforms
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7.2.4 Experimental procedure
The healthy adult breathing flow (in IE1-group) was reproduced in the UAM. Metabolic
CO2 production was simulated by bleeding CO2 at a flow rate of 98 scc/min (at a 20 KPa
CO2 source pressure) into the piston chamber of the PP. The end-tidal (EtCO2) at this setting
was 5.4 % ± 0.3, which is comparable to the EtCO2 of a resting healthy adult. CO2 data
was recorded before (zero-therapy, ZT) and during the application of 30 L/min of NHF. An
identical procedure was performed for all other waveforms with 6 repetitions for each.
7.3 Results
7.3.1 EtCO2 with and without NHF
The capnogram was recorded for 20 consecutive breathing cycles for each experimental
repeat. The 20 cycles of capnogram in repeat one (for healthy waveform (WF5) in IE1-
group) have been superimposed and cascaded with those of the other repetitions as shown in
Fig. 7.2a. The variations in EtCO2 from cycle to cycle is due to mixing. Fig.7.2b shows the
average of all 120 capnograms (20 cycles in each of the 6 repeats) for the WF5 (in IE1-group)
with and without NHF. An identical plot is shown in Fig. 7.2c for the WF4 waveform (COPD
waveform). Note the characteristic ’shark fin’ shape of the COPD waveform (which is due
to airway obstruction (Mieloszyk et al. (2014))). The spontaneous breathing plots for a no
NHF condition in Fig. 7.2b and Fig. 7.2c show a minimum CO2 concentration of about 0.2
% which is due to rebreathing of dead space CO2 during inspiration. Note how this falls to
0.04 % (atmospheric CO2 concentration) when NHF of 30 L/min is applied. This indicates a
reduction in re-inspired dead space CO2 by NHF, which is in line with findings in Chapters 5
and 6, and together support the washout mechanism of NHF proposed by Dysart et al. (2009).
In Fig.7.2b and Fig. 7.2c the EtCO2 falls by approximately 20 % when NHF of 30 L/min is
applied.
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(a) A train of 6 capnograms for WF5, 20 cycles in each
(b) Average of 120 capnograms with and without 30 L/min of NHF for WF5
(c) Average of 120 capnograms with and without 30 L/min of NHF for WF4
Fig. 7.2 (a) A train of 6 capnograms for the healthy waveform (WF5) (b) Average of 120 capnograms for
WF5 (c) Average of 120 capnograms for WF4
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The average EtCO2 (of 120 capnograms) for each waveform (in both IE1-group and
IE2-group) have been presented in Fig. 7.3. The error bars represent two standard deviations
in EtCO2. In Fig. 7.3, the EtCO2 vary slightly between waveforms (e.g. see IE1-group
waveforms) however the error bars overlap. Also, a difference in EtCO2 and error bar overlap
is seen in the pairs of plots belonging to the same waveform (e.g. see label WF4 - IE1-group
and IE2-group pair).
Fig. 7.3 A plot of the average EtCO2 of 120 capnograms associated with flow waveforms in both groups
(IE1-group and IE2-group). The errorbars represent two standard deviations in EtCO2 over the 120 capnograms
The present finding shows that the characteristic shape of the COPD capnogram (’shark
fin’) - due to airway obstruction - can be reproduced from the corresponding breathing flow
pattern. This supports the clinical reports that the breathing flow pattern is modified by
airway obstruction (Williams et al. (2013)) which in turn affects the shape of the capnogram
(Mieloszyk et al. (2014)). Though error bar overlap in EtCO2 are observed amongst flow
patterns of the same I:E ratio it is not conclusive if this means no statistically significant
difference in EtCO2. In what follows a test of statistical difference in EtCO2 is performed.
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7.3.2 Test of statistical significance
A single factor Anova test was performed to find if the difference in EtCO2 was statistically
significant amongst waveforms of the same I:E ratio. Further, a two-sample t-test (assuming
unequal variances) on pairs of EtCO2 belonging to the same waveform but differing in I:E
ratio was performed. In both tests, the critical value to confirm the null hypothesis was set to
0.02. The results are presented in Table 7.1, which shows evidence of statistically significant
difference in EtCO2 (p-value < 0.02) within the same group of I:E ratio (single factor Anova
test, Table 7.1). Except for WF4, I:E ratio made a statistically significant difference in EtCO2
(p-value < 0.02) in pairs belonging to the same I:E ratio (two-sample t-test, Table 7.1). WF4
was not distinct in characteristics from the other waveforms.
Table 7.1 Results of a single factor Anova test and a two-sample t-test







IE1 259 4 65 20 0.0001
IE2 84 4 21 5 0.0006
two-sample t-test
WF1 WF2 WF3 WF4 WF5
p-value 0.003 0.0001 0.002 0.05 0.002
Another two-sample t-test was performed for each I:E ratio group to find the specific
pairings of flow waveforms that showed statistically significant difference in EtCO2. Note
that 5 flow waveforms will yield 10 pairs in each I:E ratio group. The results are presented
in Table 7.2 in which 7 pairs (70 % of 10 pairs) - in bold ink - show statistically significant
difference in EtCO2 (p-value < 0.02) within the IE1-group. Only 4 pairs (40 % of 10 pairs)
in the IE2-group have statistically significant differences in EtCO2.
It is concluded that the differences in EtCO2 of waveforms that are similar in all but
pattern are statistically significant (p-value < 0.02) (a single factor Anova test, Table 7.1).
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IE1 0.068 0.000 0.048 0.017 0.000










IE1 0.08 0.000 0.000 0.000 0.000
IE2 0.036 0.031 0.015 0.013 0.49
Also, EtCO2 is sensitive to I:E ratio as 4 out of 5 flow waveforms (WF1, WF2, WF3 and WF5
but not WF4) showed a statistically significant difference in EtCO2 (p-value < 0.02) (two-
sample t-test, Table 7.1). Furthermore, it is deduced from Table 7.2 that though statistically
significant disparities in EtCO2 was found in each group (Table 7.1), intragroup differences
in EtCO2 in the higher I:E ratio group (IE1-group, I:E ratio = 0.67) was greater (70 %) than
in the lower I:E ratio group (IE2-group, I:E ration = 0.47) - only 40 % of the pairs showed a
significant difference in EtCO2.
7.3.3 Shape parameter and EtCO2
Harmonic distortion (Hd) describes the degree to which a periodic signal deviates from a










where Hn is the root-mean-square amplitude of the nth harmonic (found using Fourier
decomposition) of the waveform. n = 25 was used as beyond this, changes in Hd was found
to be insignificant. Hd was computed for the entire breathing cycle, for the inspiratory phase
and then the expiratory phase. EtCO2 correlated better with a product of the inspiratory
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Hd and the peak inspiratory flow. This product is designated as ID f . The EtCO2 and their
corresponding ID f are presented in Fig. 7.4. The Spearman’s correlation coefficient (ρ)
and error (2 standard deviations) in the measurement of EtCO2 are also shown in Fig. 7.4.
The coefficient of determination (R2) (0.75 and 0.88) and ρ (0.9 and 1) indicate a strong
correlation between ID f and EtCO2 (see Fig. 7.4). It is not clear what implication this has
for breathing.
Fig. 7.4 plot of EtCO2 against IDf
In Eq. 7.2, average[EtCO2]IE2 and average[EtCO2]IE1 are respectively, the average
EtCO2 in the IE1-group and IE2-group. Using the formula in Eq. 7.2 the average EtCO2 of
the IE2-group was found to be 2 % greater than that of the IE1-group. It is concluded that a
35 % fall in I:E ratio (percentage difference between the I:E ratio of 0.67 (IE1-group) and




The coefficient of variability, defined as the ratio of the standard deviation in EtCO2 within




7.4.1 Effects of waveform shape
NHF reduces physiological dead space and respiratory frequency, and improves gas exchange
(Dysart et al. (2009); Mündel et al. (2013); Riera et al. (2013)). The fall in EtCO2 (≈
20 %) upon the application of 30 L/min of NHF supports the report that NHF improves
gaseous exchange by reducing the proportion of CO2 in re-inspired dead space air (Dysart
et al. (2009)). The present data suggests that breathing flow waveforms of different patterns,
but similar in tidal volume, period and I:E ratio show statistically significant differences in
EtCO2. Further, the results indicate that two breathing waveforms that differ only in I:E ratio
can produce different EtCO2. It is more probable (70 %) to find a statistically significant
difference in EtCO2 between a group of waveforms (differing only in pattern) which have a
greater I:E ratio than those of a lower I:E ratio (40 %).
To preserve tidal volume, a fall in I:E ratio (longer expiration, shorter inspiration) is
matched by a rise in peak inspiratory breathing flow and a fall in peak expiratory breathing
flow. It is reasonable to expect a higher EtCO2 with a lower I:E ratio as a longer expiratory
time suggests more CO2 retention. In Fig. 7.3, the EtCO2 corresponding to the lower I:E ratio
i.e. 0.46 (IE2-group) tended to be greater. Tobin et al. (1983) observed that the inspiratory
time (Ti) of 28 COPD subjects (mean age = 67.5 years) was 1 second less than that of healthy
adults. Sorli et al. J et al. (1978) concluded that CO2 retention (marked by higher EtCO2) in
COPD patients is due to shallow breathing, which arises from reduced Ti. This is in unison
with the observation by Gorini et al. (1996) who found the highest arterial partial pressure of
CO2 amongst COPD patients with the smallest Ti. IE1-group and IE2-group differed in Ti
by 0.43 seconds. In the present data, a fall in I:E ratio by 35 % (0.67 to 0.43) corresponded
to 2 % rise in EtCO2. Though the present results agrees qualitatively with findings in the
literature (Gorini et al. (1996); J et al. (1978); Tobin et al. (1983)) it is concluded that the fall
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in EtCO2 due to a fall in I:E ratio by 35 % is small (2 %). The variability in EtCO2 due to
flow pattern difference was 1 - 2 %, though statistically significant, it is also small.
The product of inspiratory flow and inspiratory harmonic distortion (ID f ) correlate
appreciably with EtCO2. The expiratory breathing flow has been reported to be modulated
by the inspiratory flow pattern (Frey et al. (2001)) and inspiratory muscle dysfunction has
been observed to increase EtCO2. Bégin and Grassino (1991) found that airway resistance
correlated well with arterial CO2 tension (also correlates well with EtCO2). In a study by
Loveridge (1984) healthy subjects were observed to show a greater variability in breathing
pattern than COPD subjects. Since airway obstruction during COPD influences the flow
pattern (by changing its shape and height) and EtCO2, ID f is speculated to be an index
related to the ventilatory response to CO2 tension.
7.4.2 Limitations of this work
The piston chamber is rigid, unlike the physiologic lung which is compliant (lung compliance
is ≈ 200 mL/cmH2O for healthy young adults). Note that a constant bleed rate differs from
the physiologically realistic system in which CO2 flow is distributed over time. Also, this
work is limited by the number of breathing flow patterns used.
7.5 Conclusion
Breathing patterns similar in tidal volume, respiratory rate, and I:E ratio but differing in
shape can produce statistically significant difference in EtCO2 however the variability can be
small (1 - 2 %). Further a 35 % fall in I:E ratio of breathing waveform with no change in tidal
volume and respiratory rate produce only a 2 % rise in EtCO2. NHF reduces EtCO2 by 20 %.
Chapter 8
Effect of NHF on CO2: A Mathematical
Model
8.1 Introduction
Gray (1951) introduced the multiple factor ventilation control theory in which pulmonary
ventilation was independently modulated by O2, CO2 and blood pH, unlike earlier models
where only one of these was thought to be the primary stimulant of ventilation. Gray’s model
was limited to steady state ventilation. Grodins et al. (1967), Defares et al. (1960), Milhorn
et al. (1965) and other workers extended the work of Gray (1951) by including equations
which described "chemical transport, concentration equilibria and blood flow behavior" to
predict the dynamic changes in ventilation (Grodins et al. (1967)).
Quite simple models (no respiratory control dynamics, steady state assumed) have also
been used to explain respiratory phenomenon. For instance, Chilton and Stacy (1952) used a
one compartment (lungs only) model in which the mass balance equations of CO2 and O2 in
the lung and lumped pulmonary blood capillaries were used to predict alveolar CO2 tension.
Also, Swanson and Sherrill (1983) and Benallal et al. (2002) used a two compartment model
(dead space and lung control volumes), assuming a steady CO2 and O2 exchange rates, to
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predict end-tidal (EtCO2) and arterial CO2 gradient during rest and exercise. In these models
instantaneous mixing of CO2 with pulmonary air was assumed. Unlike the one compartment
model, the two compartment model allows for the prediction of CO2 tension in the dead
space and the examination of how the dead space volume influences both alveolar and dead
space CO2.
To date, the numerical study by Van Hove et al. (2016) (see Chapter 5) and Kumar
et al. (2015) represent the only attempts to describe the mechanism of action of NHF using
computational fluid dynamics (CFD). Both studies investigated the influence of NHF on
airway pressure but Van Hove et al. (2016) further investigated NHF-induced CO2 flushing
from the nasal cavity. These numerical studies were limited to a healthy adults’ tracheal flow
and did not consider particular disease cases.
The present work was motivated by the desire to predict changes in alveolar and dead
space gas fractions when NHF is applied, with a simple model and without computationally
expensive iterative calculations. The speed of solution and flexibility of such a model was
thought to offer a useful tool for explaining how NHF may be beneficial to central sleep apnea
and COPD patients. The results for the dead space CO2 simulation were then compared to
the bench-top experimental results reported in Chapter 6.
8.2 Method
8.2.1 Model setup
A two compartment model identical to that used by Swanson and Sherrill (1983) and Benallal
et al. (2002), but refined (addition of NHF and compartmentalized dead space unit) for the
present purpose, was used. The model comprises two compartments, a dead space unit and
the alveolar unit (Fig. 8.1). The dead space unit represents the volume of all airway regions
where gaseous exchange does not occur whilst the alveolar unit represents the combined
volume of lung regions that exchange gas with pulmonary capillaries. A major addition to
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the present model is the sub-division of the dead space volume into several control volumes
(numbering 1, 2, 3 . . . N-1, N), forming a one-dimensional mesh (of size N) on which fluxes
are calculated using the finite volume approach. Compartmentalization allows for the study
of gas concentration in specific areas (e.g. the trachea) and makes the model more physical
as it takes a finite time and volume for CO2 to mix with air. The labels, fdCO2 , fACO2 , VA (t),
Vd and F (Fig. 8.1) respectively represent dead space CO2 fraction, alveolar CO2 fraction,
alveolar volume, dead space subcompartment volume and breathing airflow. Fnh f is the
applied NHF flow rate. The volume of the dead space (all subcompartments together) is
denoted as VD.
8.2.2 Gas exchange equations
The pulmonary capillaries are also lumped into one unit, which exchanges O2 and CO2 with
the alveolar compartment. The system of equations which describe gas exchange (Eq. 8.1 to
Eq. 8.7) assume the following:
• There is no gas diffusion across the walls of the dead space
• There is instantaneous mixing of gas within the alveolar unit
• Metabolic CO2 production and O2 exchange occur at a constant rate.
V̇O2 and V̇CO2 (Fig. 8.1) are the O2 and CO2 fluxes across the blood gas interface and have
values of 0.0035 L/s and 0.005 L/s (Benallal and Busso (2000)) respectively at steady state.
The rate of accumulation of CO2 fraction in the first dead space unit, the one nearest the






F [ f iCO2 − ( f dCO2)1]
Vd
(8.1)
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Fig. 8.1 A two-compartment model of the respiratory system (adapted from Benallal et al. (2002))
where f iCO2 is the inspired CO2 fraction from the atmosphere. The accumulation of CO2
fraction in the subsequent dead space compartments and the alveolar unit are respectively
















where the index n = 1,2,3. . . N respectively represent the first, second, third up to the last
dead space control volume (N). QA is the total gas flux into the alveolar unit at any given
time and is defined by the conservation of mass (Eq. 8.4). Eq. 8.1 - 8.3 represent convective
fluxes from one subcompartment to the next with diffusion assumed to be negligible in the
dead space.
QA = F −V̇O2 +V̇CO2 (8.4)
The rate of change of CO2 fraction in the alveolar unit, the dead space compartment
closest to the alveolar unit, and the subsequent dead space compartments during expiration




















F [( f dCO2)n − ( f dCO2)n−1]
Vd
(8.7)
where n = N, N-1, N-2,. . . .3, 2, 1. The equations describing O2 transport are identical in
form to Eq. 8.1 through Eq. 8.7 (which are for CO2 transport).
The volume of the airway from the nostril up to the end of the trachea is about 80 ml
(which is about half of the dead space volume of 150 ml) (Leader et al. (2004); Zheng
et al. (2000)). Gas was sampled from the model trachea (n = 20). In the experimental work
conducted to validate the results from the present model, gas was sampled at the tracheal.
Note that mixing is essentially instantaneous in each subcompartment and this can lead to
unphysically high transport rates unless sufficient compartments are used. By having too
few compartments and instantaneous mixing throughout a compartment, the rate at which
changes in CO2 concentration are communicated downstream is unphysically high, though
the overall transport rate will be correct (injected CO2 will be transported too fast, but also
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diluted too much). Where reference is made to the nostril it is in regards to the first dead
space control volume (n=1).
8.2.3 Lung mechanics
In the setup of the lung mechanics, the following assumptions were made:
• The rate of change of lung volume is equal to the breathing flow i.e. the air is
incompressible
• The pleural pressure is equally distributed over the lung
• The lung is homogenous and has equally distributed elastance
Alveolar volume (VA (t)) varies with the driving function, which is the pleural pressure (Ppl).
The Ppl , which is defined in terms of other lung parameters (of the form used by Ben-Tal
(2006)) as shown here in Eq. 8.8 was used in this model.









where Patm, R, Vt , E and FRC respectively denote the atmospheric pressure, linear airway
resistance, tidal volume, lung elastance and functional residual capacity for which estimates
are available. The values of these parameters are specified in Table 8.2.
The flow of air, F during breathing is defined as the rate of change of alveolar volume,





Inspiratory flow commences when the alveolar pressure (PA) is lower than the atmospheric
pressure (Patm). A higher PA is however required to drive expiration. The relationship












The system of ordinary differential equations (ODEs) defined by Eq. 8.1 through Eq.
8.10 were solved using the ODE solver, odeint , implemented in python 3.5. A timestep of
0.05 seconds was used for the simulation (no significant change in CO2 was observed with
lower values). Table 8.1 summarizes all the quantities that can be predicted with the present
model. All parameters used in the present model along with their values are presented in
Table 8.2.
Table 8.1 A list of quantities predicted by the model
Quantity Parameter
Gas exchange
fdO2 Dead space O2 fraction
fAO2 Alveolar O2 fraction
fdCO2 Dead space CO2 fraction
fACO2 Alveolar CO2 fraction
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Table 8.2 Inputs to the model
Quantity Symbol value Reference
O2 exchange flux Do 0.005 L/s Benallal et al. (2002)
Metabolic CO2 flux Dc
0.004
(L/s)
Benallal et al. (2002)
Initial alveolar O2
concentration iCo2 0.136 Ben-Tal (2006)
Initial alveolar CO2






concentration PatmO2 21 % Ben-Tal (2006)
Atmospheric CO2
concentration PatmCO2 0.04 % Benallal et al. (2002)
Vapor pressure of
H2O @ 37◦
pw 47 mmHg Ben-Tal (2006)
Dead space volume Vd 0.15 L Benallal et al. (2002)
Tidal volume Vt 0.5 L Tobin et al. (1983)
Breathing period T 4.35 s Tobin et al. (1983)
Functional residual
capacity FRC 2.5 L Benallal et al. (2002)
Lung elastance E 8
cmH2O/L
Otis et al. (1950)
Linear resistance R 2
cmH2O/L/s
Sharp et al. (1964)
Nasal high flow NHF 0-60 L/min Ward (2013)
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8.3 Results
8.3.1 Healthy adult breathing
The PPl and PA for a healthy state are presented in Fig. 8.2. PPl starts falls from -7.3 cmH2O
at the start of inspiration to -12.7 cmH2O at the end of inspiration (Fig. 8.2) and over this
period, alveolar pressure falls to a peak of -1.5 cmH2O, returning back to (atmospheric
pressure) by the close of inspiration. The breathing flow pattern, tidal volume profile and
Fig. 8.2 Forcing function (pleural pressure) and the predicted alveolar pressure
PPl versus tidal volume loop are shown in Fig. 8.3. It is seen that the breathing flow has an
I:E ratio of 1 which is unphysical. This is recognised as a limitation which can be addressed
by defining a pleural pressure (driving function) which can produce a breathing flow with
physiological I:E ratio. This limitation may affect EtCO2 as seen in Chapter 7. It is however
observable that the breathing flow and alveolar pressure patterns are similar. The tidal volume
profile reaches a peak of 0.44 L by the end of inspiration. The area enclosed by the PPl versus
tidal volume loop denote the total work of breathing (elastic plus resistive).
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Fig. 8.3 Breathing flow, tidal volume profile and pressure-volume curve
The dependency of the O2 and CO2 partial pressures (sampled from the trachea, n = 20)
on dead space mesh size (number of control volumes of the dead space) was explored. The
capnograms obtained by setting the mesh size (N) to 2, 10, 20, 30 and 40 are indicated in
Fig. 8.4. The difference in peak CO2 concentration between N = 30 and N = 40 is 0.02 %.
Note that the plateau phase of a capnogram (Chapter 1, Fig. 1.8) indicates the expulsion of
mixed alveolar and dead space air. The increase in flatness of the plateau region (1.5 s <
time < 3 s) with mesh size shows that finer mesh increases rate of mixing of alveolar and
dead space gas. N = 30 was used.
In Fig. 8.5 the O2 (Fig. 8.5a) and CO2 (Fig. 8.5b) gas tensions in the alveolar unit, the
trachea (n = 16) and the nostril (n = 1) are shown for 25 breathing cycles. The model is
initialized to assumed CO2 and O2 concentrations which converge to a steady cycle after
50 seconds (12 cycles). Tracheal and nasal O2 peak values are equal to that in atmosphere
(150 mmHg). The minimum tracheal and nasal O2 tension approaches the mean alveolar
O2 tension (97 mmHg). The maximum alveolar O2 tension is about 100 mmHg and never
reaches the atmospheric value (760 mmHg). The tracheal and nasal CO2 peaks near alveolar
CO2 peak (pure lung air reaching trachea unmixed with fresh air) but do not reach it (42
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Fig. 8.4 Effect of mesh size on CO2 concentration
mmHg). The minimum tracheal and nasal CO2 tension nears atmospheric value (0.3 mmHg)
but the alveolar CO2 concentration never reaches this low.
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(a) Alveolar, tracheal and nasal O2 tension
(b) Alveolar, tracheal and nasal CO2 tension
Fig. 8.5 Peak alveolar, tracheal and nasal O2 are 97 mmHg, 150 mmHg and 150 mmHg. Corresponding
values for CO2 are 42 mmHg, 40.5 mmHg and 39 mmHg
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8.3.2 Validation
The tracheal concentration of CO2 obtained from the model has been compared to bench-top
experimental results conducted with the setup shown in Chapter 6. In the experiment, CO2
was bled at a rate of 98 scc/min (with CO2 source pressure maintained at 20 KPa) to produce
a CO2 concentration of 5.3 % in the trachea (equivalent to 40.3 mmHg).
Fig. 8.6 Simulated and experimental CO2 profiles during spontaneous breathing
The model and experimental capnograms were compared (Fig. 8.6). It is seen that the
EtCO2 concentration of both experiment and simulation agree and their rise and fall times
also agree. The CO2 profile of the model has a sharper rising phase than the experimental
CO2 profile though the slope of the falling phase are same for both. The instantaneous mixing
in the model and difference in metabolic CO2 flow rate between model and experiment may
account for this difference. The difference in flow patterns (See Fig. 8.7) may also be a factor.
Table 8.3 shows a summary of quantities pertinent to the healthy state, derived from the
plots shown in Fig. 8.3 and Fig. 8.5. Published data on these quantities are also presented.
Note that some of the references are from restricted populations and may vary for individuals.
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Fig. 8.7 Simulated and experimental flow profiles during spontaneous breathing
It is seen that the model results are realistic and comparable to simulated and physiological
findings of other workers.
Table 8.3 A comparison of model results to published data




150 153 Ferris et al. (1946)
end-tidal CO2














1.5 1.2 Sondergaard et al. (2003)
Pleural pressure
(cmH2O)
-7.2 to -12.5 -5 to -8 Guyton and Hall, 2006
Tidal volume (L) 0.44 0.5 Tobin et al. (1983)
Work of breathing
(J/breath) 0.28 0.24 Cabello and Mancebo (2006)
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8.3.3 Application of nasal high flow
In the lung, gas exchange occurs via molecular diffusion however expulsion of CO2 from the
lungs into the atmosphere predominantly occurs via advection. It has been experimentally
observed that when NHF therapy is applied, ‘the cannula jet drives the flow backward
through the upper portion of the nasal cavity until the flow turns in the nasopharynx and
flows forwards along the nasal cavity floor’ (Spence (2011)). The recirculation of air in
the nasal cavity augments mixing and the clearance of CO2 from the anatomic dead space
(Spence (2011)). This prevents the rebreathing of CO2-rich gas into the lungs. In a previous
collaborative work, Chapter 5 (see Van Hove et al. (2016)) a more sophisticated CFD model
was used to predict CO2 tension in the trachea. Here, a simple idea was explored. Spence
(2011) found that the velocity of the cannula flow decreases with distance from the nostril
towards the nasopharynx. Consequently, it was thought that only a fraction of the cannula
jet reached the nasopharynx, turned around, moved forward along the nasal cavity floor and
exited through the nostril. The remaining fraction exited via the nostril without reaching the
nasopharynx. This condition was modelled by adding a specified amount of the NHF rate
(3 %, 5 %, and 10 % were investigated) to the lung flow reaching the nasopharynx during
expiration (i.e. F+ Fnh f ) and substituting this into Eq. 8.9 (as shown in Eq. 8.11). NHF was
not added to the inspiratory flow as this would increase tidal volume. In the bench-top model










The EtCO2 for NHF of range 0 - 60 L/min, as sampled from the trachea (n = 20) is compared
with corresponding experimental results (Chapter 6) in Fig. 8.8. It is noticeable that modelling
the jet flow which flushes the nasopharynx as 3 % of NHF best agrees with the experimental
results for all NHF. The point-by-point deviation of the model results from the experimental
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Fig. 8.8 Prediction of EtCO2 during NHF. Continuous lines represent model predictions and dashed line
represents experimental observation










where J and i are the number of data points and data index respectively. The RMSD using
3 % NHF, 5 % and 10 % of NHF were found to be 8.4, 8.6, and 15.5 respectively. 3 % of
NHF flow was used. It is noted that the NHF geometry of the airway at certain points in
the physical upper airway may promote turbulence and enhance mixing. Such a property is
missing in the present model. Also, modelling of turbulent mixing between the cannula jet
and surrounding air is absent.
In Fig. 8.9, the model and experimental capnograms at NHF of 30 L/min are shown. The
experiment and simulation agree in terms of EtCO2 (0.1 % (v/v) difference), and rise and fall
times. The sharp rise of the model capnogram relative to experiment is due to difference in
mixing.
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Fig. 8.9 Simulated and experimental CO2 profiles for 30 L/min NHF
8.3.5 Central sleep apnea
Central sleep apnoea is the cessation of breathing when the blood CO2 tension falls below the
breath-activation threshold. This may occur for several seconds. In Chapter 6, the maximum
EtCO2 for CSA of durations of 10 seconds (CSA10), 20 seconds (CSA20), 30 seconds
(CSA30) and 40 seconds (CSA40) were investigated for no NHF and NHF ranging from 10
L/min to 60 L/min using a bench-top setup. A similar results obtained from the mathematical
model is presented in Fig. 8.10. The alveolar and tracheal EtCO2 reach a steady state at time
= 50 seconds (12 cylces). The initiation of apnea at time = 170 seconds (Fig. 8.10) produces
a steady rise in alveolar CO2 tension with the peak value depending on the duration of the
CSA. When breathing resumes, the maximum EtCO2 is produced by the first breath. The
EtCO2 then falls steadily and reaches the steady value prior to CSA.
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(a) Alveolar and tracheal CO2 profiles during CSA10
(b) Alveolar and tracheal CO2 profiles during CSA20
(c) Alveolar and tracheal CO2 profiles during CSA30
(d) Alveolar and tracheal CO2 profiles during CSA40
Fig. 8.10 Alveolar and tracheal capnograms during CSA of 10 to 40 seconds
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8.3.6 Validation
A plot of the maximum EtCO2 for CSA10 to CSA40 at NHF of 0 - 60 L/min have been super-
imposed on the experimental results (Fig. 6.4 of Chapter 6) as shown in Fig. 8.11. The error
bars represent 2 standard deviations in measurement of maximum EtCO2 over 120 cycles.
The results from the mathematical simulation agree in trend with the experimental results
Fig. 8.11 Peak CSA CO2 tension versus NHF obtained via simulation and experiment
(maximum EtCO2 reduces with NHF). Quantitatively, the mathematical model predicts the
experimental results quite well. The amount of NHF reaching the nasopharynx was assumed
to be 3% for all NHF.
At NHF = 0 (Fig. 8.10) EtCO2 is noted to rise from 40 mmHg to 62 mmHg during
CSA-40 (over 40 seconds) which corresponds to a rise rate of 0.6 mmHg/second. CO2 rise
rates have been reported to range from 0.001- 0.2 mmHg/second (Patel et al. (2011); Stocks
and Godfrey (1978)). It is however reported during apnea, arterial CO2 rises sharply in the
first minute after which it gradually plateaus towards a saturation value (Stock et al. (1989)).
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The difference may be due to buffering of arterial CO2 by bicarbonates (absent in the present
model) and constant CO2 flow rate used in the present model unlike the diffusion-driven flow
in the physiological system.
8.4 Discussion
The need to predict the EtCO2 tension when NHF is applied was a motivation for this work.
The capnogram predicted by the mathematical model and experiment (for both spontaneous
and NHF breathing) agreed in EtCO2, morphology and rise and fall times. The slope of the
falling edge also agreed however due to mixing the slope of the rising edge was sharper for
the model capnogram. The mathematical model assumes instantaneous mixing in alveolar
chamber.
The experiment and mathematical model produced EtCO2 tensions of about 37 mmHg (5
% concentration) during spontaneous breathing. This value is within the physiological range
(35 - 40 mmHg) for healthy adults (Ritchie et al. (2011)). The mean alveolar CO2 fraction of
40 mmHg falls within the reported physiological range of 35 mmHg to 45 mmHg (Allen and
Jones (1984)). During spontaneous breathing, the mean arterial CO2 partial pressure (PaCO2)
approximates the mean alveolar CO2 partial pressure (PACO2) (Benallal et al. (2002)).
A simple assumption was made that a fraction of NHF flow (3 %) reaches the nasopharynx,
returns and adds to the expiration flow to flush the nasopharynx and nasal cavity of CO2
convectively. The predictions of EtCO2 made by the model (during NHF administration)
appreciably agreed with experimental results. The model predicted the maximum EtCO2
during apnea quite well for apnea of durations 10, 30 and 40 seconds. The rise rate of
EtCO2 over an apnea time of 40 seconds was found to be the same order of magnitude as
clinically observations (Patel et al. (2011); Stock et al. (1989); Stocks and Godfrey (1978)).
A mathematical model for turbulence diffusion in the nasal cavity may improve the present
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results. Limited time did not allow the inclusion of such a model. Addition of such a model
will eliminate the current value of 3 % of NHF reaching the nasopharynx.
8.4.1 Limitations of the model
The alveolar partial pressure of CO2 depends on alveolar ventilation and metabolic CO2 pro-
duction. In both experimental and mathematical models, the CO2 bleed rate was assumed to
be constant though in the physiological system it varies depending on the bodies metabolism.
Also, in the physiologic system, the alveolar CO2 is influenced by CO2 gradient between
pulmonary capillaries and the alveolar unit. Furthermore, blood transport delays from the
heart to the alveoli, and equations describing, biocarbonate chemistry, oxygen binding and
dissociation with haemoglobin have not been included. Also, an abnormality in airway
geometry in the form of a protrusion can reduce dead space and introduce turbulence which
may improve mixing. The influence of geometry is however not incorporated into the model.
8.5 Conclusion
The two-compartment model predicts the CO2 profiles observed during spontaneous breath-
ing. Breathing under NHF conditions was modelled by adding 3 % of NHF flow to the
expiratory flow. The model EtCO2 results for apnea NHF ranging from 10 L/min to 60 L/min
were close to in vitro experimental results. Over an apnea time of 40 seconds, EtCO2 rose at
a rate of 0.6 mmHg/seconds, which agrees with clinical observations.

Chapter 9
Conclusions and Future Work
9.1 Conclusions
Nasal high flow (NHF) therapy has been reported to increase airway pressure and tidal
volume (Vt) but reduce respiratory rate (RR). How these findings affect the work done to
overcome airway resistance has been unclear. To fill this gap in literature, NHF was applied
via three different cannula sizes to 3-D printed neonate and the adult upper airway models
(in mouth closed and open state). Pressure drop and flow rate were measured and used
to estimate inspiratory and expiratory resistances. The resistance information was used to
compute the muscular work required to overcome the resistance to flow.
Airway pressure was found to increase with NHF in both neonate and adult models. The
large cannula produced the greatest tracheal pressure in the mouth closed breathing state
(adult model) corresponding to to a rise of 6 - 14 % (depending on flow direction and NHF)
relative to the small cannula. The medium and large cannula produced comparable tracheal
pressure. In the mouth open state (adult model), the small cannula produced the greatest
tracheal pressure in the range of 9 - 23 % (depending on NHF flow) relative to the large
cannula. The medium and small cannula produced comparable tracheal pressure. At all
NHF and all breathing flows, the tracheal pressure for mouth closed breathing was found to
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be about 3 times that of mouth open breathing. Mouth open breathing requires air leakage
via the oral passage and nasal passage (greater leakage area) which is accompanied by less
molecular gas collision (lower pressure) unlike mouth open breathing where all the flow exits
via the nasal passage (small leakage area, greater pressure). The upper airway resistance
in the inspiration direction was greater than during expiration. This was due to a greater
rate of change in pressure during inspiration. The ratio of expiratory to inspiratory tracheal
pressure increased with NHF for both mouth closed and open states. In mouth closed state,
tracheal pressure in expiration was higher than that of expiration by 9 %, 72 % and 103 %
respectively for NHF20, NHF40 and NHF60. In mouth open state, 11 %, 88 % and 125 %
corresponded to NHF20, NHF40 and NHF60. The upper airway resistance of the neonate
model was a factor of 4 greater than the adult model at peak inspiratory flow of 5 L/min and
30 L/min repectively for the neonate and adult.
NHF can provide part or all of the pressure required to drive the inspiration breathing
flow through the upper airway. This known as the ZPIF effect. This reduces inspiratory
work of breathing. Expiratory work of breathing increases with NHF as the momentum of
the NHF jet must be negated by the expiratory flow. Total work of breathing (inspiration
plus expiration) increases if minute volume does not change when NHF is applied. Work of
breathing reduces in NHF dependent manner if the RR and minute volume fall with NHF.
NHF has been observed to do so in COPD patients (Braunlich et al, 2013). A fall in minute
volume by 40 % reduced rWOB/min by 90 % (at NHF of 60 L/min) compared to a no NHF
condition. Work of breathing may fall further with a fall in I:E ratio. Mouth closed breathing
demanded 3 times the work of breathing as mouth open breathing (if minute volume is
assumed to for by the same amount for both mouth states). Neonatal work of breathing also
falls with minute volume.
A CO2 flushing mechanism (reduction in dead space CO2 concentration due to NHF ) is
believed to be responsible for the observed increase in oxygenation when NHF is applied.
An in vitro experiment using an anatomically accurate airway model and a physiological
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breathing waveform to find the change in end-tidal CO2 concentration with and without NHF.
The results showed that end-tidal CO2 decreased in an NHF-dependent manner until NHF of
40 L/min and plateaus. The CFD results of others (Van Hove et al. (2016)) show recirculation
in the anterior portion of the nasal cavity. This causes the CO2 rich gas to vent from the
nostrils reducing the CO2 concentration in the dead space and lowering the inspired CO2
volume (by 65 % at NHF of 60 L/min). This explains the fall in end-tidal CO2 concentration
in the in vitro experiment.
NHF is used to treat obstructive sleep apnea but its efficacy in relieving central sleep
apnea (CSA) patients has not been reported. It was thought that a reduction in end-tidal CO2
tension (EtCO2) during apnea can mitigate the frequency of apnea occurrence. A piston
pump drove a realistic breathing flow pattern through an upper airway model. Apnea intervals
of 10 - 40 seconds were mimicked with and without NHF. The maximum EtCO2 rose with
apnea duration, and at zero NHF its value for CSA of 10 and 40 seconds were 6.2 % (v/v)
and 8.2 % (v/v) respectively, which correspondingly reduced to 4.9 % (v/v) and 7 % (v/v)
when NHF of 60 L/min was applied. Note that the physiological EtCO2 for a healthy adult
is about 5.3 % (v/v). NHF of 60 L/min reduced EtCO2 (at CSA of 40 seconds) by 18 %.
Since EtCO2 reflects alveolar CO2 tension and a lower EtCO2 prior to CSA reduces the
susceptibility of individuals to CSA, it is concluded that NHF may reduce the spate of CSA
in patients. The rate of rise of EtCO2 (33 mmHg/min at CSA of 40 seconds) is noted to be an
order of magnitude higher than the rise rate reported in the literature (5 mmHg/min) (Patel
and Nouraei (2015); Stock et al. (1989)).
A rise in alveolar CO2 leads to a rise in ventilation which in turn reduces alveolar CO2
(negative feedback mechanism). It was speculated that, aside from breathing frequency
and tidal volume, the shape of the breathing waveform may be optimized to change EtCO2.
Thus, the goal was to find out if the breathing flow pattern alone can modify end-tidal CO2
(EtCO2) and if so, to what extent. Four breathing flow patterns belonging to Stage III COPD
patients and one healthy breathing flow pattern were collected. These were scaled to the
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same tidal volume, respiratory rate and I:E ratio, leaving flow pattern as the only varying
parameter. In vitro measurement of EtCO2 with and without NHF revealed that breathing
flow patterns varying only in shape can produce statistically significant difference in EtCO2.
The variability in EtCO2 was however found to be small (1 - 2 %). A 35 % fall in I:E ratio
(all other parameters kept the same) corresponded to a 2 % rise in EtCO2. It is concluded
changes in EtCO2 due to shape and I:E ratio are small.
A two compartment mathematical model was used to predict the airway capnogram, with
and without NHF. The capnogram predicted by the model agree in shape, EtCO2 and rise and
fall times. The effect of NHF was modelled by adding a fraction of the NHF flow reaching
the nasopharynx. The maximum EtCO2 due to apnea as measured from an in vitro studies
generally agreed with the model results.
9.1.1 Original contributions
• First estimation of upper airway resistance during NHF in an anatomically realistic
upper airway model (in the inspiration and expiration direction) which is impossible to
measure in vivo.
• First quantitative estimation of resistive work of breathing during NHF in an anatomi-
cally realistic upper airway model using clinically reported NHF-induced changes in
breathing parameters.
• First estimation of the effect of cannula size on airway resistance in an anatomically
realistic upper airway model. Such estimates are difficult to make in vivo.
• A predictive model for fall in end-tidal CO2 concentration with NHF. This estimates
alveolar CO2 concentration rate of rise during apnea, and rate of fall after breathing
recommences under NHF conditions.
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In the present study, the characterization of tracheal pressure was restricted to one airway
geometry of an adult and a neonate. The insight into how NHF affects airway resistance has
been profound, nonetheless a study looking into the variation of resistance across a human
age spectrum will be interesting as an anthropometric quantity (e.g. body mass, metabolic
rate or a linear dimension) that scales well with resistance coefficients may be found. This
will involve repeating the methods used in Chapter 3 and 4 for upper airway models of
different geometries and sizes. Also, the model would benefit from the inclusion of a wet
lining to mimic mucus, compliance in soft palate and tongue would be a benefit. It will also
be interesting to find how resistance varies in models of the same geometry but different
sizes. Further, identifying areas of the airway that provide the most variation in resistance
in disease state will be insightful. This can be accomplished by making measurements in a
range of geometries including different obstructive and resistive disease states.
In a future study, instead of using separate sinusoids for inspiration and expiration, the
development of a single mathematical equation which describes breathing flow, and whose
parameters can modify I:E ratio, tidal volume and respiratory rate will be sought. Where this
equation is found to have a direct integral, it will be easy to deduce a simple approximate
algebraic mathematical formula that predicts work of breathing under NHF conditions given
the resistance coefficients. Such a simple formula will be preferred to using the Fourier
decomposition of the breathing pattern and solving it numerically.
In the present work, the tracheal pressure and upper airway resistance during mouth close
and open breathing were investigated. In the mouth open breathing state, the nasal and oral
resistance act as two resistors in parallel configuration. In a future work, it will be insightful
to know the relative contribution of the oral resistance to the total.
The present work supports the conclusions of Groves and Tobin (2007); Parke et al.
(2009) that the upper airway pressure rises with NHF but it is unclear how this translates to
and increase in end-expiratory volume (functional residual capacity) (Gotera et al. (2013)).
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The rise in lung impedance in the work of Corley et al. (2011) and Riera et al. (2013) who
used the electrical lung impedance tomography was interpreted as a rise in end-expiratory
volume. It is however unclear how impedance is related to end-expiratory volume. It will be
interesting to know the amount of positive distension pressure in the different generations of
the small airways. In this regard, joining a 3-D printed bronchial tree to the trachea of the
upper airway model used in this work may be a good starting point. Using the estimated
compliance and surface tension of an aveolus, pressure data from such an experiment can be
useful in exploring the degree to which NHF prevents alveolar atelectasis. Such an in vitro
setup can allow for the measurement of lower airway resistance under NHF conditions.
In tests associated with the measurement of tracheal CO2, CO2 was metered via a bleed
valve in the piston pump chamber at a constant flow rate. It will be physiologically more
accurate to drive CO2 bleed rate via diffusion such that a rise in piston chamber CO2 tension
will modulate the rate of flow. This can be achieved with a microcontroller-operated solenoid
valve. With such a setup, a nonlinear rise in CO2 may be observed instead of the linear rise
in CO2 tension with apnea duration. Conclusions drawn from Chapters 5 through Chapter 7
may remain same qualitatively but not quantitatively as the end-tidal CO2 with and without
CO2 are likely to change. As a limitation only 5 waveforms were used to investigate the
effect of flow pattern on end-tidal CO2 tension in chapter 7. The use of more waveforms will
be desirable as it will improve the quality of the findings.
In Chapter 8, NHF was modelled by assuming that 3 - 5 % of jet flow reaches the
nasopharynx and adds to the expiratory breathing flow. This assumption can be dispensed by
including a mathematical model of turbulent diffusion into the system of equations developed
for the dead space volume where recirculation current (which promotes turbulent mixing)
have been observed (Spence (2011)). In the current model, CO2 influx into the alveolar
space was fixed at a constant rate as was done in the in vitro experiment. To make the
model physiologically more accurate a metabolic CO2 diffusion flux (driven by concentration
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gradient), blood transport delays from the heart to the alveoli, and equations describing,
biocarbonate chemistry, oxygen binding and dissociation with haemoglobin must be included.
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CO_2data = coo_data(:,2); %load CO2 data
data_time = coo_data(:,1); %load time data
data_length= length(CO_2data); %define number of data points
tc = 190/1000; %Define time constants
non_dispersed_laplace = CO_2data(2:data_length) + (diff(CO_2data)./diff(data_time)).*tc;
non_dispersed_laplace = cat(1,CO_2data(1),non_dispersed_laplace); %Put time and CO2 data together
deconv_coo = cat(2,data_time,non_dispersed_laplace) ; % Deconvoluted signal
end
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A.2 Python script for mathematical model
# -*- coding: utf-8 -*-
"""
Created on Sun Jul 30 22:14:50 2017
"""
import matplotlib.pyplot as plt
from scipy.integrate import odeint
import numpy as np
#Function in which Equations of models are defined
def odefn(x,t,PL,dPLdt,Pm,t1,N,E,frc,R,pw,k1_i,k2_i,k1_e,k2_e):
’’’
list of parameters and variables
=================================
PL = pleural pressure
dPLdt = derivative of pleural pressure
Pm = Pamt = Atmospheric or mouth pressure
t1 = time range for simulation
N = number of compartments
E = elastance
frc = functional residual capacity
R = linear resistance
pw = vapor partial pressure of water
K1_i,K2_i,K1_e,K2_e = resistance coefficients for inspiration and expiration
nhf = nasal high flow therapy
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PA = alveolar pressure
’’’
NHF = 0
nhf = 0.03*NHF/60 #+ 0.05*(0.08*NHF/60) #(in l/s)
PA = x[0]; #Lung Mech
fo= x[1]; #Alveolar O2 fraction
fc= x[2]; # Alveolar CO2 fraction
fdo= x[3:N+3]; #Dead space O2 fraction




#interpolate pleural pressure derivative
pl = np.interp(t,t1,dPLdt)
Pl_i = np.interp(t,t1,PL)
#Use resistance coefficients to estimate flow
if Pm-PA >=0 : #If inspiration
Coef = [k2_i , k1_i , -(Pm-PA)] # Coefficients of 0 = K1*q +K2*q^(2)-P
RoOT = np.roots(Coef) # Function to determine roots
cl = RoOT > 0 # select index of positive part
q = np.select(cl,RoOT) # select positive flow
else : #If expiration
Coef = [k2_e , k1_e , (Pm-PA)]
RoOT = np.roots(Coef)
cl = RoOT > 0





Vd = 0.15 #dead space volume
fo_atm =0.21 #atmospheric O2 fraction
fc_atm =0.0004 #atmospheric CO2 fracton
d_Vd = Vd/N #unit dead space volume
#Metabolic O2 and CO2 rates
coo_met = 0.0033; O2 = 0.005
frc = 2.5
QA1 = q+coo_met-O2




dPAdt = QA1*E*(Pm/PA)+ pl #Ode for alveolar pressure
dFod_dt= np.zeros(N) #array for ode for dead space O2 fracton






A.2 Python script for mathematical model 187
if 170 <t and t<190: #(e.g. 10 seconds: )
q=0
dPAdt = 0
#VA = frc #At apnea lung volume equals frc




#Inspiration (Dead space units)
if q >=0 : # Inspiratory condition #first unit is closest to mouth
dFod_dt[0]= q*(fo_atm-fdo[0])/d_Vd #O2 Ode for first dead space unit volume
dFcd_dt[0]= q*(fc_atm-fdc[0])/d_Vd #CO2 Ode for first dead space unit volume
for g in range(1,N):
if g <= round(0.5*N) :
dFod_dt[g]= q*(fdo[g-1]-fdo[g])/d_Vd #O2 ode for remaining DS units
dFcd_dt[g]= q*(fdc[g-1]-fdc[g])/d_Vd #CO2 ode for remaining DS units
else:
dFod_dt[g]= q*(fdo[g-1]-fdo[g])/d_Vd #O2 ode for remaining DS units
dFcd_dt[g]= q*(fdc[g-1]-fdc[g])/d_Vd #CO2 ode for remaining DS units
#Inspiration (Alveolar unit)
#===========
# Alveolar O2 ODE for inspiration
dFodt= (q*fdo[N-1]-O2-fo*(QA1))/VA
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# Alveolar CO2 ODE for inspiration
#-------------------------
dFcdt= (coo_met + q*fdc[N-1]-fc*(QA1))/VA
#Expiration (Alveolar units)
#============
if q<0: #expiration condition
q=abs(q)
q2= q+nhf
#Alveolar CO2 ODE for expiration
dFodt= (-O2 +q*fdo[N-1]+fo*(QA1))/VA
dFcdt= (coo_met -q*fdc[N-1]-fc*(QA1))/VA
#Expiration (Dead space units)
dFod_dt[N-1]= (q)*(fo-fdo[N-1])/d_Vd
dFcd_dt[N-1]= (q)*(fc-fdc[N-1])/d_Vd
for g in range(N-1,0,-1):












return ODe_Sys #Return system to solver
#_________________________________________________________________
#Function to solve ODE - initial conditions defined here
def ODE_SOLVER():
#Parameters
Pm =760 #Atmospheric pressure
frc =2.5 #Functional residual capacity
E =8; # Lung elastance
pw = 47; #vapor pressure of water at 37 degrees celsius
cf = 0.735 #cmH20 to mmHg
k1_i = 3.7*cf; k2_i = 4.1*cf # Inspiratory Airway resistance coefficients
k1_e = 3.5*cf ; k2_e = 2.9*cf # Expiratory airway resistance coefficients
t1 = np.arange(0,350,0.1) # time range definition344
dx = t1[1]-t1[0] #time interval
#______________________________________________________________________
#Forcing function (pleural pressure)
#______________________________________________________________________
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R =2; #airway resistance
w =2*np.pi/4.3; #Angular velocity
TV =0.47; #tidal volume
E1 =8 #Elastance
PL_ini = 756.8 # Initial pleural pressure




#Constants and Initial conditions
#_________________________________________________________
N=30 #number of dead space compartments
#initial co2 tension in dead space compartments
fdc_ini =(0.0042-0.0041)*np.random.random_sample((1,N))+0.00042
#initial O2 tension in dead space compartments
fdo_ini =(0.21-0.2)*np.random.random_sample((1,N))+0.21
y1 = np.append([Pm,0.10,0.05263],fdo_ini)
# All initial conditions put in one array
y0 = np.append(y1,fdc_ini)
# all parameters put into one array
Pmts=(PL,dPLdt,Pm,t1,N,E,frc,R,pw,k1_i,k2_i,k1_e,k2_e)
#*************************************
#Solve system of ODES using odeint













#Extract alveolar gas quantities
fo_alv = sol[:,1] # Extract alveolar O2 fraction
fc_alv = sol[:,2] # Extract alveolar CO2 fraction
PAO2 = fo_alv*(palv-pw) # Calculate alv. O2 partial pressure
PACO2 = fc_alv*(palv-pw) # Calculate alv. CO2 partial pressure
#Recomputing flow and volume as it was not returned by ODE solve
for d in range(1,len(palv)):
if Pm-palv[d]>0 :
Coef = [k2_i , k1_i , -(Pm-palv[d])]
RoOT = np.roots(Coef)




tV[d] = q*dx +tV[d-1]
else :
Coef = [k2_e , k1_e , (Pm-palv[d])]
RoOT = np.roots(Coef)
cl = RoOT > 0
q = np.select(cl,RoOT)
F[d] = -np.float(q)




# matplotlib qt # display plots in separate Window
t=t1 # assigning t1 to t
plt.close(’all’)
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plt.plot(t[r1:r2],PL[r1:r2]-760,’k-’)





































plt.title(’Tracheal O$_2$ tension ’,fontsize=16)
plt.xlabel(’Time, seconds’, fontsize=14)






plt.ylabel(’Nasal O$_2$ tension, mmHg’,fontsize=14)
# CO2 plots
plt.figure(4)






plt.ylabel(’Alveolar CO$_2$ tension, mmHg’,fontsize=14)
plt.subplot(1,2,2)







plt.ylabel(’Tracheal CO$_2$ tension, mmHg’,fontsize=14)
trach2= (760-pw)*sol[:,2+2*N -round(N/2)]
a=(100/760)*trach2[1430:1483]
a= np.transpose(a)
a.tofile(’mesh.csv’,sep=’\n’,format=’%10.5f’)
ODE_SOLVER()

